Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3011985	p-reninm	mu/l (mu/l)	3854	5835	0.46%
3011985	fp-reninm	mu/l (mu/l)	1032	1544	0.00%
3011985	p-reninm	— (—)	593	701	100.00%	Distribution not available
3011985	fp-renin	— (—)	152	183	100.00%	Distribution not available
3011985	fp-renin	mu/l (mu/l)	149	175	0.00%
3011985	fp-reninm	— (—)	115	136	100.00%	Distribution not available
3011985	fp-reniini,konsentraatio	mu/l (mu/l)	31	37	0.00%
3011985	p-reniinm	mu/l (mu/l)	24	27	0.00%
3011985	p-oreninm	— (—)	21	21	100.00%	Distribution not available
3011985	p-areninm	— (—)	21	21	100.00%	Distribution not available
3011985	p-vreninm	— (—)	19	19	100.00%	Distribution not available
3011985	p-reniini,konsentraatio	mu/l (mu/l)	11	11	0.00%
3011985	p-vreninm	mu/l (mu/l)	7	7	0.00%	Distribution not available
3011985	p-areninm	mu/l (mu/l)	6	6	0.00%	Distribution not available
3011985	p-oreninm	mu/l (mu/l)	5	5	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Endocrine, nutritional and metabolic diseases

1161

1491

4.02

317.39

1.9

1.3

71.48

54.53

mu/l

0.98

1056

1351

Hypertension

1706

1495

6.65

307.65

1.6

1.7

76.30

52.54

mu/l

1.98

1539

1365

Cardiovascular diseases

947

1014

5.18

307.65

1.7

2.0

60.06

60.59

mu/l

0.02

869

936

Other disorders of fluid, electrolyte and acid-base balance

956

1027

9.56

307.65

1.9

1.3

72.11

54.81

mu/l

0.72

824

907

Disorders of other endocrine glands

1160

1957

6.10

307.65

2.8

1.3

72.67

58.95

mu/l

0.75

1055

1744

Hypertension, essential

1710

1445

6.97

307.65

1.5

1.6

75.74

46.33

mu/l

4.46

1538

1320

Hyperaldosteronism

308

50.22

307.65

2.7

1.2

72.08

53.36

mu/l

0.23

273

Metabolic disorders

1676

2823

3.77

307.65

1.8

1.4

79.30

61.15

mu/l

1.44

1490

2537

Benign neoplasm of other and unspecified endocrine glands

988

474

25.61

307.65

1.5

1.4

59.24

50.59

mu/l

0.42

927

416

Hypertensive diseases

1705

1498

6.63

307.65

1.6

1.7

76.30

52.51

mu/l

1.98

1539

1368

Other disorders of adrenal gland

416

138

39.68

307.65

4.3

1.3

84.26

43.57

mu/l

2.69

391

125

Adrenocortical insufficiency

369

114

44.79

307.65

4.6

1.2

84.82

44.92

mu/l

2.14

349

104

Secondary hypertension

401

126

35.45

307.65

2.2

1.3

90.53

30.26

mu/l

4.94

350

111

Hypertensive diseases (excluding secondary)

1358

921

8.89

307.65

1.6

1.7

76.71

59.30

mu/l

0.75

1234

846

Benign neoplasm: Adrenal gland

885

250

52.53

307.65

1.4

59.91

66.74

mu/l

0.17

834

220

Benign neoplasm of other and unspecified endocrine glands

988

473

25.67

307.65

1.5

1.4

59.24

63.28

mu/l

0.14

927

414

Benign neoplasm: Adrenal gland

885

264

49.72

307.65

1.4

1.5

59.91

54.83

mu/l

0.16

834

235

Exclusions for E4_PCOS_BROAD

636

716

9.61

307.65

3.4

1.3

78.33

60.07

mu/l

1.09

594

631

Hypokalaemia

630

372

19.35

307.65

1.8

1.3

58.65

50.71

mu/l

0.29

537

332

Cardiovascular diseases (excluding rheumatic etc)

1140

1165

5.78

307.65

1.6

1.9

64.76

58.76

mu/l

0.25

1046

1075

Antihypertensive medication - note that there are other indications

967

887

6.08

307.65

1.7

2.0

63.71

49.67

mu/l

0.64

881

820

Anaemias

343

242

9.63

233.97

1.8

1.5

91.42

85.70

mu/l

0.05

304

228

Other heart diseases

630

919

4.60

225.69

1.4

1.8

74.77

60.01

mu/l

0.53

566

841

Hypothyroidism (congenital or acquired)

368

263

8.18

207.14

2.4

1.6

77.78

49.47

mu/l

1.20

335

248

Hypothyroidism and >3 levothyroxin purchases

359

260

8.08

200.50

2.4

1.6

78.71

42.75

mu/l

1.96

326

245

Hypothyroidism, levothyroxine purchases

359

260

8.08

200.50

2.4

1.6

78.71

42.75

mu/l

1.96

326

245

Hypertensive heart and/or renal disease

350

444

6.26

183.77

1.4

1.5

69.10

39.97

mu/l

2.09

305

400

Diseases of arteries, arterioles and capillaries (FINNGEN)

354

401

6.32

178.97

1.4

1.5

86.46

48.47

mu/l

2.39

300

363

Cerebrovascular diseases (FINNGEN)

406

576

5.14

169.69

1.4

1.5

77.33

46.17

mu/l

2.07

363

524

Disorders of lipoprotein metabolism and other lipidaemias

1021

2390

2.72

167.16

1.5

1.4

85.24

60.77

mu/l

2.35

918

2138

Hypothyroidism, drug reimbursement

215

153

10.27

159.46

2.6

1.4

52.13

37.42

mu/l

1.18

195

144

Hypo-osmolality and hyponatraemia

297

533

5.75

157.11

2.2

1.3

95.91

48.05

mu/l

0.76

258

476

Benign neoplasms

1226

2870

2.41

152.64

1.6

62.96

73.02

mu/l

0.70

1122

2551

Type 2 diabetes, wide definition

1051

2746

2.53

150.63

1.5

82.70

54.52

mu/l

3.33

939

2448

Diabetes mellitus

1322

3509

2.27

147.27

1.6

78.09

56.66

mu/l

2.34

1184

3150

Hypertensive Heart Disease

288

408

5.90

146.45

1.4

1.5

56.88

38.71

mu/l

1.15

254

367

Diabetes, varying definitions

1313

3504

2.26

144.94

1.6

78.30

56.51

mu/l

2.39

1175

3147

Heart failure and antihypertensive medication

297

325

6.15

143.30

1.5

1.6

104.46

58.15

mu/l

0.82

259

292

Drug-induced adrenocortical insufficiency

108

20.37

133.86

2.7

1.2

58.32

45.76

mu/l

0.21

Type 2 diabetes

1237

3312

2.24

133.37

1.5

80.63

56.52

mu/l

2.38

1104

2962

Sleep disorders (combined)

1241

3761

2.19

129.26

1.5

69.67

63.27

mu/l

0.45

1100

3375

Benign neoplasms

973

2255

2.47

127.95

1.7

1.6

62.29

73.96

mu/l

0.71

894

2009

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1189

3326

2.21

124.46

1.6

1.5

77.59

56.62

mu/l

2.53

1067

2981

Diabetes medication

1271

3643

2.14

123.66

1.6

77.67

58.07

mu/l

1.88

1131

3276

Sleep apnoea

1154

3608

2.20

122.27

1.5

69.88

63.70

mu/l

0.42

1023

3231

Sleep apnoea, including avohilmo

1204

3652

2.16

121.88

1.5

68.80

63.27

mu/l

0.38

1064

3273

Atrial fibrillation and flutter

355

536

4.39

120.17

1.4

1.5

71.54

46.47

mu/l

1.19

316

488

Hypopituitarism

164

213

8.12

119.25

2.3

1.3

74.89

61.54

mu/l

0.29

150

188

Atrial fibrillation and flutter with reimbursement

310

412

4.91

118.11

1.4

1.5

73.39

44.73

mu/l

1.21

271

376

Pure hypercholesterolaemia

814

2190

2.52

117.55

1.5

1.4

78.38

62.20

mu/l

1.13

731

1955

Malaise and fatigue

630

1918

2.78

115.81

1.8

1.5

59.84

59.50

mu/l

0.02

547

1719

Episodal and paroxysmal disorders

1308

3230

2.09

114.94

1.5

1.6

59.84

62.56

mu/l

0.18

1180

2901

Other nutritional deficiencies

832

3475

2.37

114.28

1.5

1.6

81.54

65.86

mu/l

1.06

734

3115

Abnormalities of breathing

1061

2880

2.21

110.96

1.5

1.6

59.15

67.69

mu/l

0.69

959

2583

Pain in throat and chest

1010

2774

2.25

110.70

1.5

1.6

76.32

65.25

mu/l

0.60

901

2486

Diabetes, insulin treatment (Kela reimbursement)

1217

3608

2.08

110.65

1.6

1.5

79.49

58.74

mu/l

2.38

1092

3230

General symptoms and signs

1309

3210

2.06

109.88

1.6

1.5

64.02

67.07

mu/l

0.16

1156

2910

First line medication for Crohn's disease

1318

3583

2.02

107.91

2.1

1.3

64.63

65.22

mu/l

0.03

1185

3218

Type 2 diabetes, definitions combined

1116

3171

2.12

105.59

1.4

1.5

78.22

55.56

mu/l

2.13

1008

2832

Type 2 diabetes, strict (exclude DM1)

1119

3193

2.11

104.87

1.4

1.5

78.05

55.53

mu/l

2.11

1010

2851

Depression medications

287

280

5.21

104.45

1.8

1.6

59.81

42.92

mu/l

1.04

259

265

Abnormal blood-pressure reading, without diagnosis

125

139

9.59

103.31

1.7

1.3

38.52

40.50

mu/l

0.08

112

118

Headache

793

2868

2.34

102.44

1.6

1.5

61.62

65.53

mu/l

0.16

697

2595

Type 2 diabetes, definitions combined, including avohilmo

1114

3176

2.10

102.16

1.4

1.5

77.45

55.92

mu/l

1.95

1004

2835

Obesity

778

3372

2.32

101.51

1.5

1.6

79.13

63.79

mu/l

1.17

687

3028

Obesity and other hyperalimentation

779

3392

2.30

100.36

1.5

1.6

79.03

63.99

mu/l

1.14

688

3043

Cardiac arrhythmias

723

1959

2.47

99.40

1.5

1.7

63.92

58.01

mu/l

0.31

647

1770

Other (not insulin) diabetes medications

1125

3346

2.05

97.34

1.4

1.5

76.80

57.33

mu/l

1.76

1005

2995

Other CVD (FINNGEN)

146

153

7.70

92.73

1.5

57.09

37.51

mu/l

0.48

127

140

Symptoms and signs involving the circulatory and respiratory systems

1151

2896

2.01

90.43

1.6

56.97

67.61

mu/l

0.93

1046

2599

Other heart diseases, wide

1087

3397

2.00

89.51

1.4

1.6

70.50

66.53

mu/l

0.21

969

3072

Obesity due to excess calories

592

2435

2.47

89.29

1.5

1.6

79.17

59.88

mu/l

1.45

511

2192

Used for control exclusion in common control thyroid runs

1183

3060

1.98

89.11

1.9

1.4

67.36

62.30

mu/l

0.34

1069

2738

Neoplasms

854

2072

2.23

88.79

1.7

52.84

73.60

mu/l

1.85

791

1837

Heart failure, not strict

884

2887

2.14

88.09

1.4

90.50

58.97

mu/l

2.83

779

2570

Nausea and vomiting

357

1139

3.14

84.87

1.9

1.4

59.97

65.53

mu/l

0.18

305

1014

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1096

4101

1.93

84.23

1.5

77.04

62.57

mu/l

1.07

960

3691

Postprocedural endocrine and metabolic disorders, not elsewhere classified

190

404

4.84

83.45

2.7

1.3

51.45

49.86

mu/l

0.06

171

361

Any reimbursement code in KELA

620

1242

2.52

82.62

1.8

1.4

57.57

58.37

mu/l

0.03

562

1137

Hyperlipidaemia, other/unspecified

409

1381

2.84

81.24

1.3

102.04

60.55

mu/l

2.03

354

1221

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

447

1689

2.70

80.68

2.0

1.5

64.27

58.21

mu/l

0.29

400

1502

Biguanides

1063

3404

1.94

80.12

1.4

1.5

80.48

57.39

mu/l

2.10

956

3042

Other metabolic disorders

197

449

4.51

79.38

2.6

1.4

50.99

54.20

mu/l

0.13

177

401

Tramadol

902

2895

2.02

76.93

1.4

1.6

75.41

60.20

mu/l

0.90

800

2604

Any gastric operation

892

2189

2.06

75.23

1.6

64.90

67.68

mu/l

0.12

802

1972

GASTRO-related operations

892

2189

2.06

75.23

1.6

64.90

67.68

mu/l

0.12

802

1972

Insulin medication

656

2563

2.21

75.05

1.7

1.5

92.35

58.88

mu/l

2.60

583

2288

Renal tubulo-interstitial diseases

947

3786

1.94

74.18

1.5

74.78

59.34

mu/l

1.40

827

3395

Renal failure

480

1780

2.50

73.28

1.5

1.4

91.67

57.26

mu/l

2.43

415

1570

Autoimmune diseases

1210

3398

1.83

73.26

1.9

1.4

68.73

61.98

mu/l

0.52

1094

3045

Neurological diseases

958

2456

1.98

72.59

1.5

1.7

64.63

66.48

mu/l

0.09

866

2219

Autoimmune diseases excluding thyroid diseases

1122

3388

1.85

71.78

1.9

1.4

65.84

62.01

mu/l

0.27

1013

3036

Abnormalities of heart beat

405

1532

2.66

71.38

1.5

56.65

60.53

mu/l

0.18

348

1358

Paroxysmal tachycardia

213

454

4.02

71.10

1.4

1.6

57.08

50.98

mu/l

0.20

193

413

Statin medication

787

2130

2.09

71.01

1.7

1.6

75.85

54.94

mu/l

1.70

708

1932

Dyspnoea

962

3928

1.89

70.49

1.5

61.95

64.00

mu/l

0.13

865

3496

Chronic kidney disease

330

1146

2.91

69.28

1.4

84.91

57.74

mu/l

1.60

278

1011

Insulin, intermediate and long-acting

613

2796

2.18

69.02

1.7

1.5

90.78

60.33

mu/l

2.33

547

2486

STROKE

644

2066

2.19

68.45

1.4

1.5

76.22

47.43

mu/l

2.77

586

1841

Hyperkalaemia

125

7.92

68.28

2.5

1.2

100.98

58.13

mu/l

0.85

109

Hypertensive Renal Disease

13.05

66.99

1.4

131.17

35.54

mu/l

1.63

Exclusions for E4_PCOS_CONSORTIUM

825

2633

1.98

66.38

2.0

1.5

60.97

59.30

mu/l

0.08

752

2356

Medical observation and evaluation for suspected diseases and conditions

764

1901

2.08

66.12

1.6

1.5

66.84

67.46

mu/l

0.02

673

1700

Codeine

1042

3133

1.84

65.43

1.5

1.6

70.93

59.41

mu/l

0.76

928

2826

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

323

1160

2.84

64.54

1.3

1.5

100.39

53.81

mu/l

3.06

281

1034

Other soft tissue disorders, not elsewhere classified

986

3327

1.84

64.03

1.5

1.6

65.34

64.27

mu/l

0.06

893

2989

Disorders of the thyroid gland

1007

3651

1.82

63.03

2.0

1.4

70.23

58.01

mu/l

1.02

899

3267

Hypothyroidism, other/unspecified

951

3434

1.84

62.43

2.0

1.4

70.27

57.99

mu/l

0.97

848

3074

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

364

843

2.76

62.27

1.5

1.7

69.61

49.88

mu/l

0.77

323

772

Disorders of mineral metabolism

131

262

5.17

62.05

2.3

1.4

36.00

38.73

mu/l

0.16

115

231

Implicit Sepsis

774

3119

1.95

62.01

1.5

1.4

69.55

64.54

mu/l

0.24

694

2755

Insulin, combination of fast acting with intermediate-acting or long-acting

657

3000

2.04

61.92

1.7

1.5

92.35

59.79

mu/l

2.54

583

2672

Hypothyreosis and Thyroxine purchase for inclusion criteria

983

3601

1.82

61.58

2.0

1.4

68.99

57.53

mu/l

0.91

875

3226

Condition for Implicit Sepsis (Organ dysfunction codes)

903

3574

1.85

61.29

1.5

70.65

63.49

mu/l

0.40

808

3184

Oral corticosteroids

1133

3953

1.75

61.20

1.6

66.25

66.61

mu/l

0.02

1002

3558

Autoimmune diseases excluding thyroid diseases, strict definition

1038

3237

1.80

60.82

1.8

1.4

65.54

62.79

mu/l

0.17

938

2906

Parasetamol

858

2291

1.92

60.56

1.6

58.16

67.54

mu/l

0.74

758

2094

Codeine or tramadol medication

1213

3943

1.72

60.34

1.5

1.6

71.61

61.26

mu/l

0.77

1080

3533

Other diseases of intestines

1117

3751

1.74

59.41

1.5

1.6

61.30

67.76

mu/l

0.42

1000

3378

Oedema, not elsewhere classified

346

1351

2.58

57.81

1.6

1.4

70.85

57.49

mu/l

0.60

291

1210

Disorders of parathyroid gland

249

816

3.07

57.25

2.0

1.2

55.33

52.69

mu/l

0.08

217

721

Asthma, excluding more controls

839

2381

1.89

56.99

1.5

1.6

62.93

62.68

mu/l

0.01

757

2154

Glucagon-like peptide-1 (GLP-1) analogues

565

2238

2.10

56.38

1.3

1.4

78.29

57.73

mu/l

1.63

489

1977

Asthma, unspecified (mode), excluding more controls

568

2144

2.10

56.30

1.6

1.5

56.60

63.01

mu/l

0.44

506

1931

ILD medications: prednisolone, methylprednisolone, prednisone

1152

3868

1.69

55.10

1.6

67.95

64.96

mu/l

0.18

1023

3476

Asthma

862

2513

1.85

55.08

1.5

1.6

61.98

63.41

mu/l

0.08

775

2269

Inflammatory bowel disease treatment related agents

1192

4064

1.68

55.00

1.6

65.17

66.28

mu/l

0.06

1059

3659

Type 1 diabetes

299

1121

2.70

54.76

2.3

1.5

92.01

57.30

mu/l

1.40

262

1004

Non-invasive ventilation

230

697

3.14

54.74

1.4

1.6

45.56

63.44

mu/l

0.62

208

632

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

145

352

4.26

54.16

2.5

1.4

46.58

50.95

mu/l

0.15

129

314

Persons encountering health services in other circumstances, wide

1248

3931

1.66

54.02

1.5

1.6

65.13

66.52

mu/l

0.07

1112

3527

Other headache syndromes

445

2016

2.23

53.85

1.6

47.12

57.99

mu/l

1.00

409

1787

Diseases of oesophagus, stomach and duodenum

1101

3985

1.69

53.03

1.6

1.5

67.77

66.41

mu/l

0.07

980

3576

Pain in limb

802

3198

1.83

52.44

1.5

1.6

65.43

63.98

mu/l

0.07

713

2877

Asthma, unspecified (mode)

574

2260

2.03

52.26

1.6

1.5

56.32

63.87

mu/l

0.56

509

2033

Migraine

498

2008

2.13

52.09

1.7

54.66

56.23

mu/l

0.07

456

1808

Insulin, fast-acting

407

1805

2.28

51.87

1.9

1.5

95.07

61.01

mu/l

1.82

357

1609

Benzodiazepine use

1029

4348

1.70

51.86

1.5

1.6

59.00

66.36

mu/l

0.58

898

3919

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

132

309

4.41

51.69

1.7

1.8

104.90

45.99

mu/l

1.28

120

286

Neurological diseases, wide definition

325

597

2.76

51.49

1.6

1.8

55.80

72.01

mu/l

0.43

295

548

Disorders of thyroid, IBD co-morbidities

199

426

3.45

51.25

2.2

1.7

80.21

53.35

mu/l

1.13

171

385

Opioids

1031

3174

1.72

50.92

1.6

66.31

59.21

mu/l

0.58

928

2863

Obesity related asthma

394

1740

2.30

50.90

1.5

78.14

60.61

mu/l

0.92

356

1546

Asthma (mode)

834

2541

1.82

50.31

1.5

1.6

57.56

65.94

mu/l

0.67

748

2295

Other functional intestinal disorders

457

2044

2.15

50.08

1.6

1.5

59.49

65.19

mu/l

0.24

394

1815

ILD medications

1166

3912

1.65

49.86

1.6

71.54

64.64

mu/l

0.45

1039

3518

Symptoms and signs involving the nervous and musculoskeletal systems

594

3099

1.93

49.00

1.5

64.72

63.94

mu/l

0.03

542

2749

Insulin, fast-acting or short human

410

1870

2.22

48.84

1.9

1.5

94.35

62.21

mu/l

1.69

360

1668

Hypothyroidism, strict autoimmune

719

2582

1.86

48.67

2.0

1.3

74.72

58.08

mu/l

1.07

644

2305

Symptoms and signs involving cognition, perception, emotional state and behaviour

981

4099

1.69

48.62

1.4

1.6

74.63

61.16

mu/l

0.83

866

3679

Diarrhoea and gastroenteritis of presumed infectious origin

716

3593

1.82

48.61

2.2

1.5

75.07

66.68

mu/l

0.42

638

3227

Obesity, other/unspecified

382

1703

2.27

48.23

1.5

1.6

81.47

57.86

mu/l

1.26

346

1540

Other arrhythmias

659

2699

1.88

48.06

1.4

1.6

56.26

57.36

mu/l

0.05

586

2421

Disorders of gallbladder, biliary tract and pancreas

994

3835

1.68

47.70

1.5

70.13

61.23

mu/l

0.59

905

3403

Other bacterial diseases

955

3932

1.69

47.43

1.7

1.5

68.02

66.25

mu/l

0.09

836

3532

Asthma (diagnoses ohter than nonallergic)

871

4377

1.71

47.22

1.5

1.6

60.04

63.62

mu/l

0.25

777

3920

Type 1 diabetes, wide definition, subgroup 1

248

917

2.74

46.83

2.2

1.6

91.16

58.94

mu/l

1.16

220

822

Asthma (only as main-diagnosis), excluding more controls

728

2381

1.83

46.35

1.5

1.6

59.63

62.68

mu/l

0.17

650

2154

Mood disorders, excluding more controls

979

3569

1.68

46.32

1.5

1.6

63.38

60.10

mu/l

0.22

861

3223

Syncope and collapse

438

1839

2.13

46.32

1.5

1.4

69.54

60.28

mu/l

0.38

394

1641

Dorsalgia

1011

3286

1.68

46.27

1.5

1.6

65.85

63.64

mu/l

0.10

902

2951

Intestinal infectious diseases

936

4377

1.67

45.95

2.0

1.5

70.57

64.21

mu/l

0.35

833

3932

Complications of surgical and medical care, not elsewhere classified

977

4242

1.66

45.91

1.5

1.6

67.77

64.21

mu/l

0.20

866

3802

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1112

3921

1.63

45.84

1.5

1.6

62.60

66.61

mu/l

0.25

996

3520

Other antidepressants

1041

3289

1.66

45.66

1.5

1.6

72.70

58.09

mu/l

1.00

910

2968

Type 1 diabetes, wide definition

257

980

2.66

45.65

2.2

1.6

89.49

58.15

mu/l

1.16

226

874

Depression or dysthymia

745

2313

1.82

45.23

1.5

1.6

85.33

59.17

mu/l

1.45

653

2093

Mood disorders

1052

4263

1.63

45.14

1.6

62.42

63.85

mu/l

0.09

929

3838

Spondylopathies

807

2811

1.76

44.72

1.4

1.5

59.85

64.98

mu/l

0.37

716

2510

Hyperparathyroidism

207

705

2.95

44.66

1.6

1.2

56.46

52.22

mu/l

0.12

179

626

Mood [affective] disorders

1048

4262

1.63

44.61

1.6

62.26

63.87

mu/l

0.10

925

3837

Benign neoplasm: Pituitary gland, craniopharyngeal duct

181

5.28

44.59

2.2

1.3

52.03

58.66

mu/l

0.18

159

Persons encountering health services for specific procedures and health care

1085

4201

1.61

43.64

1.6

65.20

66.71

mu/l

0.08

966

3772

Asthma (only as main-diagnosis)

739

2513

1.79

43.37

1.5

1.6

59.45

63.41

mu/l

0.24

660

2269

Other symptoms and signs involving the nervous and musculoskeletal systems

445

2195

2.05

43.32

1.5

58.18

65.52

mu/l

0.37

407

1948

Dizziness and giddiness

740

3463

1.75

42.69

1.4

1.5

74.65

57.05

mu/l

0.93

650

3091

Benign neoplasm: Pituitary gland, craniopharyngeal duct

189

5.06

42.45

2.2

1.4

52.03

42.29

mu/l

0.40

168

Depression

976

4148

1.63

42.24

1.6

64.49

64.56

mu/l

0.00

867

3734

Ischemic heart diseases

783

2850

1.73

41.79

1.4

1.5

86.12

58.45

mu/l

1.73

695

2531

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

370

808

2.31

41.60

1.6

1.5

50.63

71.29

mu/l

0.80

330

739

Ischaemic heart disease, wide definition

772

2801

1.74

41.58

1.4

1.5

91.62

57.68

mu/l

2.11

683

2489

Symptoms and signs involving the digestive system and abdomen

1001

3081

1.64

41.22

1.6

1.5

62.11

68.31

mu/l

0.39

889

2770

Disorders of calcium metabolism

186

4.99

41.15

2.6

1.3

30.71

38.43

mu/l

0.46

163

Chronic lower respiratory diseases

1201

4192

1.56

41.03

1.5

1.6

65.17

66.33

mu/l

0.07

1074

3766

Complications of procedures, not elsewhere classified

791

4083

1.69

40.54

1.5

1.6

69.15

63.68

mu/l

0.28

703

3657

Pain, not elsewhere classified

287

1222

2.38

40.44

1.6

1.5

58.35

71.42

mu/l

0.48

261

1110

Lower back pain or/and sciatica

1009

4410

1.60

40.21

1.5

1.6

63.70

62.47

mu/l

0.06

898

3953

Abdominal and pelvic pain

990

3079

1.62

39.69

1.5

63.83

68.31

mu/l

0.26

889

2768

Pain in joint

578

2072

1.86

39.50

1.7

1.6

73.65

60.33

mu/l

0.52

511

1860

Hard cardiovascular diseases

775

2934

1.71

39.46

1.4

1.5

89.59

58.90

mu/l

1.94

691

2608

Diverticular disease of intestine

684

2602

1.76

38.94

1.4

62.57

62.67

mu/l

0.00

609

2317

Infections, IBD-co-morbidities

162

364

3.28

38.83

1.7

1.6

93.11

61.51

mu/l

0.64

141

328

Examination and observation for other reasons

576

1893

1.86

38.82

1.6

1.5

69.74

67.70

mu/l

0.06

531

1692

Care involving use of rehabilitation procedures

649

3551

1.75

38.58

1.6

1.5

59.85

66.21

mu/l

0.35

585

3176

Viral Sepsis

204

762

2.72

37.99

1.7

1.4

89.78

51.64

mu/l

1.08

185

671

Abnormal findings on examination of blood, without diagnosis

449

2170

1.96

37.99

1.6

1.4

79.43

64.72

mu/l

0.80

406

1914

Implicit viral Sepsis

203

760

2.71

37.64

1.7

1.4

89.93

51.75

mu/l

1.08

184

669

Fibromyalgia

124

350

3.63

37.47

1.6

56.84

47.62

mu/l

0.35

114

317

Nutritional anaemias

454

2307

1.93

37.37

1.5

1.4

91.78

58.98

mu/l

1.36

390

2049

General examination and investigation of persons without complaint and reported diagnosis

638

1900

1.80

37.34

1.5

62.05

67.49

mu/l

0.24

579

1699

Implicit bacterial Sepsis

368

1633

2.09

37.24

1.5

1.4

78.81

56.45

mu/l

1.06

325

1432

Volume depletion

232

4.26

36.89

2.1

1.3

115.62

56.10

mu/l

0.80

205

Persons encountering health services in other circumstances

387

1925

2.03

36.82

1.6

54.17

61.30

mu/l

0.41

339

1722

Nerve, nerve root and plexus disorders

1025

4142

1.56

36.75

1.5

1.6

68.57

62.37

mu/l

0.34

907

3715

Low back pain

702

3198

1.70

36.65

1.6

67.08

63.94

mu/l

0.11

624

2867

Fever of other and unknown origin

489

2435

1.88

36.60

1.7

1.5

72.49

66.25

mu/l

0.26

430

2197

Malignant neoplasm of endocrine gland

112

303

3.81

36.14

2.7

1.4

43.39

42.37

mu/l

0.03

102

275

Sub-endpoint used in defining T1D endpoints

308

1393

2.20

36.06

2.2

1.5

84.02

61.43

mu/l

0.84

272

1246

Thyroiditis, ILD-related definition

146

473

3.15

35.38

3.4

1.4

136.17

48.06

mu/l

2.13

130

424

Complications of medical and surgical care

698

3989

1.67

35.37

1.5

63.46

60.74

mu/l

0.14

625

3558

Other and unspecified iron deficiency

318

1496

2.15

35.26

1.5

85.00

61.88

mu/l

0.67

274

1332

Cholelithiasis

801

3463

1.63

35.11

1.5

71.46

56.91

mu/l

1.01

734

3069

Bacterial Sepsis

410

1874

1.96

34.95

1.5

1.4

81.10

56.45

mu/l

1.34

363

1645

Anxiety disorders, excluding more controls

819

3368

1.62

34.66

1.6

72.95

61.22

mu/l

0.70

721

3045

Cholelithiasis, broad definition with cholecystitis

825

3522

1.61

34.53

1.5

72.55

56.79

mu/l

1.18

759

3122

Diseases of arteries, arterioles and capillaries

607

2617

1.74

34.39

1.3

1.4

74.20

59.89

mu/l

1.09

527

2314

Sciatica+with lumbago

502

2639

1.82

34.31

1.5

59.82

64.62

mu/l

0.27

450

2351

Acute renal failure

206

818

2.56

33.97

1.5

1.4

96.54

54.19

mu/l

1.44

187

721

Spondylosis

516

2472

1.80

33.70

1.4

50.18

63.46

mu/l

1.36

467

2186

Other dorsopathies, not elsewhere classified

972

3298

1.56

33.65

1.6

58.94

63.70

mu/l

0.25

872

2962

Other disorders of kidney and ureter

159

557

2.92

33.63

1.4

87.20

60.76

mu/l

0.74

137

492

Asthma, including avohilmo

1122

4360

1.50

33.17

1.5

1.6

63.22

66.18

mu/l

0.20

1006

3913

Intracranial trauma

502

2072

1.82

33.09

1.6

1.7

64.36

69.02

mu/l

0.18

453

1870

Asthma, hospital admission 2, infections

542

3059

1.76

33.01

1.5

62.84

63.78

mu/l

0.04

483

2732

Asthma-related infections

542

3059

1.76

33.01

1.5

62.84

63.78

mu/l

0.04

483

2732

Hypothyroidism, strict autoimmune, 3 medication purchases required

792

3374

1.61

32.78

1.9

1.4

74.23

55.23

mu/l

1.45

705

3015

Other intervertebral disc disorders

799

3047

1.61

32.73

1.5

1.6

64.40

64.69

mu/l

0.01

714

2727

Gastrointestinal diseases

582

1649

1.78

32.47

1.6

1.7

53.51

72.08

mu/l

1.17

526

1496

Concussion

432

2009

1.87

32.00

1.6

1.7

62.43

69.88

mu/l

0.31

392

1813

Any mental disorder

1090

3633

1.51

31.96

1.4

1.6

59.83

63.02

mu/l

0.19

952

3283

Genitourinary diseases

597

1715

1.76

31.90

1.5

62.95

78.56

mu/l

0.80

539

1574

Convulsions, not elsewhere classified

232

987

2.35

31.86

1.8

1.5

56.77

73.95

mu/l

0.65

206

889

Certain infectious and parasitic diseases

986

3219

1.54

31.82

1.6

1.5

62.06

63.80

mu/l

0.09

879

2900

Autoimmune diseases related-to ILD

811

4559

1.57

31.82

1.8

1.5

81.55

60.54

mu/l

1.29

726

4083

Other special examinations and investigations of persons without complaint or reported diagnosis

641

1901

1.72

31.73

1.6

1.5

55.36

67.46

mu/l

0.78

575

1700

Cholecystectomy

665

3591

1.65

31.58

1.6

1.5

65.85

56.31

mu/l

0.61

617

3172

Vocal cord dysfunction

130

386

3.17

31.58

1.6

66.33

74.01

mu/l

0.09

116

353

Acute tubulo-interstitial nephritis

556

2873

1.73

31.56

1.6

1.5

61.48

56.45

mu/l

0.28

482

2570

Aplastic and other anaemias

393

1967

1.91

31.32

1.3

1.4

73.67

63.22

mu/l

0.43

343

1742

Iron deficiency anaemia

377

1956

1.93

30.98

1.5

1.4

84.94

61.60

mu/l

0.81

324

1745

Excluding asthma or asthma-COPD overlap

807

2532

1.60

30.94

1.5

1.6

60.88

63.10

mu/l

0.12

719

2285

Spinal stenosis

469

2041

1.82

30.80

1.3

1.4

60.89

62.60

mu/l

0.08

413

1796

Other anaemias

365

1828

1.94

30.71

1.3

1.4

72.75

62.69

mu/l

0.40

320

1617

Anxiety disorders

879

4056

1.54

30.70

1.6

71.04

62.19

mu/l

0.52

778

3646

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

581

3210

1.69

30.55

1.5

1.4

69.75

59.46

mu/l

0.53

521

2835

Combinations of oral blood glucose lowering drugs

274

1290

2.15

30.47

1.3

1.4

117.62

59.45

mu/l

2.26

239

1143

Other and unspecified anaemias

361

1813

1.94

30.39

1.3

1.4

72.78

62.63

mu/l

0.40

316

1602

Other pulmonary diagnosis

804

2532

1.60

30.37

1.5

1.6

60.21

63.10

mu/l

0.17

715

2285

Finngen Rheumatological endpoints

936

3500

1.53

30.28

1.5

1.6

68.92

62.79

mu/l

0.30

834

3153

Migraine with aura

226

986

2.32

30.25

1.6

1.7

61.93

52.42

mu/l

0.31

205

888

Neurotic, stress-related and somatoform disorders

868

4023

1.54

30.15

1.6

71.58

62.39

mu/l

0.54

767

3620

Soft tissue disorders

982

3375

1.52

29.90

1.5

1.6

64.32

63.97

mu/l

0.02

882

3036

Diseases of the skin and subcutaneous tissue

1000

3328

1.51

29.80

1.5

1.6

62.06

67.48

mu/l

0.35

896

3005

Constipation

805

3710

1.56

29.70

1.5

57.16

66.11

mu/l

0.61

703

3319

Psychiatric diseases

1061

3573

1.49

29.68

1.5

1.6

61.99

63.10

mu/l

0.06

933

3227

Osteopathies and chondropathies

517

2859

1.73

29.66

1.7

1.4

63.50

58.00

mu/l

0.29

454

2542

Coronary atherosclerosis

632

2463

1.67

29.62

1.3

1.4

98.21

55.40

mu/l

2.53

554

2177

418

2286

1.83

29.30

1.6

1.5

66.89

63.01

mu/l

0.15

374

2050

Anxiety (asthma-related co-morbidities)

568

2668

1.69

29.18

1.7

68.14

61.67

mu/l

0.27

495

2423

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

564

3375

1.68

29.18

1.5

64.12

62.51

mu/l

0.07

503

3002

Migraine without aura

190

785

2.45

28.81

2.0

1.7

58.01

54.11

mu/l

0.13

180

711

Dorsopathies

977

3321

1.51

28.76

1.6

56.81

64.16

mu/l

0.62

879

2985

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

849

3473

1.54

28.66

1.6

1.5

68.12

63.76

mu/l

0.23

747

3119

849

3473

1.54

28.66

1.6

1.5

68.12

63.76

mu/l

0.23

747

3119

Other diseases of liver

196

826

2.41

28.55

1.7

1.4

83.36

52.03

mu/l

1.30

175

736

Osteoporosis

250

1109

2.18

28.48

1.8

1.3

58.74

54.62

mu/l

0.16

216

983

Hypotension

159

608

2.65

28.41

1.5

1.4

57.93

60.68

mu/l

0.05

139

535

Temporomandibular joint disorders

167

655

2.58

28.32

2.1

1.5

57.75

61.57

mu/l

0.10

148

585

Other septicaemia

325

1639

1.96

28.30

1.7

1.3

88.79

64.30

mu/l

0.82

290

1451

Explicit Sepsis

375

1936

1.87

28.22

1.7

1.5

83.69

63.27

mu/l

0.77

333

1703

Selective serotonin reuptake inhibitors

943

3303

1.51

28.11

1.5

1.6

68.13

58.29

mu/l

0.75

834

2982

Recurrent or chronic depression

406

1599

1.85

27.91

1.6

80.32

60.11

mu/l

0.78

355

1452

ILD differential diagnosis

793

2541

1.57

27.90

1.5

1.6

57.99

65.94

mu/l

0.57

706

2295

COPD differential diagnosis

793

2543

1.57

27.82

1.5

1.6

58.00

65.89

mu/l

0.56

706

2297

Glomerular diseases

191

807

2.40

27.66

1.4

110.25

59.35

mu/l

1.80

158

718

Disorder of lipoprotein metabolism, unspecified

127

438

2.94

27.64

1.9

1.4

78.46

48.19

mu/l

0.75

118

389

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

527

3156

1.68

27.59

1.5

65.30

62.03

mu/l

0.14

469

2809

Heart failure,strict

459

1883

1.77

27.49

1.4

90.50

59.03

mu/l

1.86

389

1667

Symptoms and signs involving the urinary system

686

3374

1.58

27.02

1.6

1.4

55.06

67.19

mu/l

1.06

603

3005

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

885

4026

1.50

27.01

1.4

1.6

74.91

64.24

mu/l

0.58

778

3631

Epilepsy

274

1346

2.05

27.00

1.5

93.45

68.30

mu/l

0.45

244

1193

Asthma, hospital admissions , main diagnosis only

758

4444

1.54

26.88

1.5

1.6

58.99

65.29

mu/l

0.45

677

3981

Septicaemia

356

1846

1.87

26.72

1.7

1.4

84.80

65.24

mu/l

0.68

317

1633

Other CVD

177

735

2.44

26.62

1.5

1.4

56.55

55.77

mu/l

0.02

156

646

Exposure to unspecified factor

888

4652

1.49

26.58

1.5

1.6

74.65

63.41

mu/l

0.43

780

4187

Other/unspecified dorsalgia

349

1869

1.87

26.51

1.5

57.55

61.71

mu/l

0.17

313

1666

Influenza and pneumonia

980

4414

1.47

26.50

1.6

68.86

64.96

mu/l

0.22

870

3967

Glomerular disorders in diseases classified elsewhere

132

478

2.81

26.35

1.4

106.62

65.39

mu/l

1.08

114

428

Pain (limb, back, neck, head abdominally)

683

2144

1.60

26.26

1.5

1.6

57.65

62.90

mu/l

0.28

607

1930

Polycystic ovarian syndrome, consortium definition

673

2563

1.59

26.20

1.7

1.6

66.14

48.89

mu/l

1.57

596

2305

Other specific joint derangements/joint disorders

690

2952

1.58

26.18

1.7

1.6

74.88

62.88

mu/l

0.53

605

2675

Functional dyspepsia

264

1306

2.04

25.82

1.5

1.4

35.00

56.21

mu/l

2.79

233

1154

Infections of the skin and subcutaneous tissue

523

3170

1.65

25.77

1.5

1.6

70.66

68.62

mu/l

0.08

462

2844

Valvular heart disease excluding rheumatic fever

410

1685

1.79

25.57

1.3

1.4

78.81

66.11

mu/l

0.40

360

1500

Gastro-oesophageal reflux disease

620

3478

1.59

25.51

1.6

1.5

68.22

64.69

mu/l

0.16

546

3106

Non-rheumatic valve diseases

408

1674

1.79

25.50

1.3

1.4

78.99

66.34

mu/l

0.40

359

1490

All anxiety disorders

573

2858

1.62

25.43

1.7

1.6

68.07

62.52

mu/l

0.23

500

2588

Continuous positive airway pressure

165

576

2.50

25.42

1.3

1.5

101.75

69.05

mu/l

0.64

139

517

Use of hypnotics and sedatives

992

3958

1.46

25.26

1.5

1.6

64.38

66.26

mu/l

0.10

852

3580

Diseases of liver

326

1747

1.88

25.22

1.7

1.4

88.77

61.61

mu/l

1.04

286

1557

Dentinal caries

235

1118

2.11

25.18

1.6

1.5

87.99

66.35

mu/l

0.54

207

1005

Asthma/COPD (KELA code 203)

874

4179

1.48

25.17

1.5

1.6

62.39

66.34

mu/l

0.24

791

3754

Bacterial infection, other or unspecified

451

2395

1.71

24.89

1.7

1.4

67.61

65.25

mu/l

0.10

400

2119

Rheumatism, unspecified

158

646

2.48

24.68

1.4

65.18

48.95

mu/l

0.63

141

581

Elevated blood glucose level

100

322

3.17

24.67

1.8

1.4

86.11

59.79

mu/l

0.64

282

Bleeding

734

3515

1.53

24.63

1.4

1.5

65.43

66.13

mu/l

0.03

645

3129

Dermatitis and eczema

993

4541

1.44

24.46

1.6

66.36

64.90

mu/l

0.07

881

4080

Dental caries

257

1275

2.02

24.26

1.6

1.5

93.97

72.77

mu/l

0.51

227

1150

Lumbar disc prolapse

583

2917

1.60

24.22

1.5

1.6

63.06

65.68

mu/l

0.11

525

2605

Cerebrovascular diseases

649

2990

1.56

24.19

1.4

72.84

58.84

mu/l

0.96

579

2637

Nonalcoholic fatty liver disease

114

401

2.90

24.09

1.4

1.5

84.63

46.52

mu/l

1.21

105

361

Hernia of abdominal wall, postoperative

162

677

2.42

24.07

1.4

109.08

57.82

mu/l

1.01

145

596

Angina pectoris

534

2215

1.64

23.87

1.3

1.4

95.08

55.44

mu/l

1.94

472

1960

Dentofacial anomalies [including malocclusion]

272

1385

1.96

23.73

2.1

1.6

76.12

55.66

mu/l

0.94

242

1254

COPD/asthma related infections

998

3476

1.44

23.68

1.6

1.5

59.28

63.73

mu/l

0.32

891

3121

COPD/asthma/ILD related infections

998

3476

1.44

23.68

1.6

1.5

59.28

63.73

mu/l

0.32

891

3121

Pregnancy hypertension

393

2038

1.75

23.63

1.7

60.17

53.30

mu/l

0.28

358

1842

Other neurological diseases

626

3244

1.56

23.57

1.5

1.4

67.29

57.57

mu/l

0.60

570

2859

Diseases of pulp and periapical tissues, including avohilmo

991

3586

1.44

23.51

1.6

63.33

63.89

mu/l

0.03

890

3215

Polyarthropathies

621

2650

1.57

23.28

1.5

1.6

74.22

63.80

mu/l

0.59

547

2395

Dental pulpitis 1

989

3592

1.44

23.03

1.5

1.6

62.69

64.00

mu/l

0.07

888

3221

Dental pulpitis 4

988

3592

1.43

22.86

1.5

1.6

62.75

64.00

mu/l

0.07

887

3221

Dental pulpitis 4, only avohilmo

1008

3705

1.43

22.63

1.5

1.6

60.86

64.36

mu/l

0.23

897

3324

Dental pulpitis 1, only avohilmo

1009

3715

1.42

22.46

1.5

1.6

59.87

64.71

mu/l

0.35

898

3333

Disorders of eyelid, lacrimal system and orbit

747

3967

1.48

22.24

1.6

1.5

52.99

61.55

mu/l

0.74

669

3536

Haemorrhage from respiratory passages

274

1340

1.91

22.06

1.5

1.4

66.30

64.49

mu/l

0.06

236

1178

Systemic connective tissue disorders

320

1781

1.81

21.98

1.5

1.4

78.72

55.07

mu/l

0.62

284

1575

Diseases of the eye and adnexa

779

2625

1.49

21.94

1.6

60.57

68.81

mu/l

0.55

695

2380

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

433

2282

1.67

21.93

1.7

59.39

54.72

mu/l

0.19

393

2053

Cystitis

763

3153

1.49

21.91

1.6

58.65

61.47

mu/l

0.15

666

2851

142

586

2.46

21.79

2.0

1.6

59.53

53.20

mu/l

0.27

127

526

Erysipelas

472

2662

1.63

21.70

1.4

69.41

66.76

mu/l

0.10

403

2370

Cough

339

1844

1.78

21.69

1.5

55.03

63.78

mu/l

0.42

305

1635

All pneumoniae

910

4424

1.43

21.52

1.6

67.36

65.70

mu/l

0.08

804

3978

Pneumonias (Asthma/COPD co-morbidities)

904

4414

1.42

21.33

1.6

67.42

65.09

mu/l

0.12

799

3969

Myalgia

215

1064

2.04

21.12

1.6

61.63

51.76

mu/l

0.47

187

948

Pneumonia, organism unspecified

812

4076

1.45

21.01

1.6

1.5

66.72

64.91

mu/l

0.09

714

3656

Atherosclerosis, excluding cerebral and coronary sclerosis

330

1489

1.78

20.82

1.3

1.4

101.74

51.97

mu/l

3.46

275

1321

Non-selective monoamine reuptake inhibitors

351

1975

1.74

20.81

1.4

1.5

60.66

55.84

mu/l

0.22

311

1765

Ovarian cyst

348

1135

1.79

20.63

1.6

1.5

51.68

52.55

mu/l

0.03

310

1020

Paralytic ileus and intestinal obstruction

217

1087

2.01

20.58

1.5

1.4

55.70

63.25

mu/l

0.18

191

964

Substance abuse, excluding more controls

474

2601

1.60

20.44

1.3

1.6

72.18

65.71

mu/l

0.18

406

2353

Irritable bowel syndrome

250

1321

1.91

20.31

1.6

1.5

51.93

58.14

mu/l

0.27

225

1183

Benign neoplasm of colon, rectum, anus and anal canal

478

2135

1.61

20.20

1.3

1.4

75.01

59.57

mu/l

0.67

423

1900

Viral and other specified intestinal infections

188

878

2.11

20.16

2.1

1.6

85.43

72.28

mu/l

0.24

167

793

Other systemic involvement of connective tissue (FG)

238

1232

1.94

20.15

1.6

1.4

47.81

56.41

mu/l

0.49

210

1092

Other and unspecified dermatitis

445

2776

1.61

20.05

1.5

59.06

60.88

mu/l

0.09

385

2472

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

875

4367

1.41

19.86

1.5

1.6

68.35

65.69

mu/l

0.13

772

3923

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

110

422

2.65

19.75

1.7

1.4

50.86

70.49

mu/l

0.54

372

Heart failure, strict

475

2149

1.60

19.68

1.4

89.59

60.10

mu/l

1.80

403

1901

Unspecified kidney failure

312

2.93

19.57

1.6

1.4

105.86

79.53

mu/l

0.42

275

Other anxiety disorders

404

2186

1.65

19.55

1.7

1.6

63.25

61.33

mu/l

0.07

356

1987

Other disorders of urethra and urinary system

599

2982

1.51

19.50

1.5

1.6

52.70

57.90

mu/l

0.34

517

2695

Dermatitis

525

3428

1.54

19.38

1.5

66.84

61.52

mu/l

0.22

457

3062

Irregular menses

421

2107

1.63

19.25

1.9

1.6

69.48

51.42

mu/l

1.34

379

1911

Visual disturbances and blindness

433

2714

1.61

19.16

1.7

1.5

65.26

64.48

mu/l

0.02

392

2411

Type 1 diabetes, strict (exclude DM2)

104

393

2.68

19.11

2.9

1.7

74.36

61.33

mu/l

0.30

360

Abnormal findings on diagnostic imaging of other body structures

133

567

2.38

19.09

1.6

1.4

61.35

51.75

mu/l

0.31

123

499

Type 1 diabetes, definitions combined

105

399

2.66

19.08

2.9

1.7

73.67

60.94

mu/l

0.29

366

Amenorrhoea

243

3.18

19.03

2.8

1.7

78.15

49.21

mu/l

1.10

226

Other retinal disorders

520

2714

1.55

19.03

1.6

1.4

55.93

62.51

mu/l

0.45

451

2405

Insulin, fast-acting (human)

143

630

2.30

18.97

2.1

1.5

86.21

64.27

mu/l

0.77

125

565

1025

3946

1.38

18.95

1.6

1.5

60.17

63.36

mu/l

0.21

922

3531

All-cause Heart Failure

464

2114

1.59

18.79

1.4

87.09

60.60

mu/l

1.51

395

1871

Stroke, including SAH

517

2487

1.55

18.64

1.4

73.05

57.93

mu/l

0.88

457

2184

Dialysis, with operation codes

125

525

2.42

18.55

1.4

118.01

62.21

mu/l

0.92

110

471

Benign neoplasm of colon, rectum, anus and anal canal

507

2989

1.54

18.46

1.3

1.4

73.83

57.05

mu/l

0.82

447

2640

Fall on same level

1037

4260

1.36

18.39

1.5

1.6

61.36

67.89

mu/l

0.51

914

3844

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

116

473

2.49

18.37

1.6

1.3

48.68

67.02

mu/l

0.54

102

417

Personality disorders, excluding more controls

228

1210

1.90

18.33

1.6

61.63

57.87

mu/l

0.11

202

1108

Other disorders of lacrimal gland

300

1731

1.75

18.33

1.8

1.4

54.97

57.49

mu/l

0.09

269

1540

Benign neoplasm: Colon

415

1977

1.62

18.26

1.3

1.4

81.41

56.74

mu/l

1.07

360

1758

Care involving dialysis

314

2.86

18.23

1.4

70.46

67.20

mu/l

0.05

276

Hypoglycaemia, other or unspecified

240

3.14

18.14

2.5

1.4

63.58

81.98

mu/l

0.18

213

Other general symptoms and signs

141

3.86

18.11

1.2

1.4

73.90

103.32

mu/l

0.16

128

Other disorders of glucose regulation and pancreatic internal secretion

304

2.87

18.09

2.4

1.4

61.13

86.03

mu/l

0.32

266

Persons encountering health services for examination and investigation

575

1901

1.52

17.94

1.5

51.65

67.46

mu/l

1.19

517

1700

Migraine with aura and triptan purchases

147

671

2.22

17.94

1.8

56.57

50.73

mu/l

0.19

135

609

Other or unspecified ileus, impaction or obstruction

157

735

2.16

17.94

1.6

1.4

63.26

57.19

mu/l

0.10

138

658

Symptoms and signs concerning food and fluid intake

355

2.71

17.93

1.4

61.93

88.43

mu/l

0.35

315

Shoulder lesions

676

2847

1.46

17.93

1.4

1.5

67.67

60.99

mu/l

0.36

602

2546

Certain disorders involving the immune mechanism

185

923

2.03

17.89

1.4

1.5

91.95

67.78

mu/l

0.43

163

826

Other noninfective gastroenteritis and colitis

220

1163

1.91

17.89

1.7

1.4

71.03

72.57

mu/l

0.04

203

1034

Other reaction to severe stress, and adjustment disorders

323

1916

1.70

17.83

1.7

1.6

69.55

60.32

mu/l

0.33

287

1738

Extracorporeal dialysis

207

3.31

17.83

1.4

65.08

61.82

mu/l

0.05

181

Somatoform disorder

163

779

2.12

17.72

1.8

1.5

72.94

56.23

mu/l

0.48

146

697

Covid-19 confirmed case

244

1344

1.83

17.47

1.5

56.45

66.38

mu/l

0.43

217

1191

Benign neoplasm of other and ill-defined parts of digestive system

165

797

2.10

17.45

1.7

1.3

46.22

61.10

mu/l

0.82

142

709

Disorders of choroid and retina

675

3422

1.44

17.34

1.6

1.4

58.69

62.57

mu/l

0.24

581

3048

Stroke, excluding SAH

481

2327

1.54

17.27

1.4

74.08

59.25

mu/l

0.79

425

2043

Symptoms and signs involving the skin and subcutaneous tissue

586

3994

1.47

17.20

1.6

1.5

53.36

59.88

mu/l

0.46

517

3567

Oxycodone

286

1604

1.74

17.09

1.7

1.4

88.47

58.11

mu/l

0.97

253

1416

Peripheral artery disease

337

1634

1.67

16.98

1.3

1.4

88.33

52.55

mu/l

2.60

288

1442

Cervical disc disorders

315

1883

1.68

16.93

1.5

1.4

71.02

65.13

mu/l

0.16

284

1662

Malignant neoplasm of kidney, except renal pelvis

339

2.70

16.83

1.7

1.4

42.83

71.02

mu/l

0.75

297

Visual disturbances

400

2541

1.58

16.82

1.7

1.5

67.03

65.49

mu/l

0.05

366

2259

Acute upper respiratory infections

911

4187

1.37

16.81

1.7

1.5

62.85

63.03

mu/l

0.01

826

3742

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

455

2911

1.54

16.79

1.5

57.15

67.17

mu/l

0.52

410

2615

Cervicocranial syndrome

107

440

2.46

16.68

1.4

56.99

62.21

mu/l

0.09

386

Major coronary heart disease event

589

2679

1.47

16.67

1.3

1.4

98.04

60.74

mu/l

1.87

530

2366

Migraine without aura and triptan purchases

152

725

2.12

16.63

1.9

1.8

51.88

52.27

mu/l

0.01

144

654

Gonarthrosis [arthrosis of knee](FG)

665

2721

1.44

16.61

1.4

1.5

64.09

61.16

mu/l

0.15

597

2427

Disorders of vestibular function (Vertigo)

390

2460

1.58

16.41

1.4

43.47

58.14

mu/l

1.75

351

2174

Soft tissue disorders related to use, overuse and pressure

233

1292

1.82

16.38

1.5

94.67

57.33

mu/l

0.72

213

1139

Benign neoplasm: Colon

421

2665

1.56

16.36

1.3

1.4

80.94

58.09

mu/l

0.99

365

2366

Sicca syndrome [Sjögren]

391

2.55

16.35

1.6

1.4

51.99

38.23

mu/l

0.45

353

Parodontitis or operation codes

781

4158

1.39

16.27

1.5

72.85

62.52

mu/l

0.53

705

3704

Adverse effects, not elsewhere classified

178

908

1.98

16.21

1.6

63.83

62.96

mu/l

0.02

163

806

Mental and behavioural disorders due to psychoactive substance use

496

3135

1.50

16.20

1.3

1.6

81.53

68.00

mu/l

0.42

426

2823

Noninfective enteritis and colitis

396

2533

1.57

16.08

1.6

1.5

62.82

66.00

mu/l

0.14

356

2259

Disorders of conjunctiva

706

4223

1.41

16.08

1.7

1.6

72.76

60.67

mu/l

0.55

638

3770

Rotator cuff syndrome

523

2616

1.49

16.06

1.5

66.91

60.94

mu/l

0.26

462

2335

Parodontitis

779

4159

1.39

16.05

1.5

72.94

62.52

mu/l

0.54

704

3704

Other diseases of pancreas

303

2.76

15.96

1.3

1.4

45.59

55.64

mu/l

0.26

268

Other diseases of urinary system

885

3658

1.37

15.92

1.5

1.6

59.73

64.69

mu/l

0.30

760

3308

Disorders of lacrimal system

351

2192

1.61

15.90

1.7

1.4

53.18

55.15

mu/l

0.08

314

1951

Asthma-related pneumonia

281

1656

1.71

15.88

1.5

1.4

66.34

62.55

mu/l

0.12

251

1468

Nephropathy related operations

120

532

2.29

15.82

1.4

1.5

110.91

58.12

mu/l

0.85

108

475

Malignant neoplasm of urinary organs

374

2.55

15.76

1.7

1.4

41.35

70.27

mu/l

0.84

329

Chronic periodontitis, including avohilmo

775

4164

1.38

15.74

1.5

72.42

62.68

mu/l

0.49

701

3707

Asthma-related pneumonia or sepsis

281

1661

1.70

15.70

1.5

1.4

66.34

63.16

mu/l

0.10

251

1471

Asthma, hospital admissions 3, pneumonia

281

1661

1.70

15.70

1.5

1.4

66.34

63.16

mu/l

0.10

251

1471

Other systemic involvement of connective tissue

241

1368

1.78

15.69

1.6

1.4

47.56

57.46

mu/l

0.62

212

1215

Cutaneous abscess, furuncle and carbuncle

226

1261

1.81

15.60

1.5

62.51

70.84

mu/l

0.30

198

1119

Sequelae of external causes of morbidity and mortality

222

1233

1.82

15.57

1.4

52.79

59.35

mu/l

0.28

198

1089

Diseases of the ear and mastoid process

1052

4019

1.33

15.49

1.6

62.58

67.59

mu/l

0.32

933

3625

Cyst of kidney

253

2.90

15.42

1.4

1.3

77.57

59.72

mu/l

0.25

219

Chronic rhinitis, nasopharyngitis and pharyngitis

285

1703

1.69

15.41

1.7

1.5

106.66

57.49

mu/l

1.70

241

1525

Excessive, frequent and irregular menstruation

344

1168

1.65

15.38

1.7

1.6

48.01

52.06

mu/l

0.18

310

1049

Generalized anxiety disorder

134

628

2.15

15.37

1.6

1.7

51.47

56.36

mu/l

0.15

115

567

Major coronary heart disease event excluding revascularizations

532

2499

1.48

15.35

1.3

1.4

96.88

60.92

mu/l

1.66

474

2203

Early onset COPD, excluding more controls

178

925

1.94

15.34

1.3

1.4

87.58

74.42

mu/l

0.30

157

819

Diabetic nephropathy, excluding more controls

173

738

1.99

15.29

1.5

125.79

80.89

mu/l

1.01

148

670

ILD medications: immunosuppressive drugs

524

3447

1.46

15.26

1.6

1.5

71.69

65.61

mu/l

0.25

471

3093

Direct fill therapy

132

619

2.16

15.15

1.6

1.5

104.76

52.73

mu/l

1.30

119

553

Other blood glucose lowering drugs, excl. Insulins

145

705

2.08

15.13

1.2

1.4

119.92

49.59

mu/l

2.10

122

620

Benign neoplasm of other and ill-defined parts of digestive system

165

841

1.98

15.13

1.7

1.4

46.22

58.29

mu/l

0.65

142

748

Injuries to the knee and lower leg

1026

4451

1.32

15.08

1.5

1.6

62.21

65.20

mu/l

0.18

915

3996

Disturbances of skin sensation

245

1414

1.75

15.07

1.6

62.30

57.68

mu/l

0.15

221

1274

Gout

214

1078

1.82

15.02

1.3

1.4

103.70

61.98

mu/l

1.47

183

949

Other and unspecified effects of external causes

240

1379

1.75

14.99

1.5

1.6

85.09

66.22

mu/l

0.31

218

1239

Transient ischemic attack

409

2209

1.54

14.99

1.4

73.15

56.76

mu/l

0.82

375

1937

Carpal tunnel syndrome

523

3245

1.46

14.97

1.4

1.5

78.31

58.57

mu/l

0.77

459

2897

Undetermined asthma, excluding more controls

115

512

2.27

14.97

1.5

45.40

56.49

mu/l

0.41

103

460

Gestational [pregnancy-induced] hypertension

222

1246

1.79

14.92

1.6

1.8

42.73

49.96

mu/l

0.56

202

1142

Cervicalgia

183

971

1.90

14.86

1.4

1.5

55.05

64.27

mu/l

0.45

167

853

Diseases of the respiratory system

599

2080

1.45

14.77

1.5

1.6

57.82

65.20

mu/l

0.42

529

1881

Other symptoms and signs involving the digestive system and abdomen

144

705

2.06

14.76

1.6

1.4

80.50

72.00

mu/l

0.11

124

627

Menorrhagia

315

1051

1.67

14.75

1.6

1.5

55.35

53.24

mu/l

0.07

285

940

Nontoxic multinodular goitre

175

918

1.93

14.73

1.4

1.3

38.05

52.18

mu/l

1.00

158

817

Disorders of lens

580

2545

1.44

14.72

1.4

1.5

57.40

66.13

mu/l

0.59

499

2282

Type 1 diabetes, strict definition, subgroup 1

298

2.68

14.69

2.4

1.8

59.09

67.04

mu/l

0.22

272

COPD (mode)

253

1166

1.73

14.66

1.2

1.4

79.62

66.38

mu/l

0.48

220

1029

Substance abuse

474

3073

1.48

14.63

1.3

1.6

72.18

69.28

mu/l

0.07

406

2763

Falls/tendency to fall

995

3763

1.33

14.62

1.5

1.6

62.78

69.30

mu/l

0.46

886

3398

Type 1 diabetes, strict definition

323

2.60

14.50

2.4

1.8

59.02

64.66

mu/l

0.16

296

Clear cell adenocarcinoma of kidney

167

3.31

14.45

1.9

1.3

22.90

70.11

mu/l

2.07

145

Persons with potential health hazards related to communicable diseases

317

1962

1.61

14.43

1.6

1.7

64.59

66.13

mu/l

0.05

284

1786

Myocardial infarction, without ST-elevation

295

1665

1.64

14.41

1.2

1.4

82.87

55.53

mu/l

1.45

263

1457

Hernia

807

4051

1.36

14.40

1.4

1.5

68.13

64.88

mu/l

0.15

713

3630

Non-ischemic cardiomyopathy

235

1105

1.76

14.39

1.5

1.4

70.22

48.74

mu/l

1.07

206

974

Aortic aneurysm

169

867

1.93

14.37

1.3

1.4

54.48

55.43

mu/l

0.03

152

763

Diaphragmatic hernia

295

1813

1.64

14.34

1.4

64.13

57.05

mu/l

0.24

253

1600

Arthrosis

636

2475

1.42

14.29

1.4

1.5

67.67

64.21

mu/l

0.15

573

2232

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

169

3.27

14.18

1.9

1.4

22.90

90.79

mu/l

2.31

150

Other external causes of accidental injury

773

2828

1.37

14.16

1.5

1.6

76.90

64.47

mu/l

0.42

693

2556

Urticaria and erythema

310

1938

1.61

14.05

1.7

1.5

53.82

60.90

mu/l

0.36

274

1749

Phobic anxiety disorders

115

527

2.20

13.99

1.8

1.6

108.21

61.40

mu/l

0.65

482

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

307

2.61

13.97

1.7

1.4

90.94

55.00

mu/l

0.62

273

Congenital malformations, deformations and chromosomal abnormalities

496

3284

1.45

13.94

1.6

85.79

64.40

mu/l

0.72

449

2967

Disorders of synovium and tendon

445

2709

1.49

13.92

1.4

1.6

77.74

60.35

mu/l

0.56

394

2416

Acute sinusitis

443

2792

1.49

13.90

1.8

1.6

60.38

65.53

mu/l

0.25

394

2507

Myocardial infarction

402

1897

1.53

13.88

1.3

1.4

88.93

59.21

mu/l

1.52

359

1679

Undetermined asthma

115

529

2.20

13.86

1.5

1.4

45.40

61.75

mu/l

0.66

103

474

Disorders resulting from impaired renal tubular function

123

3.67

13.76

1.4

1.3

64.48

43.12

mu/l

0.79

112

Familial hypercholesterolemia

112

512

2.21

13.73

1.4

1.3

133.62

46.52

mu/l

2.10

100

457

Other disorders of skin and subcutaneous tissue

552

3572

1.42

13.70

1.7

1.5

66.98

57.44

mu/l

0.68

485

3179

Unspecified haematuria

317

1708

1.60

13.70

1.6

1.4

52.53

68.86

mu/l

0.98

279

1509

Presence of other functional implants

454

2174

1.49

13.66

1.3

1.4

51.04

57.59

mu/l

0.45

378

1931

Acute upper respiratory infections of multiple and unspecified sites

619

3328

1.40

13.61

1.8

1.5

71.41

64.38

mu/l

0.36

562

2980

Other joint disorders

766

3004

1.36

13.54

1.7

1.6

59.68

65.87

mu/l

0.37

679

2725

Diseases of pulp and periapical tissues

295

1840

1.61

13.53

1.5

73.19

67.09

mu/l

0.21

267

1648

Unknown and unspecified causes of morbidity

249

2.77

13.50

1.4

87.36

50.53

mu/l

0.64

220

Gout, idiopatic and unspecified

189

1046

1.82

13.49

1.3

1.4

103.01

61.32

mu/l

1.27

163

917

Diabetic nephropathy

176

944

1.87

13.39

1.5

124.06

75.69

mu/l

1.23

151

840

Gonarthrosis,primary

738

3424

1.36

13.33

1.4

1.5

63.66

61.68

mu/l

0.10

667

3029

Allergic asthma (mode), excluding more controls

196

1079

1.79

13.31

1.5

1.6

86.31

55.59

mu/l

1.08

174

983

Senile cataract

523

2257

1.44

13.27

1.4

58.67

61.88

mu/l

0.16

448

2025

Dysphagia

188

1044

1.81

13.26

1.4

46.88

59.65

mu/l

0.52

158

919

Chronic pancreatitis

115

540

2.16

13.24

1.4

50.10

57.14

mu/l

0.24

480

Diseases of the digestive system

352

2292

1.54

13.24

1.5

1.4

47.70

68.51

mu/l

1.62

306

2026

Neuromuscular dysfunction of bladder

388

2.38

13.22

1.3

1.4

39.46

57.39

mu/l

0.55

346

External causes of morbidity and mortality

614

2190

1.41

13.15

1.5

1.6

79.00

60.75

mu/l

0.52

542

1981

Diseases of the musculoskeletal system and connective tissue

473

1609

1.48

13.12

1.6

1.7

61.04

67.51

mu/l

0.26

418

1471

Accidents

764

2828

1.36

13.06

1.5

1.6

76.93

64.47

mu/l

0.41

681

2556

Collagenous colitis

354

2.44

13.02

1.5

1.4

53.72

67.19

mu/l

0.19

313

Conjunctivitis

627

3977

1.38

12.98

1.7

1.6

68.80

60.73

mu/l

0.32

563

3565

Diseases of inner ear

436

2923

1.47

12.97

1.4

41.94

59.57

mu/l

2.74

392

2576

Gingivitis and periodontal diseases

780

2993

1.35

12.93

1.4

1.5

60.24

62.22

mu/l

0.12

695

2696

Abnormal findings on diagnostic imaging of lung

361

2319

1.52

12.90

1.4

71.96

61.41

mu/l

0.36

321

2035

Allergic asthma (mode)

196

1090

1.78

12.89

1.5

1.6

86.31

58.47

mu/l

0.93

174

995

Mouth breathing

349

2287

1.53

12.88

1.5

49.45

71.90

mu/l

2.00

316

2037

COPD

339

1810

1.55

12.88

1.3

1.4

82.83

63.48

mu/l

0.97

294

1590

Parodontitis and operation codes

720

4160

1.35

12.84

1.5

66.01

63.93

mu/l

0.11

650

3705

Gout, FINNGEN

214

1246

1.73

12.84

1.3

1.4

103.70

58.33

mu/l

1.70

183

1093

Asthma and allergy

113

526

2.14

12.83

1.6

1.7

83.31

52.45

mu/l

0.77

481

Correction of physiology of bite - demanding therapy visit

285

2.60

12.83

2.4

1.5

75.24

44.05

mu/l

0.59

263

Vitamin deficiency, wide

154

3.24

12.77

1.4

1.3

129.34

43.16

mu/l

0.67

137

Vitamin deficiency

154

3.24

12.77

1.4

1.3

129.34

43.16

mu/l

0.67

137

Behavioural syndromes associated with physiological disturbances and physical factors

261

1603

1.64

12.75

1.8

1.7

62.68

67.46

mu/l

0.15

232

1453

Asthma and allergy, excluding more controls

113

528

2.13

12.71

1.6

1.7

83.31

50.43

mu/l

0.85

482

Ischaemic Stroke, excluding all haemorrhages

426

2188

1.48

12.70

1.4

73.89

57.85

mu/l

0.82

375

1918

Type1 diabetes, definitions combined, early onset

280

2.60

12.63

3.1

1.8

61.21

76.33

mu/l

0.44

251

Post-traumatic stress disorder

281

2.59

12.63

1.9

1.6

68.92

48.48

mu/l

0.34

255

Substance use, excluding alcohol

171

938

1.84

12.60

1.2

1.6

116.53

64.10

mu/l

0.75

145

847

Deforming dorsopathies

232

1390

1.68

12.53

1.5

62.92

62.27

mu/l

0.02

203

1228

Sequelae with surgical and medical care as external cause

170

934

1.84

12.48

1.3

1.4

47.50

60.01

mu/l

0.85

154

830

Other chronic obstructive pulmonary disease, including avohilmo

404

2275

1.48

12.46

1.2

1.4

77.22

62.39

mu/l

0.81

353

2008

Intestinal stricture

241

1461

1.66

12.45

1.5

1.4

66.40

64.57

mu/l

0.04

213

1299

Gonarthrosis

560

2285

1.41

12.44

1.4

1.5

66.51

61.67

mu/l

0.23

501

2052

Other diseases of blood and blood-forming organs

261

2.65

12.38

1.6

1.4

93.52

59.73

mu/l

0.53

232

L01XX Other antineoplastic agents

200

2.90

12.32

3.3

1.3

75.59

49.30

mu/l

0.30

178

Other disorders of eyelid

339

2154

1.53

12.31

1.3

1.4

50.58

57.91

mu/l

0.36

303

1895

Ovarian dysfunction

228

2.75

12.24

2.9

1.3

75.84

46.35

mu/l

0.68

207

Osteoporosis with pathological fracture (FG)

263

2.63

12.21

1.6

1.3

67.29

45.88

mu/l

0.41

235

Mixed hyperlipidaemia

109

3.64

12.20

2.0

1.3

95.71

61.05

mu/l

0.34

Other and unspecified polyneuropathies, also in other diseases

156

842

1.87

12.14

1.3

1.4

66.00

51.69

mu/l

0.48

144

744

Pruritus

450

2.20

11.98

1.5

43.35

45.23

mu/l

0.07

399

Spondylolisthesis/Spondylolysis

159

869

1.85

11.90

1.5

1.4

70.26

63.54

mu/l

0.15

141

768

Persons encountering health services for specific procedures, not carried out

296

2.50

11.88

2.1

1.5

102.60

53.59

mu/l

0.46

262

Codes for special purposes

355

2379

1.50

11.85

1.5

1.6

51.62

63.67

mu/l

0.94

321

2139

Follow-up examination after treatment for conditions other than malignant neoplasms

353

1526

1.52

11.85

1.5

62.64

59.10

mu/l

0.09

321

1354

Polyuria

172

964

1.80

11.84

1.6

1.4

44.91

59.14

mu/l

0.89

151

850

Other disorders of bladder

105

498

2.13

11.83

1.6

1.4

67.51

57.54

mu/l

0.19

444

Immunodeficiencies

183

2.95

11.81

1.5

1.4

178.75

101.81

mu/l

0.41

164

Provisional assignment of new diseases of uncertain etiology

354

2373

1.50

11.80

1.5

1.6

51.74

63.81

mu/l

0.94

320

2133

Focal epilepsy

172

967

1.79

11.70

1.5

59.04

69.08

mu/l

0.32

157

854

Enthesopathies of lower limb, excluding foot

187

1078

1.75

11.69

1.4

1.5

57.78

65.85

mu/l

0.30

169

956

All influenza

197

1152

1.72

11.68

1.5

85.28

60.80

mu/l

0.80

177

1029

Other arthritis (FG)

252

1571

1.61

11.67

1.4

1.5

73.21

60.75

mu/l

0.40

223

1385

Bronchitis

890

4516

1.30

11.67

1.6

64.64

61.56

mu/l

0.18

802

4041

Benign paroxysmal vertigo

234

1434

1.64

11.64

1.5

1.4

30.65

59.38

mu/l

5.06

207

1279

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

764

3416

1.33

11.63

1.7

1.5

57.42

67.00

mu/l

0.56

689

3067

Azathioprine

131

678

1.95

11.60

1.7

1.6

73.01

56.87

mu/l

0.57

116

608

Polyneuropathies and other disorders of the peripheral nervous system

173

979

1.78

11.55

1.3

1.4

65.32

56.75

mu/l

0.27

159

859

Gout, strict definition

135

707

1.93

11.55

1.2

1.4

128.13

63.43

mu/l

1.49

114

622

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

763

3416

1.32

11.51

1.7

1.5

57.55

67.00

mu/l

0.54

687

3067

Vascular disorders of the intestines

202

2.81

11.49

1.2

1.4

144.32

69.66

mu/l

0.49

177

Malignant neoplasm, wide definition for exclusion

763

3417

1.32

11.49

1.7

1.5

57.55

66.98

mu/l

0.54

687

3068

Urticaria

251

1570

1.61

11.48

1.7

1.6

52.33

57.99

mu/l

0.22

220

1419

Other chronic obstructive pulmonary disease

321

1754

1.53

11.47

1.2

1.4

82.75

61.56

mu/l

1.06

278

1541

Nonorganic sleeping disorders, excluding more controls

146

786

1.87

11.46

1.5

1.6

63.90

59.17

mu/l

0.11

130

715

ILD medications: azathioprine

131

681

1.94

11.46

1.7

1.6

73.01

55.89

mu/l

0.61

116

611

Arthropathies

781

3011

1.32

11.43

1.7

1.6

64.02

65.79

mu/l

0.08

697

2732

Other symptoms and signs involving the urinary system

401

2.25

11.42

1.3

1.4

51.73

74.04

mu/l

0.72

353

Other and unspecified drugs and medicaments

345

2.35

11.40

1.5

1.4

61.92

69.27

mu/l

0.08

300

Personality disorders

228

1397

1.64

11.35

1.6

61.63

60.24

mu/l

0.04

202

1271

Other diseases of blood and blood-forming organs, wide

185

1073

1.74

11.35

1.7

1.4

76.59

72.44

mu/l

0.07

163

955

Panic disorder

121

614

1.99

11.34

1.6

1.7

53.37

54.32

mu/l

0.02

108

559

Factors influencing health status and contact with health services

263

811

1.63

11.32

1.5

53.04

71.65

mu/l

0.62

236

739

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

214

1294

1.66

11.20

1.6

1.7

105.01

57.35

mu/l

0.86

186

1185

Noninfectious colitis NAS

114

570

2.02

11.17

1.7

1.5

71.95

67.51

mu/l

0.07

104

501

Disorders of skin appendages

386

2662

1.46

11.15

1.6

64.20

60.06

mu/l

0.19

350

2388

Pre-eclampsia or poor fetal growth

249

1562

1.60

11.14

1.8

1.7

56.07

52.86

mu/l

0.08

220

1421

Other diseases of stomach and duodenum

241

2.61

11.05

1.5

1.3

51.13

51.63

mu/l

0.01

214

Other and unspecified nerve root and plexus disorders, also in other diseases

159

890

1.80

11.04

1.3

1.5

51.85

58.11

mu/l

0.22

143

798

Abnormal results of function studies

338

2.34

11.00

1.9

1.4

64.16

53.80

mu/l

0.14

302

Pain in thoracic spine

128

670

1.93

10.99

1.5

42.68

58.49

mu/l

0.80

113

596

Other symptoms and signs involving cognitive functions and awareness

321

2007

1.51

10.95

1.4

66.93

56.05

mu/l

0.44

282

1766

Diseases of oral cavity, salivary glands and jaws

769

3004

1.32

10.89

1.5

62.70

65.81

mu/l

0.16

683

2706

Specific personality disorders

194

1155

1.69

10.82

1.5

1.7

63.15

59.71

mu/l

0.09

172

1056

Conduction disorders

209

1047

1.67

10.80

1.3

1.5

80.86

53.51

mu/l

0.89

181

933

Dipeptidyl peptidase 4 (DPP-4) inhibitors

477

2.10

10.76

1.3

1.4

122.51

49.00

mu/l

1.62

413

Cardiodefibrillation

270

1743

1.56

10.74

1.3

1.4

74.76

61.44

mu/l

0.44

238

1534

Other diseases of upper respiratory tract

938

3835

1.28

10.70

1.5

1.6

68.23

63.69

mu/l

0.26

827

3452

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

139

729

1.86

10.68

1.4

1.6

91.21

72.20

mu/l

0.24

123

656

Other bacterial intestinal infections

142

776

1.84

10.68

1.8

1.4

98.42

62.74

mu/l

0.68

124

687

Other diseases of hard tissues of teeth

533

2903

1.37

10.67

1.6

1.5

63.26

66.58

mu/l

0.13

475

2612

Monoamine oxidase A inhibitors

110

554

2.01

10.60

1.5

1.4

64.23

60.67

mu/l

0.06

501

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

363

2.26

10.57

1.5

1.4

61.09

65.99

mu/l

0.05

320

Congenital malformations of the urinary system

201

2.73

10.50

1.4

1.5

53.04

92.80

mu/l

0.38

181

Vitamin B12 deficiency anaemia

409

2.17

10.49

2.0

1.3

111.18

49.10

mu/l

0.77

361

Glomerulonephritis

416

2.16

10.48

1.2

1.4

99.10

55.55

mu/l

0.82

366

Nontoxic goitre/thyroid nodule

246

1571

1.58

10.37

1.4

43.88

59.22

mu/l

1.32

220

1388

Other abnormal findings of blood chemistry

153

3.00

10.35

1.2

1.3

63.47

45.13

mu/l

0.45

139

Abnormal involuntary movements

109

552

1.99

10.34

1.4

91.35

50.24

mu/l

0.72

486

Hypermobility syndrome

197

2.73

10.34

2.2

1.7

29.47

45.23

mu/l

0.92

182

Conjunctivitis (acute, non atopic)

225

1403

1.61

10.34

1.7

1.5

87.37

67.48

mu/l

0.33

206

1268

Other specified/unspecified arthritis

220

1370

1.62

10.31

1.4

1.5

77.48

60.10

mu/l

0.53

193

1220

Disorders of adult personality and behaviour

234

1479

1.59

10.30

1.5

1.6

65.19

59.23

mu/l

0.18

210

1345

Artrosis, including avohilmo

714

2983

1.32

10.30

1.5

1.6

67.83

66.47

mu/l

0.06

644

2672

Cerebral palsy and other paralytic syndromes

452

2.10

10.28

1.5

1.4

80.58

55.73

mu/l

0.37

398

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

143

718

1.82

10.27

1.8

1.9

52.98

78.06

mu/l

0.88

130

657

Diseases of salivary glands

164

947

1.75

10.27

1.8

1.5

72.03

56.11

mu/l

0.42

141

844

Fracture of rib(s), sternum and thoracic spine

227

1426

1.60

10.27

1.4

74.42

60.99

mu/l

0.43

202

1262

Extreme obesity with alveolar hypoventilation

149

3.01

10.21

1.2

1.3

50.95

65.38

mu/l

0.32

134

Benign neoplasm of meninges

441

2.11

10.17

1.7

1.4

47.98

37.11

mu/l

0.23

388

Psychotic depression

228

2.58

10.12

1.6

1.5

29.08

48.36

mu/l

1.17

206

Pulmonary heart disease, diseases of pulmonary circulation

233

1479

1.58

10.07

1.6

1.4

52.24

59.28

mu/l

0.31

209

1310

Focal epilepsy, strict definition

155

886

1.76

10.05

1.6

1.5

60.43

69.76

mu/l

0.26

143

779

COPD related to multimorbidity

279

1545

1.53

10.04

1.2

1.4

79.34

59.55

mu/l

0.99

243

1362

Benign neoplasm of brain and other parts of central nervous system

247

2.51

10.03

1.6

1.4

39.21

48.20

mu/l

0.32

215

Benign neoplasm of meninges

444

2.10

10.00

1.7

1.4

47.98

49.37

mu/l

0.02

394

TMD related operations

143

801

1.80

9.97

2.2

1.5

68.20

55.51

mu/l

0.35

124

717

Hyperkinetic disorders, excluding more controls

343

2.23

9.92

1.8

48.16

70.32

mu/l

1.16

319

Thyrotoxicosis

204

1260

1.63

9.92

2.0

1.4

63.95

54.22

mu/l

0.43

173

1123

446

2959

1.39

9.89

1.4

1.5

80.84

68.07

mu/l

0.32

389

2653

Acute pharyngitis

120

633

1.90

9.88

2.2

1.5

49.79

70.35

mu/l

1.43

110

564

Mental and behavioural disorders due to alcohol

393

2709

1.42

9.87

1.4

1.5

73.74

71.66

mu/l

0.04

338

2435

Thoracic aortic aneurysm

110

569

1.95

9.85

1.4

39.48

63.23

mu/l

1.21

505

Other sleep disorders

394

2.15

9.81

1.6

1.5

62.74

58.27

mu/l

0.11

346

Abnormal findings on examination of urine, without diagnosis

147

2.98

9.81

1.9

1.3

60.67

45.91

mu/l

0.42

131

Carbimazole or st.post thyroidectomy, condition for graves disease

174

1037

1.69

9.74

1.9

1.5

48.28

53.89

mu/l

0.30

146

927

Pulmonary heart disease

217

1366

1.60

9.74

1.6

1.4

52.20

60.46

mu/l

0.34

195

1208

AV-block

119

573

1.90

9.70

1.3

1.4

67.23

52.45

mu/l

0.50

507

466

3046

1.38

9.69

1.4

1.5

87.72

67.53

mu/l

0.57

408

2732

Pulmonary embolism

217

1368

1.60

9.69

1.6

1.4

52.20

60.30

mu/l

0.34

195

1211

Personal history of other diseases and conditions

474

2.04

9.68

1.7

1.6

98.60

67.51

mu/l

0.35

426

Intracerebral haemorrhage

436

2.08

9.66

1.3

1.4

53.57

57.51

mu/l

0.07

382

Myocardial infarction, strict

351

1771

1.45

9.66

1.3

1.4

85.92

60.04

mu/l

1.12

313

1568

Cluster headache, wide

117

3.21

9.63

1.5

30.01

47.35

mu/l

0.79

100

Intracranial injury

433

3027

1.39

9.60

1.6

1.5

64.48

59.87

mu/l

0.19

392

2701

Non-allergic asthma (mode), excluding more controls

150

853

1.75

9.59

1.4

1.5

43.77

55.53

mu/l

0.65

135

762

Contact with and exposure to communicable diseases

241

1554

1.55

9.58

1.6

1.8

59.91

66.42

mu/l

0.22

221

1425

Injuries to the ankle and foot

552

3775

1.34

9.57

1.5

1.6

69.26

65.41

mu/l

0.18

480

3412

Bacterial intestinal infections, IBD co-morbidities

140

789

1.79

9.57

1.8

1.4

100.00

60.59

mu/l

0.76

121

699

Deposits [accretions] on teeth

273

2.36

9.55

1.3

1.6

159.48

100.79

mu/l

0.39

245

Venous thromboembolism

401

2784

1.40

9.54

1.6

1.4

57.79

59.02

mu/l

0.05

359

2455

Other and unspecified tonsillitis

264

1473

1.53

9.53

1.8

1.6

64.24

73.66

mu/l

0.39

242

1339

Melanocytic naevi

226

1445

1.57

9.52

1.6

1.5

34.03

64.39

mu/l

5.80

203

1293

Nephrotic syndrome

103

3.37

9.49

1.2

1.3

154.90

52.39

mu/l

0.80

Benign neoplasm of brain and other parts of central nervous system

254

2.44

9.47

1.6

1.4

39.21

54.51

mu/l

0.56

227

Viral hepatitis, IBD co-morbidity

139

2.98

9.46

1.4

1.7

104.57

77.42

mu/l

0.22

128

Chronic gastritis

207

1299

1.60

9.44

1.6

1.3

63.43

58.11

mu/l

0.17

170

1151

Dermatographic urticaria

261

2.41

9.40

1.5

1.6

36.14

47.52

mu/l

0.44

240

L04AD Calcineurin inhibitors

482

2.01

9.39

1.9

1.5

93.44

76.56

mu/l

0.16

439

Viral pneumonia

103

530

1.96

9.38

1.3

1.5

84.74

74.63

mu/l

0.13

471

conjunctival haemorrhage

300

2.30

9.28

2.0

1.3

107.18

57.58

mu/l

0.55

266

Blepharochalasis

227

1463

1.56

9.26

1.2

1.4

45.32

62.37

mu/l

0.93

200

1287

Thyrotoxicosis, other and/or unspecified

152

886

1.73

9.25

1.9

1.4

53.93

50.89

mu/l

0.13

132

790

Focal epilepsy, mode (most common among epilepsy diagnosis)

147

849

1.74

9.24

1.6

1.5

60.12

69.37

mu/l

0.25

134

747

Erosion of teeth, including avohilmo

159

906

1.71

9.21

1.9

1.6

58.76

63.32

mu/l

0.17

140

819

Gastroduodenal ulcer

183

1119

1.64

9.19

1.4

1.3

58.59

67.70

mu/l

0.26

157

978

Hernia of abdominal wall

345

2426

1.43

9.12

1.3

1.5

88.66

61.89

mu/l

0.99

309

2154

Ulcer of lower limb, not elsewhere classified

107

564

1.91

9.09

1.5

1.4

85.77

61.94

mu/l

0.73

495

COPD, hospital admissions

321

1878

1.45

9.09

1.2

1.4

82.75

59.54

mu/l

1.23

278

1659

Disorders of vitreous body

379

2653

1.40

9.08

1.4

55.58

56.62

mu/l

0.05

333

2339

Other cataract

329

1766

1.45

9.06

1.4

53.09

59.67

mu/l

0.37

288

1573

Other disorders of ear

745

3888

1.28

9.05

1.5

62.61

64.64

mu/l

0.10

646

3483

Mycoses

203

1282

1.59

9.05

1.9

1.4

69.83

61.22

mu/l

0.17

173

1145

Artificial joint operation, meniscal resection

730

3797

1.28

9.01

1.4

1.5

63.73

65.29

mu/l

0.08

660

3369

Kidney transplant status

177

2.70

8.99

1.5

1.4

74.16

64.41

mu/l

0.12

159

Inflammatory diseases of female pelvic organs

492

2756

1.35

8.94

1.6

44.97

53.47

mu/l

0.76

429

2486

Benign neoplasm: Colon, unspecified

180

1102

1.64

8.94

1.3

67.04

60.11

mu/l

0.18

153

978

Benign neoplasm: Caecum

423

2.06

8.94

1.5

1.3

82.78

65.69

mu/l

0.22

377

Postmenopausal osteoporosis with pathological fracture

237

2.45

8.92

1.7

1.3

61.82

39.58

mu/l

0.40

205

Non-allergic asthma (mode)

150

872

1.71

8.91

1.4

1.5

43.77

58.97

mu/l

0.92

135

778

Mental and behavioural disorders due to alcohol, excluding acute intoxication

340

2394

1.42

8.88

1.4

1.5

63.31

73.60

mu/l

0.24

292

2137

Other benign neoplasms of skin

274

1819

1.49

8.86

1.5

1.4

61.08

55.76

mu/l

0.18

243

1616

Cellulitis

167

1011

1.66

8.85

1.5

83.05

56.05

mu/l

0.76

143

896

Alcohol use disorder, Swedish definition

418

2829

1.38

8.85

1.4

1.5

80.37

69.86

mu/l

0.24

366

2534

Persistent mood disorders

153

907

1.70

8.78

1.5

76.24

64.80

mu/l

0.20

135

816

Appendectomy

528

3849

1.33

8.77

1.5

1.6

51.98

67.00

mu/l

1.21

479

3446

Faecal incontinence

353

2.15

8.75

1.5

1.4

46.97

55.18

mu/l

0.12

315

Other necrotizing vasculopathies (FG)

209

2.52

8.73

1.5

1.3

200.11

45.68

mu/l

0.76

190

Idiopathic gout

347

2.16

8.72

1.1

1.4

96.62

81.25

mu/l

0.18

306

Other disorders of nervous system

252

2.37

8.70

1.4

76.78

56.30

mu/l

0.47

225

Other disorders of white blood cells

198

2.56

8.67

1.6

1.3

43.43

42.44

mu/l

0.02

174

Cardiac murmurs and other cardiac sounds

318

2.19

8.63

1.4

1.5

56.52

81.61

mu/l

0.33

280

COPD, early/later onset

321

1893

1.44

8.62

1.2

1.4

82.75

59.65

mu/l

1.23

278

1673

Sequelae of cerebrovascular disease

239

1385

1.52

8.59

1.3

1.4

71.27

54.44

mu/l

0.63

211

1216

Pain and other conditions associated with female genital organs and menstrual cycle

149

845

1.70

8.58

1.6

39.24

51.03

mu/l

0.79

129

769

Chronic sinusitis

342

2428

1.41

8.57

1.6

1.5

71.87

61.74

mu/l

0.40

294

2171

Oxicams

195

687

1.62

8.54

1.5

1.6

47.59

53.33

mu/l

0.25

178

610

Disorders of vitreous body and globe

384

2714

1.39

8.53

1.4

55.91

56.02

mu/l

0.00

338

2394

Abnormal weight loss

357

2.13

8.52

1.4

68.79

53.63

mu/l

0.23

316

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

325

2.18

8.48

2.0

1.4

37.61

48.34

mu/l

0.40

289

Other diseases of pleura

310

1917

1.44

8.44

1.5

1.4

85.42

65.04

mu/l

0.68

272

1692

Cluster headache, wide,, including avohilmo

195

2.55

8.42

1.3

1.5

51.93

44.02

mu/l

0.19

177

Benign neoplasm: Pancreas

3.46

8.41

2.4

1.3

43.55

40.37

mu/l

0.05

Otalgia

313

2.20

8.41

1.3

1.5

41.53

71.23

mu/l

0.46

281

Injuries to the head

884

4642

1.24

8.40

1.5

1.6

80.68

62.36

mu/l

0.80

792

4165

Other acute lower respiratory infections

388

2693

1.38

8.40

1.5

66.12

63.98

mu/l

0.08

344

2407

Other diseases of intestine

481

1.95

8.40

1.3

1.4

66.08

63.69

mu/l

0.04

430

Weight loss

393

2.06

8.37

1.4

65.60

52.01

mu/l

0.22

349

Radiculopathy

126

718

1.77

8.36

1.4

60.99

62.48

mu/l

0.03

117

632

Other diseases of anus and rectum

207

1337

1.55

8.36

1.4

63.34

63.73

mu/l

0.01

179

1181

Fungal Sepsis

112

3.09

8.31

1.4

1.3

72.87

51.58

mu/l

0.37

Abnormalities of gait and mobility

476

1.95

8.31

1.4

84.28

61.40

mu/l

0.41

420

Retention of urine

224

1241

1.53

8.30

1.5

1.4

65.82

61.69

mu/l

0.12

190

1097

Other problems related to primary support group, including family circumstances

470

1.95

8.30

1.9

1.7

67.24

75.94

mu/l

0.12

427

Symptoms and signs involving speech and voice

251

1694

1.49

8.30

1.5

45.94

57.81

mu/l

0.73

216

1506

Pre-eclampsia or eclampsia

177

1108

1.61

8.24

1.7

1.6

65.11

50.78

mu/l

0.32

157

1003

Gout, unspecified

143

848

1.70

8.24

1.3

1.4

100.38

60.95

mu/l

1.02

120

745

Coxibs

226

777

1.55

8.21

1.5

1.6

70.97

52.88

mu/l

0.52

199

695

Mental and behavioural disorders due to sedatives or hypnotics

265

2.29

8.21

1.1

1.5

44.92

52.95

mu/l

0.24

236

Benign neoplasm: Caecum

437

1.99

8.21

1.5

1.3

82.78

61.61

mu/l

0.29

385

Subjective visual disturbances

189

1203

1.58

8.21

1.7

1.4

61.53

57.61

mu/l

0.11

167

1067

Sleep disorders

166

1025

1.63

8.18

1.5

1.6

65.98

61.63

mu/l

0.11

149

920

Agoraphobia

3.28

8.10

1.5

193.89

55.18

mu/l

0.46

Budesonide

108

594

1.83

8.09

1.7

1.5

55.37

55.55

mu/l

0.00

525

Other pleural conditions

378

2.06

8.07

1.7

1.4

80.59

64.62

mu/l

0.28

336

Insomnia

123

704

1.76

8.06

1.4

1.6

60.19

55.67

mu/l

0.10

113

630

Injuries to the thorax

326

2323

1.41

8.05

1.4

1.5

73.22

64.35

mu/l

0.33

288

2060

Other arthrosis

415

2185

1.36

8.04

1.5

69.68

62.37

mu/l

0.29

373

1961

Other disorders of teeth and supporting structures

169

1054

1.61

8.01

1.4

69.87

67.83

mu/l

0.04

148

939

Peripheral arterial reconstruction

113

632

1.80

8.00

1.2

1.4

130.10

54.24

mu/l

2.11

555

Cervicobrachial syndrome

173

1085

1.60

8.00

1.6

1.5

68.22

62.48

mu/l

0.14

155

964

Disorders of continuity of bone

393

2.03

8.00

1.8

1.4

85.22

50.04

mu/l

0.58

348

Nonorganic sleeping disorders

146

878

1.67

7.99

1.5

63.90

59.21

mu/l

0.10

130

786

Meniscus derangement

454

2318

1.34

7.99

1.5

53.15

68.07

mu/l

0.93

404

2089

Ventral hernia

182

1156

1.58

7.99

1.3

1.4

116.47

55.42

mu/l

1.40

162

1032

Preparation and fitting of bite rail to mouth

113

633

1.80

7.98

2.2

1.5

67.06

48.99

mu/l

0.46

101

572

Benign neoplasm: Rectum, anus and anal canal

148

896

1.66

7.91

1.4

1.3

42.83

63.57

mu/l

1.27

134

791

Heart failure and bmi 25plus

274

1296

1.47

7.90

1.4

88.61

56.11

mu/l

1.48

227

1161

Early onset COPD

178

1128

1.59

7.90

1.3

1.4

87.58

62.08

mu/l

0.74

157

1000

Disturbance of activity and attention

350

2.08

7.85

1.8

1.6

48.29

77.70

mu/l

1.58

313

Bipolar affective disorders

144

870

1.67

7.75

1.5

1.6

64.97

58.80

mu/l

0.19

126

794

Emotionally unstable personality disorder

502

1.89

7.74

1.4

1.6

83.29

53.71

mu/l

0.57

457

Benign neoplasm: Pancreas

3.26

7.72

2.4

1.3

43.55

50.11

mu/l

0.10

Spontaneous rupture of synovium and tendon

338

2.09

7.70

1.2

1.4

93.62

34.05

mu/l

1.24

298

Haemorrhoids and perianal venous thrombosis

203

1332

1.53

7.69

1.4

74.95

63.03

mu/l

0.40

182

1176

Obsessive-compulsive disorder

229

2.34

7.64

1.8

1.6

107.71

58.95

mu/l

0.53

205

Missing teeth due to accident, extraction or parodontitis

526

1.86

7.64

1.4

93.63

54.59

mu/l

0.63

463

Diseases of male genital organs

394

1452

1.38

7.64

1.6

1.5

74.63

84.97

mu/l

0.42

352

1308

Need for other prophylactic measures

217

2.38

7.63

1.9

1.4

69.06

87.39

mu/l

0.16

191

Nontraumatic intracranial haemmorrhage

138

828

1.68

7.63

1.3

1.4

54.21

49.57

mu/l

0.13

124

730

Other enthesopathies

229

1545

1.49

7.62

1.5

109.73

55.18

mu/l

1.20

203

1370

Gonarthrosis, primary, with knee surgery

407

2469

1.35

7.62

1.3

1.4

75.55

56.45

mu/l

1.07

373

2166

Atopic dermatitis, strict definition with reimbursement

224

1458

1.50

7.60

1.6

1.7

85.12

64.00

mu/l

0.54

204

1327

Diseases of the myoneural junction and muscle

520

1.86

7.59

1.4

45.46

59.51

mu/l

0.46

462

Benign neoplasm: Colon, unspecified

180

1155

1.57

7.59

1.3

1.4

67.04

61.09

mu/l

0.16

153

1021

Other gastritis (incl. Duodenitis)

170

1077

1.59

7.57

1.5

1.4

98.95

58.14

mu/l

0.88

149

947

Temporomandibular joint disorders, including avohilmo

318

2280

1.40

7.56

2.1

1.6

57.19

57.06

mu/l

0.00

285

2058

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

421

3105

1.34

7.55

1.6

56.14

57.56

mu/l

0.07

373

2791

Benign neoplasm: Rectum

133

794

1.69

7.53

1.3

43.30

64.64

mu/l

1.19

119

703

Dental caries 3 and operation codes

736

3009

1.26

7.51

1.5

1.6

64.40

66.06

mu/l

0.08

633

2714

Pre-eclampsia

161

1009

1.61

7.51

1.7

67.91

51.89

mu/l

0.33

144

916

Postprocedural disorders of nervous system

295

2.16

7.51

1.8

1.6

38.46

48.69

mu/l

0.39

265

Diplopia

101

558

1.83

7.50

1.9

1.4

74.89

55.48

mu/l

0.39

492

Primary gonarthrosis, bilateral

371

2387

1.37

7.49

1.3

1.4

84.80

54.98

mu/l

1.73

345

2097

COPD, hospital admission 2, with asthma infections

213

1208

1.51

7.45

1.2

1.4

79.88

60.69

mu/l

0.70

187

1061

Melanocytic naevi

226

1529

1.49

7.44

1.6

1.5

34.03

60.13

mu/l

5.09

203

1369

Any event in cancer register

762

3631

1.25

7.44

1.7

1.5

61.07

65.77

mu/l

0.21

676

3274

Leiomyoma of uterus

382

1574

1.37

7.43

1.5

1.6

51.82

53.47

mu/l

0.08

352

1416

Other necrotizing vasculopathies

271

2.20

7.39

1.5

1.3

180.84

44.79

mu/l

0.77

243

Other/unspecified disorders of vestibular function

137

2.75

7.38

1.4

50.53

42.77

mu/l

0.12

124

Implicit fungal Sepsis

104

3.03

7.38

1.5

1.3

68.89

53.62

mu/l

0.23

Triptan medication for migraine, min. 3 purchases

436

2593

1.33

7.37

1.7

53.91

60.26

mu/l

0.40

400

2347

Adjustment and management of implanted device

128

761

1.69

7.36

1.4

1.3

69.73

56.81

mu/l

0.35

120

662

Dissociative [conversion] disorders

126

2.82

7.35

1.6

37.37

47.95

mu/l

0.35

117

KRA_PSY_EATING, excluding more controls

264

2.21

7.34

2.1

1.7

81.60

83.27

mu/l

0.01

241

Other benign neoplasms of skin

274

1928

1.43

7.34

1.5

1.4

61.08

57.72

mu/l

0.10

243

1708

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

233

2.13

7.34

1.2

1.5

52.55

55.60

mu/l

0.06

207

Polyarthrosis

156

935

1.61

7.32

1.5

1.3

52.49

55.51

mu/l

0.07

143

836

Trochanteric bursitis

106

599

1.78

7.31

1.5

52.11

46.95

mu/l

0.16

537

Endometriosis

269

1106

1.45

7.31

1.6

1.5

46.23

52.78

mu/l

0.35

246

994

Leiomyoma of uterus

504

2192

1.31

7.30

1.5

1.6

52.03

53.10

mu/l

0.05

458

1955

Malignant neoplasm

735

3497

1.25

7.30

1.7

1.5

57.14

67.05

mu/l

0.62

656

3138

Thyrotoxicosis with diffuse goitre

107

607

1.78

7.28

2.6

1.4

47.41

47.93

mu/l

0.02

542

DVT of lower extremities and pulmonary embolism

289

2050

1.41

7.25

1.6

1.4

54.15

59.51

mu/l

0.25

259

1807

Candidiasis

101

564

1.81

7.25

2.4

1.5

85.80

52.15

mu/l

0.42

498

Disorders of psychological development

428

1.90

7.23

1.5

1.7

59.66

89.04

mu/l

0.56

388

Acute bronchitis

292

2041

1.41

7.21

1.5

67.13

60.31

mu/l

0.24

261

1825

Hyperkinetic disorders

396

1.96

7.20

1.8

1.6

48.16

75.75

mu/l

1.60

355

Use of pramipexole

164

1044

1.58

7.19

1.4

69.15

58.51

mu/l

0.25

141

931

Injuries to the abdomen, lower back, lumbar spine and pelvis

279

1963

1.42

7.19

1.4

1.5

90.16

61.19

mu/l

0.62

245

1740

Cerebral aneurysm, nonruptured

361

2.02

7.18

1.3

1.5

74.82

36.89

mu/l

1.20

322

Fissure and fistula of anal and rectal regions

178

1155

1.55

7.16

1.5

95.03

66.07

mu/l

0.74

160

1031

Other obstetric conditions, not elsewhere classified

223

973

1.50

7.12

2.4

1.8

73.09

49.40

mu/l

0.95

207

895

Alcohol use disorder, ICD-based

308

2224

1.39

7.11

1.3

1.5

64.41

73.55

mu/l

0.18

263

1989

Parodontitis or/and operation codes

521

2391

1.30

7.11

1.5

1.6

71.38

60.52

mu/l

0.69

469

2134

Disorders of sclera, cornea, iris and ciliary body

410

3095

1.33

7.10

1.7

1.5

51.20

65.02

mu/l

1.57

373

2755

Urolithiasis

229

1571

1.46

7.05

1.5

1.4

75.71

65.58

mu/l

0.33

208

1383

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

277

1965

1.41

7.03

1.6

55.98

55.54

mu/l

0.02

236

1788

Cluster headache, strict, including avohilmo

176

2.48

7.03

1.3

1.5

54.95

46.69

mu/l

0.17

159

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

203

1345

1.50

7.02

2.0

1.7

61.71

64.09

mu/l

0.06

180

1231

Other disorders of conjunctiva

108

622

1.75

7.00

2.0

1.4

87.92

60.45

mu/l

0.45

100

551

Mental and behavioural disorders due to tobacco

365

1.99

6.98

1.2

1.4

201.48

56.76

mu/l

0.98

335

Dental pulpitis 2

554

2206

1.29

6.94

1.5

57.48

71.11

mu/l

0.74

482

1979

Smoking dependency

366

1.99

6.93

1.2

1.4

201.48

57.30

mu/l

0.97

335

Other disorders of eye and adnexa

105

602

1.76

6.91

1.7

1.5

90.91

51.21

mu/l

1.06

536

Myeloproliferative diseases

339

2.03

6.91

1.3

1.4

66.91

52.99

mu/l

0.17

299

Speech therapy

204

1375

1.49

6.89

1.4

51.06

57.13

mu/l

0.19

189

1222

Benign neoplasm: Rectum

133

814

1.65

6.89

1.3

1.4

43.30

58.47

mu/l

0.79

119

724

Hyperplasia of prostate

252

993

1.45

6.84

1.5

1.4

71.79

81.13

mu/l

0.27

217

886

Benign neoplasm: Rectum, anus and anal canal

148

932

1.60

6.82

1.4

42.83

58.23

mu/l

0.90

134

828

Migraine, single triptan purchase ok & required. ICD-code if available is included

632

3412

1.26

6.79

1.7

1.6

51.64

63.22

mu/l

1.24

584

3055

Triptan medication for migraine, single purchase ok

632

3412

1.26

6.79

1.7

1.6

51.64

63.22

mu/l

1.24

584

3055

Allergic conjunctivitis

439

3315

1.31

6.77

1.6

60.12

57.22

mu/l

0.14

388

2987

Other shoulder lesions

383

1.95

6.76

1.4

1.5

43.77

43.16

mu/l

0.02

343

Sulfonylureas

228

1250

1.46

6.76

1.3

1.4

93.56

51.08

mu/l

1.67

192

1093

Dislocation, sprain and strain of joints and ligaments at neck level

114

674

1.70

6.74

1.7

1.6

56.88

50.65

mu/l

0.14

605

Other postsurgical states

249

2.19

6.73

1.5

107.44

90.11

mu/l

0.09

221

Melanocytic naevi of trunk

483

1.84

6.72

1.5

26.77

63.66

mu/l

3.85

431

Impotence

180

2.42

6.71

1.6

1.4

85.84

78.48

mu/l

0.07

163

Dental pulpitis 3

326

1.89

6.70

1.9

2.0

65.92

65.16

mu/l

0.02

297

Other inflammation of eyelid

549

1.78

6.70

1.4

60.64

50.34

mu/l

0.31

481

Other noninflammatory disorders of uterus, except cervix

172

758

1.56

6.69

1.3

1.4

61.36

51.20

mu/l

0.33

149

665

Pacemaker

207

1367

1.48

6.69

1.3

1.4

55.60

56.45

mu/l

0.03

183

1194

Other and unspecified myopathies

310

2.05

6.65

1.3

1.4

45.80

68.59

mu/l

0.53

270

Dental pulpitis 2, only avohilmo

563

2259

1.28

6.64

1.5

57.49

71.88

mu/l

0.82

490

2030

Voice disturbances

202

1370

1.48

6.64

1.5

45.97

59.55

mu/l

0.71

174

1222

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

214

940

1.48

6.63

2.4

1.8

72.55

50.22

mu/l

0.83

200

864

Unspecific neurodegenerative disorder

105

1219

0.59

6.62

1.1

1.3

31.03

60.15

mu/l

2.68

1062

Special screening examination for other diseases and disorders

324

2.02

6.61

1.9

1.4

98.13

70.01

mu/l

0.32

288

Supplementary factors related to causes of morbidity and mortality classified elsewhere

224

1553

1.45

6.56

1.5

61.88

61.81

mu/l

0.00

196

1392

N06DA Anticholinesterases

1049

0.53

6.54

1.2

1.3

40.65

52.36

mu/l

0.28

911

Use of anticholinesterases

1049

0.53

6.54

1.2

1.3

40.65

52.36

mu/l

0.28

911

Visual impairment including blindness (binocular or monocular)

214

2.27

6.50

1.6

1.4

34.85

53.93

mu/l

0.76

186

Tinnitus

179

1190

1.51

6.50

1.5

1.4

100.94

58.63

mu/l

1.06

157

1073

Extrapyramidal and movement disorders

256

1822

1.41

6.49

1.3

1.4

54.67

60.40

mu/l

0.23

223

1616

Fracture of foot, except ankle

178

1182

1.51

6.49

1.5

1.6

86.69

59.30

mu/l

0.82

153

1062

Other complications of surgical and medical care, not elsewhere classified

410

1.90

6.49

1.5

1.4

104.94

66.06

mu/l

0.47

365

Abnormal serum enzyme levels

200

1342

1.48

6.48

1.5

1.4

76.80

64.69

mu/l

0.37

184

1179

Type of accident

206

1410

1.47

6.46

1.5

61.74

64.62

mu/l

0.07

182

1259

Chronic periodontitis, complicated

397

1.91

6.44

1.7

1.4

52.16

59.00

mu/l

0.19

355

Inflammatory disease of uterus

111

661

1.69

6.41

1.6

1.7

35.87

51.50

mu/l

1.19

593

Autoimmune hyperthyroidism

222

2.23

6.39

2.6

1.3

58.58

39.41

mu/l

0.72

203

Sarcoidosis

107

632

1.71

6.38

1.4

101.39

51.66

mu/l

0.67

560

Chronic periapical parodontitis

158

1027

1.55

6.37

1.4

72.87

67.88

mu/l

0.12

141

918

Benign neoplasm: Cerebral meninges

399

1.90

6.35

1.6

1.4

52.74

49.96

mu/l

0.04

357

Melanocytic naevi of trunk

493

1.80

6.31

1.5

26.77

50.67

mu/l

2.68

440

Abscess of anal and rectal regions

344

1.97

6.30

1.2

1.4

62.30

62.94

mu/l

0.01

310

Transport accidents

348

2313

1.34

6.28

1.6

78.52

64.08

mu/l

0.35

317

2088

Speech and linguistic disorders, excluding more controls

272

2.06

6.26

1.4

1.7

49.01

70.64

mu/l

0.95

254

Benign neoplasm: Cerebral meninges

402

1.88

6.22

1.6

1.4

52.74

33.18

mu/l

0.41

352

Later onset COPD, excluding more controls

140

689

1.59

6.19

1.2

1.4

77.47

58.03

mu/l

0.74

118

600

Visual field defects

326

1.98

6.17

1.5

1.4

89.93

46.08

mu/l

0.49

288

Enterocolitis due to Clostridium difficile

410

1.87

6.16

1.6

1.3

87.43

52.42

mu/l

0.61

358

Intestinal adhesions without obstruction

299

2.03

6.14

1.4

47.08

49.50

mu/l

0.06

263

Transplanted organ and tissue status

418

1.86

6.13

1.5

114.88

49.33

mu/l

0.73

376

Diabetic retinopathy, excluding more controls

246

976

1.43

6.10

1.6

1.5

76.64

75.29

mu/l

0.03

212

884

Dental caries 3

651

2683

1.24

6.10

1.5

62.22

65.97

mu/l

0.19

563

2418

Dislocation, sprain and strain of joints and ligaments of knee

468

3411

1.28

6.08

1.4

1.6

79.04

69.16

mu/l

0.42

425

3073

Problems related to lifestyle

441

1.83

6.07

1.3

1.6

142.75

59.73

mu/l

0.54

393

Sequelae of injuries, of poisoning and of other consequences of external causes

177

1193

1.49

6.04

1.4

1.5

59.53

62.44

mu/l

0.08

160

1069

Other and unspecified disorders of vitreous body

305

2251

1.35

6.03

1.4

50.27

56.03

mu/l

0.29

270

1985

Diabetes mellitus in pregnancy

229

1040

1.43

5.99

1.8

1.9

53.02

48.93

mu/l

0.12

212

950

L04AA Selective immunosuppressants

165

1099

1.51

5.98

1.6

1.5

70.92

61.28

mu/l

0.17

151

982

Cardiomyopathy

117

720

1.63

5.98

1.3

1.5

68.75

54.08

mu/l

0.35

105

645

Isolated proteinuria

2.89

5.97

1.3

63.12

43.07

mu/l

0.50

Acetic acid derivatives and related substances

214

765

1.46

5.96

1.4

1.6

79.85

53.05

mu/l

0.87

190

683

Other diseases of the digestive system

208

1450

1.44

5.96

1.2

1.4

48.10

69.44

mu/l

0.90

180

1280

Other and unspecified urticaria

145

940

1.55

5.95

1.8

1.6

38.20

54.03

mu/l

1.69

132

842

Acute pancreatitis

137

877

1.57

5.95

1.5

1.4

66.69

59.80

mu/l

0.17

124

771

Enlarged lymph nodes

109

660

1.66

5.94

1.6

1.4

56.57

78.19

mu/l

0.45

100

596

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

172

2.36

5.93

1.4

92.85

58.53

mu/l

0.29

154

Open wound of forearm

345

1.93

5.91

1.3

1.5

83.66

55.53

mu/l

0.32

300

Ptosis of eyelid

460

1.80

5.90

1.4

68.63

58.21

mu/l

0.17

404

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

277

2.05

5.88

1.5

1.4

35.53

44.09

mu/l

0.27

248

Sequelae of other external causes

198

2.25

5.87

1.3

1.4

89.87

48.78

mu/l

0.45

175

Dental caries 1 and operation codes

689

2882

1.23

5.84

1.5

67.77

69.23

mu/l

0.06

598

2595

Chronic laryngitis and laryngotracheitis

107

649

1.66

5.81

1.5

1.4

71.65

62.76

mu/l

0.20

581

Disorders of ocular muscles, binocular movement, accommodation and refraction

342

2576

1.32

5.77

1.6

50.39

64.47

mu/l

1.35

303

2330

Other diseases of lip and oral mucosa

124

782

1.60

5.76

1.9

1.4

57.17

53.83

mu/l

0.09

108

692

Injury, poisoning and certain other consequences of external causes

452

1761

1.29

5.76

1.6

74.22

59.92

mu/l

0.28

399

1592

Invasive ventilation

266

2.05

5.74

1.4

71.64

62.08

mu/l

0.22

230

Calculus of kidney and ureter

208

1463

1.43

5.71

1.6

1.4

80.20

63.75

mu/l

0.56

188

1286

Exposure to other specified factors

557

4218

1.24

5.68

1.6

71.62

66.38

mu/l

0.21

501

3783

Dental caries 3, only avohilmo

662

2758

1.23

5.68

1.5

63.00

66.11

mu/l

0.15

570

2486

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

214

1515

1.42

5.66

1.6

1.7

105.01

59.87

mu/l

0.80

186

1374

Crohn's disease NAS

234

2.11

5.65

1.5

29.06

45.05

mu/l

0.90

208

Left ventricular outflow tract obstruction (LVOTO), broad definition

445

1.79

5.62

1.3

1.4

145.32

77.32

mu/l

0.60

406

Osteomyelitis

228

2.13

5.62

1.5

1.3

64.92

54.63

mu/l

0.24

195

Achilles tendinitis

460

1.77

5.61

1.3

1.4

70.30

58.76

mu/l

0.30

407

Aneurysms, operations, SAH

118

741

1.60

5.59

1.3

1.4

66.45

55.34

mu/l

0.34

107

660

Fibroblastic disorders

159

1067

1.50

5.58

1.3

1.4

50.31

53.36

mu/l

0.09

135

948

Other and unspecified disorders of white blood cells

146

2.43

5.57

1.6

1.4

55.49

42.55

mu/l

0.30

131

Injuries to the neck

161

1084

1.49

5.56

1.6

1.5

66.11

59.31

mu/l

0.16

141

974

Fracture of lower leg, including ankle

405

3153

1.28

5.53

1.4

1.5

54.44

65.57

mu/l

0.69

362

2806

Disorders of refraction and accommodation

193

1343

1.44

5.51

1.7

1.6

61.87

71.54

mu/l

0.39

167

1216

Umbilical hernia

191

1332

1.44

5.51

1.3

1.5

85.50

62.61

mu/l

0.52

172

1177

Atopic dermatitis, strict definition

210

1459

1.42

5.51

1.6

1.7

80.37

64.08

mu/l

0.40

192

1330

Viral infections of the central nervous system

291

1.98

5.50

1.6

1.4

33.13

78.81

mu/l

0.75

255

Ocular pain

326

1.92

5.49

1.6

1.5

66.14

48.02

mu/l

0.57

293

Alzheimer disease, including avohilmo

998

0.58

5.49

1.1

1.3

29.31

52.77

mu/l

1.75

869

Other local infections of skin and subcutaneous tissue

412

1.81

5.48

1.4

69.62

73.63

mu/l

0.05

364

Chronic nephritic syndrome

135

2.48

5.47

1.2

1.3

84.23

45.00

mu/l

0.66

120

Other extrapyramidal and movement disorders in other diseases

159

1072

1.49

5.47

1.4

69.52

58.51

mu/l

0.32

144

957

Unspecified mental disorder

304

2290

1.33

5.47

1.4

1.6

51.92

65.04

mu/l

0.81

264

2061

Other and unspecified injuries of lower leg

285

1.98

5.45

1.6

1.5

60.48

53.35

mu/l

0.13

249

Allergic urticaria

341

1.89

5.45

1.6

1.5

85.49

45.79

mu/l

0.54

305

Leisure time condition

126

809

1.57

5.44

1.5

51.04

57.13

mu/l

0.15

109

715

Unstable angina pectoris

256

1553

1.37

5.44

1.3

1.4

103.89

52.70

mu/l

1.24

224

1362

Other disorders of optic [2nd] nerve and visual pathways

218

2.13

5.43

1.3

1.4

68.38

51.98

mu/l

0.40

192

Trigger finger

105

646

1.64

5.42

1.5

106.01

45.85

mu/l

0.52

580

Vitreous haemorrhage

399

1.82

5.42

1.6

1.4

88.67

56.00

mu/l

0.77

350

Benign neoplasm: Stomach

421

1.80

5.42

1.5

1.3

39.47

64.19

mu/l

1.13

378

Postprocedural disorders of digestive system, not elsewhere classified

118

2.58

5.40

1.6

1.3

41.00

124.58

mu/l

0.55

109

Noninflammatory disorders of female genital tract

316

1188

1.34

5.39

1.6

40.91

52.71

mu/l

1.04

280

1069

Other and unspecified glaucoma

239

2.07

5.37

1.2

1.3

104.61

50.12

mu/l

0.75

206

Dental caries, including avohilmo

609

2531

1.23

5.36

1.5

62.65

69.26

mu/l

0.31

531

2277

Speech and linguistic disorders

308

1.91

5.36

1.6

49.08

74.15

mu/l

1.15

278

GI-bleeding

203

1440

1.41

5.33

1.2

1.4

50.37

68.82

mu/l

0.70

172

1271

Mental disorders, not otherwise specified

351

1.87

5.32

1.6

42.45

48.83

mu/l

0.27

317

Dental caries 1

609

2533

1.23

5.31

1.5

61.49

70.00

mu/l

0.42

531

2279

Familial hypercholesterolemia, with ischemic heart disease

359

1.85

5.28

1.2

1.4

167.52

51.38

mu/l

1.48

308

D07AA Corticosteroids, weak (group I)

109

681

1.61

5.27

1.4

1.6

55.20

66.02

mu/l

0.28

611

Benign lipomatous neoplasm

206

1469

1.41

5.27

1.5

1.4

69.24

62.57

mu/l

0.14

191

1292

Poisoning by drugs, medicaments and biological substances

173

1196

1.45

5.25

1.5

1.6

99.39

61.27

mu/l

0.54

151

1081

Misadventures to patients during surgical and medical care

101

621

1.64

5.25

1.5

65.66

60.29

mu/l

0.16

551

Gastric ulcer

119

761

1.57

5.24

1.4

1.3

71.73

52.79

mu/l

0.52

103

671

Female infertility

222

980

1.40

5.20

2.0

1.6

64.93

54.64

mu/l

0.28

205

890

Other and unspecified local infections of skin and subcutaneous tissue

376

1.82

5.18

1.4

72.70

76.33

mu/l

0.04

330

Aortic valve malfunction, age under 60 years

420

1.78

5.17

1.3

1.4

151.41

58.19

mu/l

0.92

384

Social phobias

319

1.89

5.16

2.0

1.7

34.65

50.44

mu/l

1.60

289

Malignant neoplasm of thyroid gland

292

1.94

5.12

2.0

1.4

38.26

42.64

mu/l

0.13

264

Dental caries 1, only avohilmo

622

2606

1.22

5.11

1.5

62.31

65.98

mu/l

0.17

541

2345

Eating disorders

407

1.78

5.07

2.5

1.6

72.08

73.23

mu/l

0.01

367

Dementia, including avohilmo

142

1447

0.67

5.07

1.2

1.4

50.28

56.85

mu/l

0.19

118

1271

COPD, hospital admissions 3, with asthma pneumonia sepsis

162

944

1.47

5.05

1.2

1.4

82.11

61.29

mu/l

0.60

143

828

Hemiplegia

172

2.23

5.04

1.4

112.52

44.93

mu/l

0.48

154

Congenital malformations of the circulatory system

104

630

1.61

5.04

1.4

1.6

110.22

76.15

mu/l

0.36

567

Dementia in Alzheimer disease

495

0.40

5.02

1.1

1.3

41.86

47.78

mu/l

0.08

428

Chronic periodontitis

110

699

1.58

5.01

1.5

1.4

64.05

62.87

mu/l

0.02

101

621

Benign neoplasm: Ascending colon

552

1.66

5.01

1.2

1.3

86.22

59.74

mu/l

0.59

493

Disorders of muscles

402

1.78

5.01

1.3

1.5

52.79

44.60

mu/l

0.31

357

Coxarthrosis [arthrosis of hip](FG)

383

2170

1.28

4.98

1.4

63.42

58.69

mu/l

0.20

338

1922

Open wound of lower leg

101

630

1.61

4.97

1.7

1.4

70.96

59.92

mu/l

0.28

556

Any prescribed medicine buy

+∞

4.96

1.2

0.0

35.18

—

mu/l

—

Poisoning by medicine

153

1048

1.47

4.91

1.5

1.6

102.47

61.97

mu/l

0.49

131

950

Myeloproliferative diseases (CML excluded)

304

1.89

4.89

1.3

1.4

75.69

51.51

mu/l

0.26

270

Alzheimer disease

827

0.56

4.89

1.1

1.3

29.97

54.71

mu/l

1.44

717

Abdominal aortic aneurysm (AAA)

280

1.92

4.88

1.3

1.4

95.20

74.85

mu/l

0.27

241

Dental operations

513

2126

1.24

4.86

1.5

58.09

71.92

mu/l

0.70

447

1902

Coeliac disease

534

1.66

4.85

1.9

1.5

50.36

51.51

mu/l

0.04

472

All influenza (not pneumonia)

104

658

1.59

4.83

1.6

1.5

92.64

60.76

mu/l

0.68

588

Juvenile arthritis (FINNGEN)

156

2.27

4.83

1.9

1.6

49.33

54.64

mu/l

0.16

136

Traumatic subdural haemorrhage

385

1.77

4.82

1.2

1.4

32.80

58.66

mu/l

1.48

348

Benign neoplasm: Stomach

437

1.73

4.82

1.5

1.4

39.47

47.06

mu/l

0.29

382

Inflammatory diseases of the central nervous system

327

1.85

4.81

1.4

54.63

54.37

mu/l

0.01

290

IgA nephropathy (IgA glomerulonephritis)

2.79

4.81

1.4

1.3

135.50

53.27

mu/l

0.56

Fenamates

119

517

1.56

4.81

1.4

1.6

44.07

49.38

mu/l

0.23

108

459

Iridocyclitis

162

1127

1.44

4.80

1.5

47.97

64.30

mu/l

1.10

146

1005

Thyrotoxicosis with toxic multinodular goitre

250

1.98

4.80

1.5

1.4

101.14

40.77

mu/l

0.97

226

Campylobacter enteritis

2.65

4.75

2.0

1.4

206.07

45.96

mu/l

0.54

Pleural effusion

607

1.61

4.73

1.4

105.69

57.88

mu/l

1.00

536

Atopic dermatitis

404

2744

1.26

4.72

1.6

1.7

69.64

64.89

mu/l

0.17

365

2486

Adenomyosis (Endometriosis of uterus)

600

1.61

4.71

1.6

1.4

29.97

55.69

mu/l

2.61

528

Dental pulpitis 3, only avohilmo

306

1.75

4.67

1.9

2.0

49.32

68.56

mu/l

0.91

278

Appendicitis, broad definition

563

4255

1.21

4.66

1.5

1.6

60.46

66.76

mu/l

0.34

504

3819

Diseases of appendix

568

4282

1.21

4.66

1.5

1.6

60.07

66.60

mu/l

0.36

508

3843

Acute pancreatitis (for exclusion)

137

929

1.48

4.65

1.5

1.4

66.69

55.63

mu/l

0.30

124

820

Oter anti-inflammatory and antirheumatic agents, non-steroids

164

627

1.46

4.65

1.6

1.5

41.84

47.47

mu/l

0.30

150

555

Other/unspecified enthesopathies of lower limb, excluding foot

281

1.90

4.64

1.4

1.5

38.36

53.21

mu/l

0.48

247

Follicular cysts of skin and subcutaneous tissue

128

857

1.50

4.63

1.4

1.5

51.05

56.89

mu/l

0.20

113

767

Dementia

132

1338

0.68

4.61

1.2

1.4

50.11

58.56

mu/l

0.25

109

1169

Pain associated with micturition

488

1.67

4.61

1.7

1.4

58.19

69.28

mu/l

0.17

422

Injury of intra-abdominal organs

2.72

4.61

1.8

1.2

151.64

53.02

mu/l

0.55

Other disorders of bone

144

989

1.46

4.59

1.5

62.92

58.90

mu/l

0.09

129

886

Other and/or unspecified nontoxic goitre

362

1.78

4.57

1.4

1.3

63.85

45.45

mu/l

0.53

322

Acute appendicitis, no complications

413

3310

1.25

4.56

1.5

1.6

68.41

67.84

mu/l

0.02

370

2984

Schizophrenia or delusion, excluding more controls

205

1488

1.37

4.55

1.3

1.6

58.17

65.80

mu/l

0.26

177

1351

Coxarthrosis

358

1908

1.28

4.54

1.4

64.07

62.51

mu/l

0.06

319

1700

Other viral diseases, not elsewhere classified

129

867

1.49

4.53

1.9

1.5

79.72

70.87

mu/l

0.15

122

778

Any dementia

105

1131

0.65

4.51

1.1

1.3

55.09

54.46

mu/l

0.01

989

Acute appendicitis

528

4109

1.21

4.50

1.5

1.6

60.99

67.36

mu/l

0.33

474

3696

Benign neoplasm: Descending colon

263

1.92

4.50

1.3

175.92

73.58

mu/l

0.65

236

Anterior Iridocyclitis

142

977

1.46

4.50

1.6

1.5

51.52

61.57

mu/l

0.49

128

871

Emotional disorders and disorders of social functioning with onset specific to childhood

159

2.19

4.48

1.7

43.30

69.16

mu/l

1.56

141

Eating disorder

320

1.82

4.47

2.1

1.7

81.60

78.30

mu/l

0.03

289

Benign neoplasm: Descending colon

264

1.91

4.46

1.3

1.4

175.92

59.28

mu/l

0.78

231

Disorders of optic nerve and visual pathways

380

1.75

4.44

1.5

57.15

51.53

mu/l

0.16

340

TMD related pain

124

2.37

4.43

2.8

1.4

43.70

38.63

mu/l

0.13

114

Poor fetal growth

532

1.63

4.43

1.9

33.67

48.36

mu/l

1.28

491

Colectomy operation

113

745

1.53

4.42

1.5

1.4

73.85

56.99

mu/l

0.45

102

658

Rosacea

479

1.66

4.41

1.6

1.5

87.66

49.92

mu/l

0.69

425

Parodontitis, under 40 years

366

1.76

4.41

1.6

1.9

81.78

65.35

mu/l

0.32

325

Parodontitis, under 40 years, or operation codes

366

1.76

4.41

1.6

1.9

81.78

65.35

mu/l

0.32

325

Other eating disorders

156

2.20

4.40

2.5

1.6

95.83

116.96

mu/l

0.11

138

Heart failure and coronary heart disease

192

1036

1.39

4.39

1.2

1.4

105.39

54.43

mu/l

1.61

164

907

Lesion of ulnar nerve

612

1.58

4.37

1.4

67.63

59.41

mu/l

0.18

555

Lichen simplex chronicus and prurigo

266

1.90

4.36

1.4

68.59

45.40

mu/l

0.35

240

Benign neoplasm of middle ear and respiratory system

309

1.83

4.36

1.6

1.4

47.81

86.81

mu/l

0.56

277

Other disorders of the musculoskeletal system and connective tissue

103

668

1.55

4.35

1.5

1.4

71.03

53.04

mu/l

0.49

589

Astigmatism

217

2.00

4.35

1.4

1.5

53.36

50.77

mu/l

0.05

193

Alzheimer’s disease, wide definition

691

0.53

4.34

1.2

1.3

34.61

52.18

mu/l

0.61

595

Polyp of the female genital tract

230

993

1.35

4.34

1.5

42.90

52.78

mu/l

0.63

205

887

Other diseases of the respiratory system

123

829

1.49

4.33

1.3

1.4

89.83

64.90

mu/l

0.50

110

724

Other respiratory disorders and diseases

123

829

1.49

4.33

1.3

1.4

89.83

64.90

mu/l

0.50

110

724

Other diseases of biliary tract

339

1.78

4.32

1.4

61.28

48.30

mu/l

0.40

293

Sequelae of injuries of upper limb

421

1.70

4.32

1.4

1.5

57.07

55.25

mu/l

0.03

377

Benign neoplasm: Ascending colon

575

1.59

4.31

1.2

1.4

86.22

57.44

mu/l

0.67

509

Superficial injury of ankle and foot

490

1.64

4.30

1.5

1.6

89.16

56.69

mu/l

0.56

440

Endometriosis of pelvic peritoneum

111

724

1.52

4.29

1.7

1.6

46.21

52.85

mu/l

0.30

105

654

Embolic stroke

132

2.29

4.29

1.3

133.60

59.49

mu/l

0.59

112

Myopia

529

1.62

4.28

1.7

1.6

66.30

74.30

mu/l

0.15

477

Reimbursement for rheumatic diseases

424

3437

1.23

4.26

1.5

58.18

59.22

mu/l

0.04

384

3045

Other abnormal immunological findings in serum

2.79

4.21

1.7

1.3

54.98

44.74

mu/l

0.14

Herpesviral [herpes simplex] infections

493

1.63

4.21

2.2

1.5

75.37

47.69

mu/l

0.37

436

Localized swelling, mass and lump of skin and subcutaneous tissue

218

1633

1.34

4.20

1.6

1.5

49.63

61.03

mu/l

0.58

195

1458

Other and unspecified rosacea

357

1.75

4.20

1.5

1.4

80.70

44.20

mu/l

0.80

320

Viral infections characterized by skin and mucous membrane lesions

292

2276

1.29

4.19

2.2

1.5

60.95

63.30

mu/l

0.07

265

2027

Crohn disease

572

1.58

4.17

1.7

1.5

56.46

55.45

mu/l

0.02

510

Hypertrophy of breast in women and men

139

968

1.44

4.16

1.6

1.5

55.24

52.76

mu/l

0.07

123

866

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

167

2.12

4.15

2.3

1.6

76.43

39.85

mu/l

1.02

154

Retinal vascular disorders

464

1.65

4.15

1.4

59.03

67.25

mu/l

0.13

407

Diagnoses used for exclusion with ILD

168

1211

1.39

4.14

1.6

1.4

83.32

60.21

mu/l

0.43

143

1077

Presence of cardiac and vascular implants and grafts

287

1686

1.29

4.13

1.1

1.4

75.18

63.34

mu/l

0.39

247

1501

Other inflammatory liver diseases

257

1.88

4.12

2.8

1.4

53.20

44.23

mu/l

0.34

230

Conductive and sensorineural hearing loss

572

3311

1.20

4.12

1.4

47.83

64.42

mu/l

1.84

498

2952

Dermatophytosis

559

1.58

4.10

1.5

1.4

48.28

59.20

mu/l

0.35

497

Parodontitis, under 40 years and operation codes

345

1.75

4.08

1.6

1.9

79.50

67.49

mu/l

0.21

305

Parodontitis, operation under 40 years and operation codes

345

1.75

4.08

1.6

1.9

79.50

67.49

mu/l

0.21

305

Other specified/unspecified soft tissue disorders

175

2.08

4.06

1.2

1.4

21.14

32.06

mu/l

0.72

156

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

407

1.68

4.02

1.5

1.4

54.53

52.90

mu/l

0.04

358

Diseases of peritoneum

430

1.66

4.02

1.6

1.4

37.30

52.94

mu/l

0.90

383

Iron deficiency anaemia secondary to blood loss (chronic)

649

1.53

4.01

1.4

61.71

66.36

mu/l

0.07

576

Unspecified/other endometriosis

362

1.72

4.01

1.6

1.7

52.31

44.86

mu/l

0.20

328

Benign neoplasm of middle ear and respiratory system

318

1.77

4.00

1.6

1.3

47.81

97.56

mu/l

0.80

288

Calcific aortic valvular stenosis, operated

167

1184

1.39

3.99

1.2

1.4

98.77

54.23

mu/l

1.06

151

1037

Calcific aortic valvular stenosis

167

1184

1.39

3.99

1.2

1.4

98.77

54.23

mu/l

1.06

151

1037

Coagulation defects, purpura and other haemorrhagic conditions

125

861

1.46

3.99

1.6

1.5

89.20

68.82

mu/l

0.30

113

759

5-aminosalicylic acid

149

1061

1.41

3.96

1.6

65.86

62.63

mu/l

0.09

130

959

Postprocedural musculoskeletal disorders, not elsewhere classified

268

1.84

3.96

1.5

1.4

78.15

43.60

mu/l

0.70

238

Viral pneumonia (unknown virus, not influenza)

247

1.88

3.93

1.4

55.03

53.52

mu/l

0.03

218

Otitis media, unspecified

404

1.65

3.92

1.7

81.39

90.26

mu/l

0.10

362

Retinal vascular occlusion

457

1.63

3.89

1.4

59.77

66.36

mu/l

0.10

402

Benign neoplasm: Transverse colon

419

1.66

3.88

1.3

92.69

62.58

mu/l

0.25

369

Dystonia

227

1.91

3.88

1.3

1.4

47.75

43.91

mu/l

0.06

204

Fall on same level involving ice and snow

401

3276

1.23

3.87

1.5

55.53

58.52

mu/l

0.13

360

2916

Alcohol dependence

181

1337

1.36

3.87

1.3

1.5

48.69

71.28

mu/l

2.22

150

1197

Inflammatory bowel disease

224

1708

1.32

3.86

1.5

61.15

61.23

mu/l

0.00

199

1532

Other bursopathies

576

1.55

3.85

1.4

41.83

49.43

mu/l

0.46

511

Preterm labour and delivery

193

1441

1.34

3.84

1.7

1.6

41.89

50.13

mu/l

0.69

173

1298

Keratitis

244

1884

1.30

3.83

1.9

1.5

53.04

59.42

mu/l

0.40

226

1679

Palmar fascial fibromatosis [Dupuytren]

633

1.52

3.81

1.3

1.4

61.65

52.23

mu/l

0.18

556

Female infertility, cervigal, vaginal, other or unspecified origin

192

952

1.35

3.81

2.0

1.6

48.49

54.66

mu/l

0.30

175

865

Sensorineural hearing loss

532

3118

1.20

3.80

1.4

49.40

64.47

mu/l

1.44

463

2774

Perforation of tympanic membrane

414

1.65

3.79

1.6

1.5

72.37

52.98

mu/l

0.41

365

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

618

1.53

3.79

1.5

1.4

33.14

62.23

mu/l

2.19

549

Injuries to the shoulder and upper arm

603

4290

1.18

3.79

1.4

1.5

63.53

63.13

mu/l

0.02

541

3830

Haemorrhage in early pregnancy

197

1443

1.34

3.78

1.5

1.7

77.36

52.71

mu/l

0.69

174

1306

Otitis externa, unspecified

453

1.62

3.77

1.4

1.5

63.87

50.89

mu/l

0.19

405

Ulcerative colitis

168

1232

1.37

3.77

1.5

64.11

65.95

mu/l

0.05

151

1104

Biological medication for rheuma

108

732

1.48

3.77

1.6

59.27

56.72

mu/l

0.05

101

660

Multiple delivery

478

0.44

3.74

1.4

1.7

44.75

60.03

mu/l

0.66

423

Otitis externa

148

1065

1.40

3.73

1.4

1.5

59.68

60.39

mu/l

0.02

129

952

Fall on and from stairs and steps

171

1260

1.36

3.73

1.5

72.47

59.25

mu/l

0.34

151

1126

Injuries to the wrist and hand

743

4647

1.16

3.71

1.6

59.75

64.32

mu/l

0.35

669

4165

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

311

1.75

3.70

1.3

71.71

65.37

mu/l

0.06

276

Glaucoma suspect

235

1815

1.30

3.70

1.4

72.26

60.56

mu/l

0.37

207

1603

Calcific aortic valvular stenosis, diagnosis (helper)

165

1184

1.37

3.70

1.2

1.4

99.62

54.23

mu/l

1.07

149

1037

Operations 2 for CAVS

165

1184

1.37

3.70

1.2

1.4

99.62

54.23

mu/l

1.07

149

1037

Salpingitis and oophoritis

135

959

1.41

3.68

1.7

1.4

46.31

52.79

mu/l

0.24

119

864

Other specified and unspecified personality disorders

387

1.66

3.67

1.3

1.5

41.34

53.54

mu/l

0.61

349

Redundant prepuce, phimosis and paraphimosis

131

922

1.42

3.66

1.5

124.32

86.42

mu/l

0.75

116

826

Degenerative diseases of the nervous system

999

0.66

3.65

1.1

1.3

38.40

53.02

mu/l

0.72

879

Ulcerative colitis, NAS

624

1.51

3.64

1.5

75.06

59.85

mu/l

0.33

555

Emotional disorders starting during childhood or adolecense, excluding more controls

139

2.13

3.64

1.5

1.6

42.63

51.33

mu/l

0.49

127

Malignant melanoma, excluding all cancers (controls excluding all cancers)

109

746

1.47

3.63

1.5

1.3

33.51

61.63

mu/l

2.43

660

Hypertrophic scar

197

1.95

3.63

1.8

1.5

29.23

46.76

mu/l

0.86

173

Unspecified fall

323

2579

1.25

3.62

1.6

1.5

58.43

64.44

mu/l

0.24

281

2300

Other skin changes

108

739

1.47

3.61

1.5

1.4

38.30

60.00

mu/l

1.35

655

Congenital malformations of heart and great arteries

559

1.53

3.59

1.4

1.6

179.32

77.88

mu/l

0.65

504

Degeneration of macula and posterior pole

283

1847

1.27

3.59

1.4

47.57

58.18

mu/l

0.55

247

1636

Seronegative rheumatoid arthritis

539

1.55

3.56

1.7

1.4

80.95

55.30

mu/l

0.43

482

COPD-related respiratory insufficiency

437

1.61

3.55

1.3

1.4

116.72

66.05

mu/l

0.77

388

Zoster [herpes zoster]

114

791

1.45

3.55

1.9

1.4

67.96

58.42

mu/l

0.19

107

698

Paracetamol of NSAID medication

127

443

1.45

3.54

1.5

1.8

55.36

64.62

mu/l

0.29

111

401

Other noninflammatory disorders of vulva and perineum

353

1.68

3.54

1.4

1.5

39.45

59.88

mu/l

0.84

317

Adalimumab

376

1.66

3.54

1.9

1.6

78.04

55.86

mu/l

0.31

338

Calcific aortic valvular stenosis, including rheumatic fever

165

1193

1.36

3.53

1.2

1.4

99.62

54.59

mu/l

1.05

149

1045

Colonic or urogenital fistula

187

1410

1.33

3.53

1.5

1.4

93.12

63.88

mu/l

0.81

168

1257

Internal derangement of knee

266

2096

1.27

3.52

1.6

1.5

70.43

63.49

mu/l

0.25

236

1888

Rheumatoid arthritis

222

1556

1.30

3.52

1.4

1.5

60.84

56.22

mu/l

0.14

198

1391

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

198

1506

1.32

3.51

1.6

48.31

60.30

mu/l

0.94

180

1347

Gestational diabetes (for exclusion)

239

1311

1.29

3.51

1.8

1.9

68.80

51.49

mu/l

0.60

219

1200

Other viral diseases

198

1503

1.32

3.49

1.8

1.6

73.71

64.64

mu/l

0.25

188

1352

Car occupant injured in other and unspecified transport accidents

125

885

1.42

3.49

1.6

112.65

56.89

mu/l

0.62

111

795

Essential (haemorrhagic) thrombocythaemia

145

2.09

3.49

1.1

1.4

33.70

55.06

mu/l

0.55

134

Acute suppurative otitis media

169

1173

1.35

3.47

1.9

1.8

50.19

65.35

mu/l

0.70

153

1069

Other/unspecified synovitis and tenosynovitis

503

1.56

3.46

1.3

1.5

55.35

41.80

mu/l

0.31

450

Restless leg syndrome

527

1.55

3.46

1.4

82.13

46.66

mu/l

0.68

464

Benign neoplasm of ovary

119

837

1.43

3.46

1.5

1.4

27.14

57.02

mu/l

4.22

110

744

Acute and subacute iridocyclitis

130

929

1.41

3.45

1.6

1.5

52.42

60.22

mu/l

0.33

116

829

Cholangitis (primary sclerosing, PSC)

208

1.89

3.44

1.3

168.57

57.98

mu/l

0.59

180

Papulosquamous disorders

275

2188

1.26

3.44

1.6

1.5

62.13

62.57

mu/l

0.01

244

1938

Impingement syndrome of shoulder

167

1244

1.35

3.43

1.4

1.5

53.10

60.42

mu/l

0.30

151

1103

Second line medication for Crohn's disease

408

3385

1.21

3.42

1.6

1.5

68.53

65.54

mu/l

0.12

359

3018

COPD, hospital admissions 1, only main diagnosis

209

1366

1.31

3.41

1.2

1.4

93.89

62.26

mu/l

1.35

182

1196

Adhesive capsulitis of shoulder

112

783

1.44

3.37

1.7

1.4

61.80

49.87

mu/l

0.51

100

701

Other juvenile arthritis

147

2.06

3.37

2.0

1.6

45.18

59.05

mu/l

0.46

127

Benign lipomatous neoplasm

206

1586

1.30

3.37

1.5

1.4

69.24

59.06

mu/l

0.22

191

1411

Injuries to unspecified part of trunk, limb or body region

389

1.63

3.37

1.5

1.4

42.75

53.49

mu/l

0.36

341

Other coagulation defects

268

1.77

3.36

1.6

1.5

41.33

78.87

mu/l

0.50

238

Psoriasis

200

1534

1.31

3.36

1.6

1.4

69.73

62.30

mu/l

0.21

178

1362

Diabetic retinopathy, strict definition

160

1042

1.36

3.36

1.9

1.5

69.76

79.80

mu/l

0.31

135

932

L04AX Other immunosuppressants

397

3292

1.21

3.36

1.6

1.5

68.14

65.22

mu/l

0.12

348

2936

114

756

1.43

3.36

1.2

1.3

28.22

54.92

mu/l

2.92

661

Glaucoma

363

2617

1.22

3.34

1.4

68.54

57.97

mu/l

0.46

324

2305

Alzheimer’s disease (Late onset)

618

0.57

3.33

1.2

1.3

34.88

54.60

mu/l

0.65

530

Superficial injury of lower leg

162

1208

1.35

3.32

1.7

1.5

66.95

63.99

mu/l

0.06

143

1081

Seropositive rheumatoid arthritis

168

1257

1.34

3.31

1.3

1.4

47.45

57.40

mu/l

0.50

151

1112

Chronic ulcer of skin, not elsewhere classified

240

1.80

3.31

1.5

1.3

92.88

63.42

mu/l

0.35

207

Peripheral artery operations in Hilmo

453

1.57

3.31

1.2

1.4

91.83

59.16

mu/l

1.11

405

Other secondary gonarthrosis

190

1.91

3.30

1.4

53.09

57.63

mu/l

0.09

167

Suicide or other Intentional self-harm

169

1270

1.34

3.29

1.4

1.6

100.87

63.26

mu/l

0.51

147

1146

Other infectious diseases

285

1.73

3.28

1.4

1.3

46.96

67.04

mu/l

0.72

249

Other and unspecified vascular occlusions

338

1.67

3.28

1.4

1.3

51.65

69.00

mu/l

0.23

301

Bulimia nervosa (incl. atypical)

109

2.22

3.26

1.4

1.6

49.73

57.44

mu/l

0.17

Generalized epilepsy

149

2.03

3.26

1.2

1.5

32.75

114.10

mu/l

0.68

130

Other peripheral vertigo

393

1.61

3.25

1.4

21.47

49.95

mu/l

2.38

346

Hypertrophic disorders of skin

220

1.83

3.23

1.8

1.5

32.49

49.95

mu/l

0.84

195

Use of donepezil

649

0.56

3.23

1.2

1.3

26.84

48.98

mu/l

0.88

561

Embolic stroke with flimmer

2.53

3.22

1.2

1.3

120.34

52.14

mu/l

0.69

Other/unspecified enthesopathies, not elsewhere classified

348

1.65

3.20

1.6

1.4

107.96

35.94

mu/l

1.16

307

Abrasion of teeth

183

1022

1.32

3.19

1.8

1.5

48.63

58.26

mu/l

0.54

163

925

Other specified/unspecified bacterial intestinal infections

251

1.77

3.17

2.0

1.4

65.58

44.27

mu/l

0.79

223

Other abnormal uterine and vaginal bleeding

153

808

1.36

3.15

1.5

1.4

66.79

51.49

mu/l

0.48

141

707

Coronary revascularization (ANGIO or CABG)

292

1642

1.24

3.14

1.2

1.4

90.99

59.73

mu/l

1.19

259

1449

Allergic contact dermatitis

621

1.47

3.14

1.7

1.5

89.87

53.75

mu/l

0.78

556

Kela-code for severe mental illness

258

2064

1.25

3.12

1.4

1.6

54.70

66.35

mu/l

0.56

222

1867

Any dementia, excluding more controls

102

1005

0.70

3.11

1.1

1.4

56.78

58.30

mu/l

0.03

885

Striking against or struck by other objects

216

1692

1.28

3.11

1.5

1.6

97.48

66.50

mu/l

0.91

193

1514

Other disorders of binocular vision

3.13

3.11

1.2

1.3

24.11

58.08

mu/l

0.64

Papillary adenocarcinoma of thyroid gland

216

1.82

3.10

1.5

1.4

40.72

43.97

mu/l

0.07

195

Excessive attrition of teeth

271

1172

1.26

3.10

1.6

65.95

58.60

mu/l

0.25

241

1066

Complications of internal orthopaedic prosthetic devices, implants and grafts

143

1059

1.36

3.10

1.5

1.4

65.03

55.10

mu/l

0.30

123

933

Mucosal proctocolitis

566

1.49

3.09

1.6

1.5

65.66

63.38

mu/l

0.05

508

Spondyloarthritis

110

780

1.42

3.09

1.6

1.4

58.17

54.39

mu/l

0.11

697

Amputation of toe

246

1.76

3.07

1.3

79.87

69.12

mu/l

0.20

213

Other menopausal disorders

198

878

1.30

3.04

1.8

1.4

57.56

54.03

mu/l

0.09

179

783

Postmenopausal bleeding

191

803

1.31

3.03

1.3

1.4

36.36

55.38

mu/l

1.43

168

710

Parkinson's disease, excluding more controls

467

1.53

3.03

1.2

1.5

34.14

59.92

mu/l

1.19

420

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

108

767

1.41

3.02

1.5

1.6

132.20

62.49

mu/l

0.64

690

Fracture of lumbar spine and pelvis

127

926

1.37

3.02

1.2

1.4

61.63

52.71

mu/l

0.28

114

817

Ganglion

138

1021

1.36

3.01

1.4

1.5

51.92

47.09

mu/l

0.11

123

916

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

409

1.57

3.01

1.3

1.6

48.73

56.50

mu/l

0.25

367

Dental operations, only avohilmo

525

2292

1.18

3.01

1.5

57.93

68.83

mu/l

0.59

460

2049

Benign neoplasm: Transverse colon

449

1.55

3.00

1.3

1.4

92.69

60.68

mu/l

0.27

397

Ménière disease

426

1.56

2.98

1.3

1.4

71.05

44.58

mu/l

0.80

378

Superficial injury of head

140

1040

1.35

2.98

1.3

1.5

58.96

53.85

mu/l

0.14

118

930

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

604

1.46

2.97

1.6

1.4

41.97

62.97

mu/l

1.09

540

Lesion of lateral popliteal nerve

176

1.89

2.96

1.4

25.37

45.68

mu/l

0.95

162

Other fall from one level to another

140

1041

1.35

2.96

1.6

1.5

71.38

72.24

mu/l

0.02

127

927

Other Crohn's disease

272

1.70

2.94

1.3

1.5

39.83

40.59

mu/l

0.02

243

Spondylopathies (FG)

630

1.45

2.94

1.7

1.5

54.08

58.70

mu/l

0.12

565

Corneal ulcer

120

873

1.38

2.93

2.2

1.5

47.49

63.78

mu/l

1.06

113

780

Benign neoplasm: Skin of other and unspecified parts of face

436

1.54

2.92

1.3

1.4

28.92

54.34

mu/l

1.90

385

Unspecified misadventure during surgical and medical care

206

1.81

2.91

1.6

1.4

57.68

54.79

mu/l

0.05

182

Antenatal screening

755

0.70

2.91

1.7

1.9

43.32

46.81

mu/l

0.13

691

Other and unspecified disorders of autonomic nervous system

5.61

2.90

1.6

1.2

29.00

19.92

mu/l

—

Carcinoma in situ of skin

289

1.67

2.88

1.4

1.3

52.83

63.53

mu/l

0.22

255

Ethmoidectomy

600

1.46

2.88

1.6

1.5

80.81

49.89

mu/l

0.63

537

Fracture of skull and facial bones

139

1040

1.34

2.85

1.6

1.5

83.75

59.71

mu/l

0.49

122

933

Tonsillectomy and adenotomy

404

2370

1.19

2.83

1.8

1.7

80.28

59.46

mu/l

0.94

366

2162

IBD patients in KELA-register

150

1136

1.32

2.83

1.5

73.77

62.05

mu/l

0.35

132

1027

Malignant melanoma of skin

480

1.51

2.82

1.6

1.4

35.73

58.77

mu/l

1.27

426

Female genital prolapse

204

920

1.28

2.82

1.4

36.63

53.73

mu/l

0.96

180

817

Hypertrophy of breast

118

863

1.37

2.81

1.5

55.27

54.04

mu/l

0.03

105

778

Bullous disorders

194

1.82

2.80

1.3

1.4

123.93

43.22

mu/l

1.01

173

Speech disturbances, not elsewhere classified

330

1.62

2.80

1.3

1.4

45.39

60.25

mu/l

0.42

287

Suppurative and unspecified otitis media

236

1678

1.25

2.79

1.8

1.7

50.03

66.13

mu/l

0.96

212

1527

Emotional disorders starting during childhood or adolescence

157

1.91

2.79

1.5

1.6

42.63

70.86

mu/l

1.35

136

Polymyalgia rheumatica

522

1.48

2.79

1.3

52.14

55.50

mu/l

0.10

458

Vasomotor and allergic rhinitis

260

2081

1.23

2.78

1.6

59.65

66.20

mu/l

0.21

226

1890

Arterial embolism and thrombosis

180

1.84

2.77

1.3

72.59

60.97

mu/l

0.12

155

Viral hepatitis

277

1.67

2.77

1.4

1.5

95.40

55.20

mu/l

0.43

251

FESS (DNB20)

573

1.46

2.75

1.6

1.5

84.02

51.41

mu/l

0.63

511

Other hearing loss

156

1174

1.31

2.73

1.5

1.4

45.78

68.61

mu/l

1.20

137

1038

Biomechanical lesions, not elsewhere classified

167

1.87

2.72

1.2

1.4

63.01

52.15

mu/l

0.11

149

Other disorders starting during childhood or adolecense, excluding more controls

147

1.91

2.72

1.6

1.7

89.57

139.43

mu/l

0.28

137

Hydronephrosis

428

1.53

2.71

1.9

1.5

105.99

57.38

mu/l

0.45

380

Explicit bacterial Sepsis

366

1.56

2.66

1.5

1.4

84.63

65.13

mu/l

0.29

320

Benign neoplasm: Skin of eyelid, including canthus

669

1.41

2.65

1.4

96.69

55.62

mu/l

0.68

595

In situ neoplasms

213

1624

1.25

2.64

1.4

66.28

54.99

mu/l

0.34

187

1452

Superficial injury of abdomen, lower back and pelvis

661

1.41

2.64

1.7

1.5

80.68

55.22

mu/l

0.40

586

Bell's palsy

504

1.48

2.64

1.4

56.60

51.96

mu/l

0.11

449

Assault

603

1.43

2.63

1.6

1.7

99.55

58.03

mu/l

0.58

550

Lateral epicondylitis

620

1.43

2.63

1.4

1.5

160.24

49.11

mu/l

0.96

557

Unspecified acute lower respiratory infection

645

1.42

2.63

1.5

77.84

61.50

mu/l

0.30

572

Open wound of shoulder and upper arm

2.58

2.63

1.6

1.2

164.92

40.65

mu/l

0.58

Carcinoma in situ of skin

297

1.63

2.62

1.4

1.3

52.83

54.22

mu/l

0.03

254

Respiratory insufficiency

266

1.66

2.61

1.3

69.21

67.86

mu/l

0.02

230

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

255

1830

1.23

2.58

2.1

1.3

71.86

60.41

mu/l

0.33

224

1625

Tumor necrosis factor alpha inhibitors

648

1.41

2.57

1.6

61.68

58.50

mu/l

0.05

584

Psoriasis vulgaris

121

903

1.35

2.56

1.7

1.4

60.82

58.69

mu/l

0.05

106

805

Stomatitis and related lesions

346

1.57

2.56

2.4

1.5

53.37

48.14

mu/l

0.15

310

Retinal detachments and breaks

218

1757

1.24

2.55

1.6

1.4

63.18

60.59

mu/l

0.07

180

1561

Other female pelvic inflammatory diseases

112

828

1.36

2.53

1.6

1.5

51.36

51.27

mu/l

0.00

738

Diseases of external ear

216

1741

1.24

2.53

1.5

75.12

59.72

mu/l

0.44

187

1549

Postpartum haemorrhage due to retained placenta

525

0.57

2.51

1.7

50.35

49.17

mu/l

0.02

487

Haemolytic anaemias

122

1.99

2.51

2.1

1.3

59.09

48.49

mu/l

0.23

108

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

627

1.41

2.49

1.6

1.4

41.97

48.90

mu/l

0.29

558

Other viral hepatitis

232

1.69

2.49

1.4

1.5

104.36

52.60

mu/l

0.48

209

Exposure to other and unspecified inanimate mechanical forces

255

1.66

2.49

1.5

58.81

52.83

mu/l

0.16

222

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

361

2084

1.19

2.48

1.4

32.87

58.44

mu/l

6.88

314

1856

Peritonsillar abscess

137

1047

1.31

2.47

1.8

1.6

58.84

54.61

mu/l

0.14

119

953

Other specific arthropathies, wide

2.41

2.47

1.5

1.3

54.63

54.04

mu/l

0.01

Crohn disease (strict definition, require KELA, min 2 HDR)

248

1.66

2.46

1.6

1.5

73.51

42.50

mu/l

0.56

219

Use of other anti-dementia drugs

744

0.66

2.46

1.2

1.3

42.18

53.53

mu/l

0.38

643

Use of memantine

744

0.66

2.46

1.2

1.3

42.18

53.53

mu/l

0.38

643

Open wound of wrist and hand

287

2365

1.20

2.46

1.6

1.5

52.54

70.87

mu/l

1.70

254

2103

Other diseases of oesophagus

382

1.53

2.45

1.4

1.3

35.23

60.82

mu/l

0.78

331

Use of antiglaucoma preparations and miotics

295

1.60

2.45

1.5

1.3

49.77

59.44

mu/l

0.23

253

Disorders of breast

342

2681

1.18

2.43

1.6

44.61

53.42

mu/l

0.66

307

2403

Spondylopathies in diseases classified elsewhere

2.99

2.43

1.3

1.2

47.90

61.20

mu/l

—

Other puerperal infections

296

1.60

2.42

1.7

1.8

69.58

52.57

mu/l

0.40

269

Other and unspecified mood [affective] disorders

265

1.63

2.41

1.4

1.6

43.50

56.26

mu/l

0.36

238

Alcohol-induced chronic pancreatitis

266

1.63

2.38

1.2

1.4

68.60

60.35

mu/l

0.13

242

Purpura and other haemorrhagic conditions

574

1.42

2.38

1.6

1.5

112.54

58.01

mu/l

0.74

507

152

1048

1.29

2.37

1.2

1.3

48.33

59.97

mu/l

0.34

130

918

Parkinson's disease, strict definition, excluding more controls

425

1.48

2.37

1.2

1.5

36.91

62.51

mu/l

1.03

381

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

140

1081

1.30

2.36

2.5

1.3

68.91

61.19

mu/l

0.17

126

958

Septal defects

238

1.65

2.36

1.4

1.6

49.71

94.59

mu/l

0.51

212

Need for immunization against other single viral diseases

2.28

2.35

1.6

1.4

44.75

56.07

mu/l

0.26

Childhood asthma (age<16), excluding more controls

394

1.45

2.35

1.9

1.7

45.61

59.55

mu/l

0.58

362

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

190

1524

1.25

2.35

1.6

1.5

52.20

62.14

mu/l

0.44

181

1357

Left bundle-branch block

260

1.62

2.32

1.5

1.4

106.05

61.72

mu/l

0.30

232

Graves disease, strict definition

428

1.48

2.32

2.4

1.5

57.94

46.19

mu/l

0.47

388

Primary_lymphoid and hematopoietic malignant neoplasms

139

1075

1.30

2.32

1.3

55.16

69.38

mu/l

0.50

125

943

Other condition

628

1.39

2.31

1.6

1.5

77.21

52.42

mu/l

0.46

558

Congenital malformations of cardiac septa

252

1.62

2.30

1.4

1.5

47.29

97.60

mu/l

0.64

224

Other maternal disorders predominantly related to pregnancy

407

2199

1.17

2.29

1.6

70.98

52.49

mu/l

0.93

366

1983

Inflammatory bowel disease, strict (require KELA)

150

1175

1.28

2.28

1.5

1.6

73.77

62.00

mu/l

0.35

132

1062

Other articular cartilage disorders

2.04

2.27

1.1

1.4

220.10

59.96

mu/l

0.83

Benign neoplasm of ovary

119

905

1.32

2.26

1.5

1.4

27.14

57.20

mu/l

4.37

110

807

Plantar fascial fibromatosis

439

1.46

2.25

1.4

1.5

36.84

47.30

mu/l

0.58

397

Other disorders of patella

118

897

1.32

2.25

1.7

1.5

86.91

54.77

mu/l

0.72

100

807

Acute nasopharyngitis (common cold)

577

1.40

2.25

1.6

1.5

78.92

75.10

mu/l

0.05

515

Alcohol abuse counselling and surveillance

0.00

2.24

0.0

1.4

—

56.26

—

Single spontaneous delivery

214

1396

0.81

2.24

1.5

1.6

34.21

54.61

mu/l

2.40

198

1233

Childhood asthma (age<16)

399

1.44

2.23

1.9

1.7

45.61

61.54

mu/l

0.69

367

Malignant melanoma

658

1.37

2.23

1.5

1.4

36.54

56.69

mu/l

1.27

582

Benign neoplasm: Skin of other and unspecified parts of face

465

1.45

2.23

1.3

1.4

28.92

52.59

mu/l

1.72

411

Fibrosis and cirrhosis of liver

287

1.58

2.22

1.6

1.4

164.61

41.27

mu/l

0.81

255

Nummular dermatitis

327

1.54

2.22

1.9

1.4

87.93

49.44

mu/l

0.51

291

Fentanyl

335

1.53

2.20

1.8

1.3

42.65

49.57

mu/l

0.22

292

Psoriatic and enteropathic arthropathies

525

1.42

2.19

1.6

1.4

78.12

50.78

mu/l

0.50

471

Crohn disease (strict definition, require KELA)

257

1.60

2.18

1.6

1.5

73.51

41.99

mu/l

0.58

225

Other disorders of iris and ciliary body

2.09

2.18

2.7

1.3

41.03

45.25

mu/l

0.08

Urethral stricture

203

1.69

2.18

1.6

1.3

70.48

73.22

mu/l

0.02

178

Vestibular neuronitis

377

1.49

2.18

1.3

1.4

50.42

55.99

mu/l

0.13

336

Chondropathies

712

1.35

2.18

1.5

73.19

52.62

mu/l

0.43

634

Suggestive for eosinophilic asthma

377

1.49

2.17

1.4

43.24

57.41

mu/l

0.38

329

Acute laryngitis and tracheitis

476

1.43

2.17

1.7

1.6

96.46

70.75

mu/l

0.38

423

L02BA Anti-estrogens

876

0.69

2.17

1.7

1.5

89.12

52.12

mu/l

0.29

786

Postpartum haemorrhage

1127

0.75

2.17

1.9

72.26

49.57

mu/l

0.49

1024

Use of galantamine

195

0.41

2.17

1.0

1.2

149.57

62.75

mu/l

—

161

Exposure to other and unspecified animate mechanical forces

2.04

2.17

1.8

1.4

59.13

52.90

mu/l

0.09

Congenital malformations of the respiratory system

2.33

2.16

1.2

1.3

70.56

200.17

mu/l

0.41

Autonomic disorders

2.19

2.16

1.5

1.4

64.19

47.40

mu/l

0.20

Seborrhoeic dermatitis

403

1.47

2.14

1.6

1.5

85.66

83.41

mu/l

0.02

362

Rheumatoid arthritis, including avohilmo

251

2101

1.20

2.09

1.4

57.96

57.85

mu/l

0.00

224

1862

Hypermetropia

268

1.58

2.08

1.3

1.6

40.74

86.83

mu/l

0.68

245

Fall on and from ladder

292

1.55

2.08

1.3

1.4

53.29

66.10

mu/l

0.32

256

Skin changes due to chronic exposure to nonionizing radiation

217

1695

1.21

2.07

1.3

1.4

32.12

58.15

mu/l

4.66

190

1482

Preparatory care for dialysis

146

1.79

2.07

1.4

1.3

84.38

55.33

mu/l

0.24

132

Injury of muscle and tendon at shoulder and upper arm level

229

1904

1.21

2.06

1.4

62.11

68.69

mu/l

0.25

205

1679

Streptococcal septicaemia

301

1.54

2.05

1.5

1.3

59.14

74.31

mu/l

0.36

264

Benign neoplasm: Sigmoid colon

108

824

1.32

2.04

1.3

88.54

63.70

mu/l

0.60

729

Amputation

342

1.50

2.03

1.3

1.4

77.94

70.23

mu/l

0.16

301

Cardiomyopathies, Primary/intrinsic

491

1.41

2.03

1.3

1.4

69.41

57.63

mu/l

0.27

444

Benign neoplasm: Skin of trunk

147

1.78

2.03

1.4

58.88

43.88

mu/l

0.27

132

Benign neoplasm: Skin of eyelid, including canthus

705

1.34

2.01

1.4

96.69

50.75

mu/l

0.81

620

Other noninfective disorders of lymphatic vessels and lymph nodes

133

1.82

2.00

1.4

42.81

54.05

mu/l

0.26

120

Acute and transient psychotic disorders

535

1.39

1.99

1.2

1.6

56.91

59.63

mu/l

0.06

483

231

1813

1.20

1.99

1.3

1.4

32.38

57.41

mu/l

4.79

203

1591

Allergic rhinitis

196

1595

1.22

1.99

1.7

69.29

63.80

mu/l

0.13

170

1449

Other peripheral vascular diseases

312

1.51

1.98

1.8

1.5

59.15

40.67

mu/l

0.47

283

Pollen allergy

112

854

1.30

1.97

1.7

77.61

64.51

mu/l

0.25

784

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

171

1.71

1.97

1.8

1.4

25.84

72.85

mu/l

2.12

152

Bronchitis, not specified as acute or chronic

353

1.48

1.97

1.4

90.83

52.54

mu/l

0.44

309

Later onset COPD

143

890

1.26

1.97

1.2

1.4

76.48

62.96

mu/l

0.48

121

773

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

418

1.44

1.96

1.3

76.78

77.81

mu/l

0.01

367

Cardiomyopathy (excluding other)

503

1.40

1.96

1.3

1.4

69.41

57.46

mu/l

0.28

455

Demyelinating diseases of the central nervous system

362

1.47

1.95

1.4

1.6

28.55

52.13

mu/l

1.48

330

Benign neoplasm: Skin of trunk

149

1.76

1.95

1.4

58.88

66.33

mu/l

0.10

133

Other disorders starting during childhood or adolescence

170

1.70

1.95

1.6

1.7

89.57

129.64

mu/l

0.24

151

Other ulcerative colitis

210

1.63

1.95

1.8

1.4

119.17

37.21

mu/l

1.35

187

Benign leiomyoma with endometriosis

104

796

1.31

1.94

1.2

1.4

33.71

56.30

mu/l

1.99

711

Superficial injury of wrist and hand

120

936

1.29

1.94

1.7

1.6

58.73

58.61

mu/l

0.00

113

835

Rash and other nonspecific skin eruption

412

1.44

1.94

1.7

1.5

46.85

42.88

mu/l

0.12

365

Delivery

220

1399

0.83

1.94

1.5

1.6

34.49

54.91

mu/l

2.45

202

1236

Outcome of delivery

570

0.72

1.94

1.4

1.9

105.76

44.05

mu/l

0.71

525

Complications of other internal prosthetic devices, implants and grafts

142

1.77

1.93

1.2

1.4

46.56

40.16

mu/l

0.15

127

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

185

1.66

1.91

1.6

1.7

85.38

125.32

mu/l

0.26

165

Nasal polyp

120

939

1.28

1.90

1.5

1.4

53.22

65.48

mu/l

0.31

102

839

Mixed and other personality disorders

340

1.48

1.89

1.3

1.6

67.75

58.73

mu/l

0.11

307

Other symptoms and signs involving general sensations and perceptions

121

1.83

1.89

1.4

1.3

58.41

46.91

mu/l

0.17

102

Disorders in reading

2.33

1.88

1.6

1.3

42.34

52.92

mu/l

0.26

In situ neoplasms

213

1778

1.20

1.87

1.4

66.28

55.76

mu/l

0.31

187

1571

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

277

1.52

1.84

1.6

1.5

106.72

41.55

mu/l

0.86

242

Sacroiliitis, not elsewhere classified

167

1.69

1.84

2.0

1.6

75.77

44.79

mu/l

0.42

151

Complications predominantly related to the puerperium

168

1373

1.23

1.84

1.5

1.7

58.09

53.63

mu/l

0.17

153

1244

Polycystic ovarian syndrome, broad definition

392

1.43

1.83

1.4

51.63

42.45

mu/l

0.15

356

Benign mammary dysplasia

708

1.32

1.83

1.7

1.4

49.02

47.99

mu/l

0.02

629

Other and unspecified disorders of adult personality and behaviour

3.11

1.81

1.1

1.3

208.89

53.52

mu/l

—

Other medical care

243

2010

1.18

1.81

1.8

1.4

43.22

57.90

mu/l

1.66

218

1775

Postpartum hemorraghe, all women as controls

1250

0.77

1.81

1.9

72.26

52.51

mu/l

0.41

1150

Other diseases of arteries and capillaries

352

1.46

1.80

1.2

1.4

111.09

47.77

mu/l

1.04

316

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

693

4084

1.11

1.80

1.4

1.5

60.44

64.56

mu/l

0.20

612

3654

Arthropathic psoriasis

503

1.38

1.80

1.5

81.82

54.33

mu/l

0.46

452

Abscess of external ear

2.37

1.78

2.0

1.1

48.93

27.69

mu/l

0.58

Hyphaema and other vascular disorders of iris and ciliary body

2.19

1.78

3.0

1.3

54.28

51.43

mu/l

0.04

Acute epiglottitis

2.37

1.78

1.6

1.3

61.27

58.21

mu/l

0.04

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

100

772

1.30

1.78

1.5

58.88

63.06

mu/l

0.12

695

Recurring oral aphthae, including avohilmo

625

1.33

1.77

2.1

1.5

41.20

45.55

mu/l

0.21

546

Exposure to other specified electric current

2.47

1.76

1.3

1.1

29.34

35.19

mu/l

—

Primary_lymphoid and hematopoietic malignant neoplasms

139

1119

1.25

1.76

1.3

1.4

55.16

69.08

mu/l

0.50

125

986

Coronary angioplasty

217

1398

1.19

1.76

1.2

1.4

69.15

60.42

mu/l

0.27

192

1236

Cardiomyopathy, other and unspecified

321

1.47

1.76

1.3

1.4

75.11

65.36

mu/l

0.09

295

Open wound of head

323

2763

1.15

1.76

1.5

92.13

66.89

mu/l

0.39

289

2455

Other specified disorders of muscle

1.95

1.75

1.1

1.3

53.47

40.14

mu/l

0.19

Fracture of shoulder and upper arm

222

1872

1.19

1.75

1.5

64.61

60.34

mu/l

0.13

196

1661

Schizophrenia, schizotypal and delusional disorders

207

1737

1.19

1.74

1.3

1.5

57.80

63.33

mu/l

0.18

179

1563

Benign neoplasm: Sigmoid colon

108

847

1.28

1.72

1.3

1.4

88.54

56.74

mu/l

0.87

753

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

274

1.50

1.71

1.2

1.6

34.43

64.92

mu/l

1.54

247

Burns and corrosions confined to eye and internal organs

1.93

1.70

1.2

1.3

45.89

42.76

mu/l

0.07

Acute alcohol intoxication

149

1214

1.23

1.70

1.4

1.5

119.50

65.72

mu/l

0.58

123

1081

Oral leukoplakia and related diseases, including avohilmo

374

1.42

1.69

1.8

1.4

62.13

50.28

mu/l

0.17

333

Endometriosis of rectovaginal septum and vagina

308

1.47

1.68

1.4

1.5

72.66

64.52

mu/l

0.10

275

Event of undetermined intent

219

1.56

1.68

1.2

1.5

85.23

45.85

mu/l

0.41

197

Sulfasalazine

182

1516

1.20

1.67

1.4

1.5

53.99

61.22

mu/l

0.23

165

1358

Right ventricular outflow tract obstruction

3.20

1.67

2.3

1.3

454.77

632.79

mu/l

—

Procreative management

220

1570

1.18

1.67

1.7

45.97

67.16

mu/l

1.80

202

1427

Duodenal ulcer

417

1.40

1.66

1.4

34.58

82.52

mu/l

1.20

363

Propionic acid derivatives

194

812

1.20

1.62

1.4

1.6

57.25

55.60

mu/l

0.05

166

729

Allergic purpura

1.85

1.62

1.5

1.3

30.56

43.38

mu/l

0.43

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

389

2807

1.13

1.62

1.8

1.6

57.75

58.39

mu/l

0.02

353

2528

Seropositive rheumatoid arthritis, wide

168

1395

1.21

1.61

1.3

1.4

47.45

58.83

mu/l

0.63

151

1247

Schizophrenia or delusion

205

1734

1.18

1.60

1.3

1.6

58.17

63.43

mu/l

0.17

177

1561

Assault by bodily force

312

1.45

1.59

1.4

1.7

56.24

62.45

mu/l

0.09

280

Endometriosis of fallopian tube

3.04

1.59

1.3

1.2

6.12

39.25

mu/l

—

Scoliosis

337

1.43

1.59

1.3

1.5

60.99

47.45

mu/l

0.47

295

Diseases of middle ear and mastoid

374

2707

1.13

1.58

1.7

53.80

62.84

mu/l

0.59

338

2443

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

144

1.68

1.58

1.6

1.3

67.06

60.16

mu/l

0.06

130

Alcoholic liver disease

405

1.39

1.57

1.2

1.4

111.61

57.32

mu/l

0.38

367

Other enthesopathy of foot (+metatarsalgia)

440

1.37

1.55

1.5

50.20

49.18

mu/l

0.03

395

Deviated nasal septum

211

1794

1.18

1.55

1.5

80.49

71.53

mu/l

0.23

189

1602

Ulcerative rectosigmoiditis

322

1.43

1.55

1.6

1.4

54.43

55.72

mu/l

0.02

290

Presbycusis

455

1.36

1.54

1.3

32.54

59.06

mu/l

1.74

402

Sequelae of injuries of lower limb

415

1.38

1.54

1.2

1.4

24.74

50.95

mu/l

2.73

367

Endometriosis ASRM stages 1,2

114

914

1.25

1.54

1.7

1.6

45.10

54.34

mu/l

0.50

108

822

Maternal care for other conditions predominantly related to pregnancy

121

964

1.24

1.53

1.8

1.9

91.77

49.80

mu/l

0.92

110

878

Abnormal spermatozoa

484

1.35

1.53

1.5

1.4

70.46

75.08

mu/l

0.05

430

Mixed specific developmental disorders

1.99

1.53

1.6

68.46

248.23

mu/l

0.66

Ectopic pregnancy

116

933

1.25

1.53

1.7

1.6

65.29

50.36

mu/l

0.42

105

851

Metatarsalgia

399

1.38

1.52

1.5

52.14

47.07

mu/l

0.18

357

Female infertility, tubal origin

177

1.59

1.51

2.3

1.6

58.11

56.95

mu/l

0.02

162

Toxic liver disease

2.18

1.51

1.5

1.2

73.39

53.56

mu/l

0.25

Other (seronegative) rheumatoid arthritis, wide

115

926

1.25

1.51

1.7

1.4

65.33

58.71

mu/l

0.12

101

828

Fracture at wrist and hand level

216

1849

1.17

1.48

1.8

1.5

79.32

67.81

mu/l

0.38

196

1648

Other and unspecified nonorganic psychotic disorders

114

920

1.24

1.47

1.3

1.6

48.81

60.90

mu/l

0.48

100

838

Endometriosis of ovary

784

1.26

1.47

1.4

1.5

50.96

51.78

mu/l

0.02

700

Injuries to the elbow and forearm

468

3810

1.11

1.46

1.6

1.5

70.30

61.34

mu/l

0.26

421

3399

Leukaemia of unspecified cell type

2.53

1.46

1.0

1.1

48.96

25.25

mu/l

—

Organic, including symptomatic, mental disorders

212

1786

0.86

1.46

1.4

63.08

55.38

mu/l

0.19

182

1574

Exfoliative dermatitis

2.53

1.46

1.4

113.91

36.28

mu/l

—

Dental caries 2 and operation codes, only avohilmo

419

2904

0.89

1.45

1.5

1.6

58.58

61.15

mu/l

0.08

376

2608

Nonsuppurative otitis media

130

919

1.22

1.45

1.7

1.8

77.61

71.34

mu/l

0.12

115

831

Diabetic retinopathy

275

1511

1.15

1.45

1.6

1.5

76.21

76.99

mu/l

0.02

236

1353

Benign neoplasm: Choroid

245

1.48

1.42

1.6

1.3

21.29

58.19

mu/l

2.17

219

Hallux rigidus

701

1.27

1.42

1.4

36.49

67.83

mu/l

1.10

627

Lung cancer and mesothelioma

101

689

1.26

1.42

1.4

117.26

59.84

mu/l

0.87

605

Endometriosis diagnosis and infertility diagnosis occurring together

491

1.33

1.42

1.5

1.6

44.02

47.17

mu/l

0.10

449

Benign neoplasm of eye and adnexa

405

1.36

1.41

1.7

1.3

34.39

66.21

mu/l

1.29

363

Atrophic disorders of skin

684

1.28

1.41

1.6

1.4

57.10

51.34

mu/l

0.16

607

Melanocytic naevi of other and unspecified parts of face

229

1.49

1.41

1.7

1.5

21.82

49.83

mu/l

2.17

208

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

149

1.62

1.41

1.6

1.3

67.06

44.45

mu/l

0.26

134

Other and unspecified iridocyclitis

149

1.62

1.41

1.3

28.68

45.19

mu/l

0.81

134

Use of rotigotine

2.28

1.41

1.3

22.92

61.55

mu/l

—

Ulcerative colitis (strict definition, require KELA)

101

809

1.25

1.40

1.5

58.26

62.54

mu/l

0.12

727

Benign neoplasm: Choroid

246

1.47

1.40

1.6

1.4

21.29

51.98

mu/l

1.70

219

Spontaneous abortion

311

1863

1.14

1.40

1.6

1.7

61.79

50.27

mu/l

0.42

277

1682

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

783

1.25

1.40

1.8

1.7

37.37

50.89

mu/l

1.13

701

Idiopathic thrombocytopenic purpura

1.78

1.39

1.1

1.3

120.31

49.90

mu/l

0.96

Actinic keratosis

202

1644

1.17

1.38

1.3

1.4

30.58

58.56

mu/l

5.10

177

1437

Alzheimer’s disease, wide definition, excluding more controls

392

0.71

1.37

1.2

1.5

36.15

60.87

mu/l

0.73

351

Postpartum hemorraghe, parous women as controls

1056

0.80

1.36

1.9

1.8

72.26

53.40

mu/l

0.38

975

Psoriatic arthropathies, ICD10

477

1.33

1.36

1.5

85.42

50.70

mu/l

0.57

428

Other disorders of breast

600

1.29

1.35

1.5

1.4

60.67

54.34

mu/l

0.15

538

Macular pucker

662

1.27

1.35

1.7

1.3

47.02

63.05

mu/l

0.58

592

Other psoriatic arthropathies

469

1.33

1.35

1.5

86.25

50.94

mu/l

0.57

422

Seborrhoeic keratosis

131

1085

1.21

1.34

1.7

1.4

62.81

60.53

mu/l

0.05

118

963

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

108

877

1.23

1.34

1.5

62.27

64.33

mu/l

0.06

790

Residual foreign body in soft tissue

175

1.55

1.34

1.6

1.4

33.63

45.02

mu/l

0.33

158

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

265

1.44

1.34

1.5

1.6

83.87

50.79

mu/l

0.26

235

Psoriatic arthropathies

479

1.32

1.33

1.5

1.4

85.42

55.40

mu/l

0.47

429

Degenerative macular diseases

497

1.31

1.32

1.3

1.4

37.99

59.41

mu/l

0.83

439

Varicose veins

424

2888

1.11

1.32

1.4

1.5

52.27

58.49

mu/l

0.34

363

2561

Pyogenic arthritis

258

1.44

1.31

1.3

1.4

44.74

55.07

mu/l

0.27

231

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

161

1363

1.18

1.31

1.3

1.4

47.20

59.45

mu/l

0.67

146

1219

Agranulocytosis

498

1.31

1.30

1.8

1.4

88.51

67.49

mu/l

0.17

440

Phlebitis and thrombophlebitis (not including DVT)

135

1127

1.20

1.29

1.5

1.4

63.57

57.58

mu/l

0.14

120

1012

Alcohol abuse, main dg, excluding more controls

640

1.27

1.29

1.5

114.90

61.57

mu/l

0.32

578

Other/unspecified seropositive rheumatoid arthritis

162

1375

1.18

1.28

1.3

1.4

47.20

59.22

mu/l

0.66

146

1229

Malignant neoplasm of breast, HER2-negative

266

2219

0.88

1.28

1.4

1.5

46.02

51.15

mu/l

0.25

232

1981

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

108

867

1.23

1.28

1.3

70.76

55.64

mu/l

0.21

769

Other melanin hyperpigmentation

1.80

1.28

1.1

1.3

18.32

45.46

mu/l

1.15

Burn and corrosion confined to eye and adnexa

1.80

1.27

1.2

1.4

47.46

48.33

mu/l

0.02

Exclusion endpoint for supernumerary teeth

2.06

1.27

1.9

1.2

25.19

33.38

mu/l

—

Medical abortion

438

2150

1.11

1.27

1.5

1.6

56.36

47.83

mu/l

0.47

391

1937

Benign leiomyoma with endometriosis

104

849

1.23

1.25

1.2

1.4

33.71

53.72

mu/l

1.76

762

6-mercaptopurine

1.75

1.25

2.1

1.3

55.27

143.09

mu/l

0.38

Anti-inflammatory and antirheumatic products, non-steroids

189

812

1.17

1.25

1.4

1.6

53.71

55.60

mu/l

0.06

165

729

Malignant neoplasm of breast

276

2250

0.88

1.24

1.4

1.5

51.71

50.68

mu/l

0.04

241

2010

Crohn disease (strict definition, all UC cases excluded)

187

1.50

1.24

1.5

1.4

51.32

44.34

mu/l

0.14

165

Other specified/unspecified systemic involvement of connective tissue

245

1.44

1.23

1.7

1.4

49.83

43.09

mu/l

0.18

223

Von Willebrand disease

2.06

1.22

1.6

1.4

26.97

60.90

mu/l

—

Use of disulfiram, acamprosate or naltrexone

390

1.34

1.22

1.4

1.5

89.34

63.56

mu/l

0.48

352

Complications of labour and delivery

369

2288

0.90

1.22

1.5

1.6

63.24

49.94

mu/l

0.63

330

2055

Puerperal sepsis

681

1.25

1.22

1.2

1.4

50.02

58.29

mu/l

0.26

614

Malignant neoplasm of breast, HER-positive

169

1938

0.86

1.20

1.4

32.03

50.83

mu/l

1.97

148

1718

Artificial opening status

205

1.47

1.20

1.7

1.4

51.06

97.06

mu/l

0.45

181

Strabismus

157

1338

1.17

1.18

1.5

37.37

72.09

mu/l

3.25

145

1198

Melanocytic naevi of other and unspecified parts of face

239

1.43

1.18

1.7

1.5

21.82

45.70

mu/l

1.84

216

Ascites

256

1.41

1.17

1.2

1.4

181.49

53.93

mu/l

0.74

223

Other hammer toe(s) (acquired)

106

819

1.22

1.17

1.3

36.95

57.34

mu/l

0.62

731

Effects of foreign body entering through natural orifice

143

1213

1.18

1.17

2.1

1.5

70.38

63.07

mu/l

0.17

131

1082

Other embolism and thrombosis

596

1.26

1.17

1.4

39.69

55.58

mu/l

0.76

534

Personality and behavioural disorders due to brain disease, damage and dysfunction

2.02

1.16

1.7

1.3

31.87

31.00

mu/l

—

Benign neoplasm of eye and adnexa

420

1.31

1.16

1.7

1.4

34.39

47.30

mu/l

0.46

371

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

110

1.65

1.16

1.4

1.3

147.34

66.95

mu/l

0.45

Malignant neoplasm of larynx

2.07

1.15

1.1

1.4

26.64

47.54

mu/l

—

Mixed connective tissue disease

291

1.38

1.15

1.6

1.4

48.88

40.87

mu/l

0.25

266

Dental caries 3 and operation codes, only avohilmo

222

973

1.15

1.6

1.7

63.13

61.83

mu/l

0.03

193

894

L01XE Protein kinase inhibitors

224

1.44

1.14

1.7

1.3

33.96

57.98

mu/l

0.98

197

Open wound of ankle and foot

430

1.31

1.14

1.3

1.5

75.00

58.30

mu/l

0.46

375

Chalazion

474

1.29

1.14

1.4

1.5

65.70

49.75

mu/l

0.41

417

Maternal care related to the fetus and amniotic cavity and possible delivery problems

238

1589

0.88

1.14

1.6

1.7

47.84

59.25

mu/l

0.58

217

1444

Postmenopausal atrophic vaginitis

159

817

1.17

1.13

1.3

1.4

40.41

55.64

mu/l

0.58

149

724

Disorders of tooth development and eruption

194

1.46

1.13

3.2

1.6

112.80

111.10

mu/l

0.01

173

Sequelae of injuries of head

183

1.48

1.13

1.7

1.5

73.04

61.25

mu/l

0.12

162

Covid-19 suspected case

120

1006

1.20

1.13

1.3

1.6

40.80

71.39

mu/l

1.80

113

912

Other and unspecified mononeuropathies of lower limb

103

1.66

1.13

2.0

1.4

141.69

38.86

mu/l

0.54

Alzheimer’s disease (Late onset), excluding more controls

347

0.73

1.12

1.2

1.5

36.55

53.10

mu/l

0.43

312

Reactive arthropathies

388

1.32

1.11

1.3

1.4

54.88

46.11

mu/l

0.25

344

Lichen sclerosus et atrophicus

467

1.29

1.11

1.7

1.4

55.37

47.74

mu/l

0.18

409

Reactive arthropathies, FINNGEN

277

1.38

1.09

1.4

63.12

57.34

mu/l

0.11

248

Other degenerative diseases of the nervous system

133

854

1.18

1.09

1.2

1.5

33.20

55.33

mu/l

1.95

107

768

Unspecified privation

451

1.29

1.09

1.4

1.5

142.00

53.57

mu/l

1.19

396

Other appendicitis

355

1.33

1.08

1.3

1.4

42.26

41.41

mu/l

0.03

312

MS-disease / Multiple Sclerosis

304

1.35

1.07

1.4

1.5

21.54

47.84

mu/l

2.34

276

Certain conditions originating in the perinatal period

284

1.35

1.07

2.2

1.8

103.98

93.27

mu/l

0.07

258

Alcoholic gastritis

1.94

1.06

1.1

1.3

73.09

60.06

mu/l

—

Melanoma in situ

137

1.54

1.06

1.5

1.3

35.61

46.27

mu/l

0.21

122

Benign neoplasm: Vulva

1.72

1.05

2.0

1.4

26.05

42.31

mu/l

0.47

Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)

1.81

1.05

1.5

1.3

41.58

62.39

mu/l

0.33

Bacterial, viral and other infectious agents

366

1.32

1.05

1.8

1.5

86.98

57.64

mu/l

0.33

328

Pedal cyclist injured in transport accident

129

1099

1.18

1.03

1.7

1.5

66.46

61.21

mu/l

0.12

119

979

Other infective otitis externa

229

1.40

1.03

1.6

1.4

56.14

44.05

mu/l

0.18

208

Malignant neoplasm of skin

368

2520

1.10

1.03

1.4

31.88

60.84

mu/l

9.11

316

2229

Acute alcohol intoxication, ICD10

113

953

1.19

1.02

1.4

1.5

144.09

65.55

mu/l

0.68

850

Pleural plaque

324

1.33

1.02

1.3

66.26

70.31

mu/l

0.05

284

Alcohol withdrawal state with delirium

281

1.36

1.02

1.1

1.4

36.18

67.79

mu/l

1.30

253

Medicines for HER+ breast cancer

181

2010

0.88

1.02

1.4

50.71

50.14

mu/l

0.01

160

1781

Ulcerative colitis (strict definition, all Crohn cases excluded)

680

1.22

1.02

1.4

1.5

72.60

61.29

mu/l

0.21

610

Exposure to other and unspecified man-made environmental factors

1.90

1.01

2.5

1.3

26.04

60.68

mu/l

—

Viral warts

412

1.29

1.01

2.1

1.5

44.31

53.51

mu/l

0.30

362

Anomalies of dental arch relationship, including avohilmo

109

823

1.19

1.01

2.8

1.5

77.90

55.89

mu/l

0.49

103

746

Other respiratory diseases principally affecting the interstitium

726

1.21

1.01

1.2

1.4

48.72

55.17

mu/l

0.21

635

Subarachnoid haemorrhage

430

1.28

1.01

1.3

1.4

50.29

50.48

mu/l

0.00

377

Pregnancy with abortive outcome

451

2163

1.09

1.01

1.5

1.6

51.10

47.70

mu/l

0.18

406

1949

Other disorders of the genitourinary system

609

1.24

1.00

1.8

1.4

63.59

47.07

mu/l

0.31

542

Other strabismus

127

1082

1.17

0.99

1.5

1.6

33.02

69.63

mu/l

3.13

116

972

Special screening examination for infectious and parasitic diseases

134

857

1.17

0.99

2.1

1.6

67.86

64.80

mu/l

0.08

121

785

Injury of muscle and tendon at wrist and hand level

637

1.23

0.99

1.5

57.51

59.91

mu/l

0.06

569

Entropion and trichiasis of eyelid

291

1.34

0.99

1.4

1.3

88.93

65.92

mu/l

0.26

252

Urethritis and urethral syndrome

1.72

0.99

1.5

1.3

32.25

38.91

mu/l

0.18

Carcinoma in situ of skin of scalp and neck

1.82

0.99

1.1

1.2

37.00

42.14

mu/l

—

Scabies

156

1.48

0.98

1.1

1.4

35.58

63.03

mu/l

0.79

141

Transient synovitis

2.19

0.98

1.0

1.3

43.78

28.51

mu/l

—

Ovarian hyperstimulation (induction)

1.81

0.97

3.3

1.6

14.11

33.14

mu/l

—

Other superficial mycoses

1.75

0.97

1.1

1.3

62.83

44.15

mu/l

—

Maternal care for known or suspected abnormality of pelvic organs

152

908

1.16

0.97

2.0

1.8

37.78

50.95

mu/l

1.09

145

829

Melanoma in situ

141

1.50

0.95

1.5

1.4

35.61

51.97

mu/l

0.35

124

Carcinoma in situ of skin of scalp and neck

1.79

0.94

1.1

1.2

37.00

53.29

mu/l

—

Exclusion endpoint for clefts

1.78

0.94

1.3

1.4

25.41

226.00

mu/l

0.70

Oral lichen ruber planus, including avohilmo

277

1.34

0.94

1.9

1.5

60.90

41.47

mu/l

0.48

253

Hidradenitis suppurativa

117

1.55

0.94

1.7

1.4

69.56

43.93

mu/l

0.41

103

Chronic viral hepatitis

200

1.41

0.93

1.5

107.73

53.46

mu/l

0.35

178

Tuberculosis, IBD comorbidity

260

1.35

0.93

1.4

42.56

61.07

mu/l

0.51

227

Childhood allergy (age < 16)

469

1.23

0.92

1.7

2.0

80.98

84.06

mu/l

0.03

429

Pneumonia due to Streptococcus pneumoniae

134

1.50

0.92

1.3

1.4

78.91

59.02

mu/l

0.25

121

Eustachian salpingitis and obstruction

305

1.32

0.90

1.2

1.7

48.97

62.23

mu/l

0.48

274

Medical treatment for female infertility

113

964

1.17

0.90

2.5

1.9

106.32

52.40

mu/l

0.85

104

892

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

627

1.21

0.90

1.3

1.4

126.06

62.46

mu/l

0.63

565

Coxarthrosis, primary

357

2840

1.09

0.90

1.4

65.57

57.07

mu/l

0.40

318

2504

Other congenital malformations of intestine

2.09

0.90

1.7

1.3

89.90

421.03

mu/l

—

Presence of other devices

112

957

1.17

0.89

1.3

1.4

45.85

60.13

mu/l

0.56

846

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, excluding all cancers (controls excluding all cancers)

1.92

0.89

1.6

1.1

54.20

75.78

mu/l

—

Delivery, wide proxy

183

1101

0.88

0.89

1.4

1.6

41.62

47.20

mu/l

0.20

164

976

Pediculosis, acariasis and other infestations

211

1.38

0.88

1.2

1.5

31.81

59.71

mu/l

1.18

190

Mandibular retrognathia

262

1.34

0.88

2.8

1.6

97.12

43.72

mu/l

0.93

239

Injury of muscle and tendon at hip and thigh level

431

1.26

0.87

1.6

1.4

43.88

51.47

mu/l

0.25

385

Acute appendicitis, with complications

115

989

1.16

0.86

1.5

34.56

62.73

mu/l

3.02

104

882

Congenital malformations of uterus and cervix

1.73

0.86

1.0

1.5

30.95

64.94

mu/l

0.57

Other disorders of veins

244

2202

1.11

0.86

1.4

49.00

55.90

mu/l

0.26

215

1979

Tuberculosis, wide

264

1.33

0.86

1.4

42.56

60.63

mu/l

0.49

229

Convalescence

221

1.36

0.85

1.5

1.4

36.30

47.03

mu/l

0.37

196

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

294

1835

1.10

0.85

1.4

1.3

32.36

56.89

mu/l

5.66

252

1633

Anomalies of pupillary function

1.64

0.85

1.5

1.3

114.12

46.65

mu/l

0.67

Benign neoplasm: Vulva

1.60

0.84

2.0

1.4

26.05

40.40

mu/l

0.42

Infections with a predominantly sexual mode of transmission

177

1571

1.13

0.84

1.7

75.85

55.45

mu/l

0.60

159

1428

Spirochaetal infections, other/unspecified

362

1.27

0.84

1.5

1.4

86.90

52.17

mu/l

0.42

320

Other benign neoplasms of connective and other soft tissue

398

1.26

0.83

1.1

1.4

43.12

63.40

mu/l

0.74

356

Other disorders of skin and subcutaneous tissue, not elsewhere classified

624

1.20

0.83

1.4

97.56

54.98

mu/l

0.74

549

Emergency coronary revascularization (for ACS)

310

2037

1.09

0.82

1.2

1.4

87.38

62.47

mu/l

0.95

275

1795

Foreign body entering into or through eye or natural orifice

310

1.29

0.82

1.6

1.5

28.30

58.68

mu/l

2.29

279

Other abnormal products of conception

192

1141

1.12

0.82

1.6

1.9

93.98

48.44

mu/l

1.04

177

1053

Diabetic neuropathy

668

1.19

0.81

1.5

1.4

84.55

83.69

mu/l

0.02

596

Contraceptive management

238

1847

0.90

0.80

1.4

1.6

52.32

59.46

mu/l

0.32

209

1675

Chronic suppurative otitis media, including avohilmo

294

1.30

0.79

1.4

33.54

73.29

mu/l

0.63

255

Malignant neoplasm of other and ill-defined sites, excluding all cancers (controls excluding all cancers)

1.68

0.79

1.5

1.2

85.83

52.89

mu/l

—

False labour

182

1020

1.12

0.78

1.9

1.8

45.09

54.67

mu/l

0.59

170

933

Dysplasia of cervi uteri

131

887

1.14

0.77

2.2

1.6

51.00

54.92

mu/l

0.11

121

806

Myocardial infarction, with ST-elevation

703

1.18

0.77

1.3

1.4

62.40

62.73

mu/l

0.01

618

Chronic diseases of tonsils and adenoids

563

3344

1.07

0.77

1.6

72.49

66.68

mu/l

0.26

514

3012

Contact with machinery

466

1.23

0.77

1.2

1.4

58.52

66.65

mu/l

0.23

421

Benign neoplasm: Conjunctiva

115

1.49

0.77

1.9

1.4

57.90

43.28

mu/l

0.18

106

Superficial injury of thorax

667

1.19

0.77

1.3

1.5

56.73

49.58

mu/l

0.20

590

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

350

1.26

0.75

1.7

1.5

34.69

47.30

mu/l

0.55

316

Benign neoplasm: Conjunctiva

116

1.47

0.74

1.9

1.4

57.90

45.49

mu/l

0.15

106

Contact with venomous snakes and lizards

1.86

0.74

1.1

41.10

52.76

mu/l

—

Parkinson's disease, including avohilmo

662

1.18

0.72

1.2

1.4

33.07

58.40

mu/l

1.46

586

Malignant neoplasm of larynx, excluding all cancers (controls excluding all cancers)

1.68

0.72

1.2

1.3

22.71

48.05

mu/l

—

Malignant neoplasm of small intestine

1.63

0.72

1.1

1.3

84.99

46.35

mu/l

0.21

Other/unspecified reactive arthropathies

256

1.29

0.70

1.4

1.5

69.67

39.80

mu/l

0.85

231

Benign neoplasm: Connective and other soft tissue of head, face and neck

1.56

0.70

1.1

1.3

37.74

57.75

mu/l

—

Chronic myeloproliferative disease

1.68

0.68

1.1

1.2

57.66

55.23

mu/l

—

Other congenital malformations of peripheral vascular system

1.68

0.68

1.3

1.2

97.99

261.45

mu/l

—

Alzheimer disease, excluding more controls

443

0.83

0.68

1.1

1.5

31.53

59.78

mu/l

1.19

399

Respiratory and cardiovascular disorders specific to the perinatal period

1.53

0.67

2.0

1.9

166.91

191.78

mu/l

0.05

Suppurative and necrotic conditions of lower respiratory tract

179

1.34

0.67

1.5

1.4

130.24

68.84

mu/l

0.37

159

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

808

1.15

0.66

2.1

1.3

60.83

60.80

mu/l

0.00

715

Malignant neoplasm of respiratory system and intrathoracic organs

786

0.85

0.66

1.4

118.15

65.42

mu/l

0.54

686

Unspecified lump in breast

790

1.15

0.66

1.7

1.4

27.14

53.06

mu/l

2.65

700

L02BG Aromatase inhibitors

144

1606

0.90

0.65

1.4

54.08

50.39

mu/l

0.06

129

1413

Amputation of ankle bones

1.62

0.65

1.7

1.3

76.75

41.71

mu/l

—

Conductive hearing loss, unspecified

350

1.23

0.63

1.3

1.5

23.19

53.82

mu/l

2.58

316

Abnormal findings in secretions and smears from cervix uteri vagina vulva

308

2247

1.08

0.63

1.8

1.7

54.90

55.41

mu/l

0.02

280

2029

Fitting and adjustment of other devices

186

1575

1.10

0.62

1.2

1.4

52.95

57.39

mu/l

0.17

164

1381

Benign neoplasm: other/unspecified salivary gland

102

0.59

0.62

1.3

1.4

77.18

52.18

mu/l

—

Parkinson's disease

628

1.16

0.61

1.2

1.4

34.14

58.98

mu/l

1.28

557

Inflammatory diseases of prostate (prostatitis)

517

1.18

0.61

1.4

72.68

78.22

mu/l

0.08

456

Superficial injury of hip and thigh

600

1.17

0.61

1.5

55.14

57.47

mu/l

0.04

519

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

462

1.19

0.61

1.2

1.4

43.87

46.68

mu/l

0.08

410

Other specified congenital malformation syndromes affecting multiple systems

1.57

0.60

1.3

29.09

216.06

mu/l

—

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

308

1.24

0.59

1.6

1.3

31.03

68.55

mu/l

1.73

279

Motor disorders

1.54

0.59

1.8

1.7

44.35

284.70

mu/l

—

Injury of eye and orbit

659

1.16

0.58

1.8

1.5

93.22

57.09

mu/l

0.56

595

Dislocation, sprain and strain of joints and ligaments of elbow

255

1.26

0.58

1.4

1.5

27.98

87.35

mu/l

0.92

225

Polyhydramnios

184

1.31

0.58

3.3

1.8

26.28

46.85

mu/l

1.49

167

Persons encountering health services in circumstances related to reproduction

354

2556

0.94

0.57

1.5

1.6

58.86

68.55

mu/l

0.48

320

2312

Benign neoplasm: Anus and anal canal

1.43

0.56

2.0

1.3

58.61

50.93

mu/l

0.11

Obstructed labour due to malposition and malpresentation of fetus

104

1101

0.89

0.56

1.6

1.9

106.87

50.14

mu/l

0.83

1004

Other and unspecified intracranial injuries

1.43

0.56

1.7

1.3

23.55

50.74

mu/l

1.33

Hallux valgus (acquired)

210

1399

1.09

0.56

1.4

54.47

58.20

mu/l

0.11

189

1264

Malignant neoplasm of breast, HER-negative

1092

0.89

0.56

1.3

1.4

70.66

52.12

mu/l

0.44

970

Osteomalacia

1.63

0.56

1.3

1.1

82.98

52.94

mu/l

—

Lichen planus

597

1.16

0.55

1.5

1.4

40.98

49.95

mu/l

0.38

528

Valvular operations

560

1.16

0.55

1.2

1.4

98.35

52.73

mu/l

0.57

503

Colorectal cancer, excluding all cancers (controls excluding all cancers)

140

1227

1.10

0.54

1.3

85.58

61.14

mu/l

0.43

122

1089

Other noninflammatory disorders of cervix uteri

195

1.29

0.54

1.5

1.4

28.44

58.99

mu/l

1.08

176

Benign neoplasm: Anus and anal canal

1.42

0.54

2.0

1.3

58.61

43.04

mu/l

0.24

Malignant neoplasm of digestive organs

166

1784

0.91

0.53

1.3

1.4

86.53

58.81

mu/l

0.52

145

1577

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

281

1804

1.07

0.53

1.3

30.04

57.20

mu/l

6.70

239

1608

Other benign neoplasm of uterus: Corpus uteri

1.55

0.53

1.0

1.3

24.70

49.34

mu/l

—

Laparoscopic left hemicolectomy

1.46

0.53

1.1

1.4

44.58

33.34

mu/l

—

Other disorders of amniotic fluid and membranes

631

1.15

0.53

1.7

1.9

44.01

54.17

mu/l

0.54

583

Undescended testicle

1.54

0.53

1.2

1.6

43.30

53.22

mu/l

—

Malignant neoplasm of bronchus and lung

661

0.86

0.53

1.4

1.3

137.40

59.77

mu/l

0.70

581

LSIL lesion of the cervix uteri, vagina or vulva

656

1.15

0.53

2.2

1.6

88.85

52.26

mu/l

0.55

603

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

275

1770

1.07

0.52

1.4

1.3

30.12

56.79

mu/l

6.34

236

1575

Malignant neoplasm of eye, brain and central nervous system

152

1.32

0.52

1.9

1.3

19.08

49.24

mu/l

2.14

133

Dental caries 2, only avohilmo

468

3884

0.95

0.52

1.6

56.84

63.90

mu/l

0.30

420

3495

Benign neoplasm: Connective and other soft tissue of head, face and neck

1.41

0.51

1.1

1.3

37.74

48.24

mu/l

—

severe traumatic brain injury, does not include concussion

104

932

1.12

0.51

1.3

1.4

67.69

56.36

mu/l

0.22

818

Fracture of femur

121

999

1.11

0.50

1.5

1.4

44.47

56.29

mu/l

0.60

103

871

Other benign neoplasms of connective and other soft tissue

426

1.18

0.50

1.1

1.4

43.12

48.34

mu/l

0.16

380

Malignant neoplasm of bladder

216

1.25

0.49

1.4

1.3

44.04

87.67

mu/l

1.37

187

Inguinal hernia

365

2325

1.06

0.49

1.4

1.5

63.01

73.31

mu/l

0.34

323

2083

Malignant neoplasm of brain

110

1.37

0.49

2.2

1.3

22.68

47.88

mu/l

1.18

101

Stenosis and insufficiency of lacrimal passages

381

1.18

0.48

1.8

1.4

38.48

40.25

mu/l

0.05

337

Benign neoplasm: Connective and other soft tissue, unspecified

1.53

0.48

1.0

1.2

9.87

61.86

mu/l

—

Pedal cyclist injured in collision with motor vehicle

110

0.63

0.48

1.3

105.16

50.31

mu/l

—

100

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

1.45

0.48

1.1

1.2

342.41

91.87

mu/l

0.39

Fracture of forearm

341

3018

1.06

0.47

1.6

1.5

67.76

55.95

mu/l

0.28

304

2684

Osteonecrosis due to drugs

1.47

0.47

1.7

1.3

70.53

50.18

mu/l

—

Injury of muscle and tendon at lower leg level

682

1.13

0.47

1.5

1.4

58.63

58.42

mu/l

0.00

610

Personal history of certain other diseases

1.46

0.47

1.7

1.3

54.34

39.70

mu/l

—

Erosion and ectropion of cervix uteri

111

1.36

0.46

1.9

1.4

44.35

44.75

mu/l

0.01

100

ILD, hospital admission 2, with pulmonary infections

343

0.81

0.46

1.3

1.4

44.53

66.50

mu/l

0.63

303

Wet age-related macular degeneration

605

1.14

0.46

1.2

1.3

68.97

54.74

mu/l

0.19

525

Foreign body on external eye

692

1.13

0.46

2.0

1.5

76.60

67.85

mu/l

0.12

626

Benign neoplasm: Connective and other soft tissue, unspecified

1.44

0.46

1.0

1.2

9.87

53.95

mu/l

—

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

170

1492

0.92

0.46

1.4

31.87

50.15

mu/l

1.85

149

1340

Alcohol abuse, main dg

721

1.12

0.46

1.5

114.90

68.09

mu/l

0.28

649

Infections of genitourinary tract in pregnancy

421

1.17

0.45

1.5

1.6

54.73

47.89

mu/l

0.16

375

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

807

1.12

0.45

1.3

103.64

60.38

mu/l

0.54

714

Adhesive middle ear disease

1.40

0.45

1.1

1.2

12.44

39.00

mu/l

—

Inflammatory disease of cervix uteri

283

1.20

0.45

1.2

1.4

64.40

37.15

mu/l

0.35

249

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

160

900

1.09

0.44

1.8

1.3

80.26

73.10

mu/l

0.13

140

792

Non-small cell lung cancer

619

1.13

0.44

1.4

149.47

57.94

mu/l

1.06

545

Seropositive rheumatoid arthritis, strict definition

742

1.12

0.44

1.2

1.5

55.88

57.05

mu/l

0.02

657

Long labour

115

1102

0.91

0.44

1.5

1.8

42.11

49.18

mu/l

0.38

109

1000

Family history of certain disabilities and chronic diseases leading to disablement

166

1.27

0.43

1.5

1.4

21.87

41.32

mu/l

1.22

150

Other benign neoplasm of uterus: Other parts/unspecified

185

0.75

0.43

1.3

1.4

22.18

43.55

mu/l

1.01

162

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

405

1.16

0.43

1.2

1.4

49.40

63.13

mu/l

0.40

359

Specific developmental disorder of motor function

1.43

0.42

1.8

44.35

278.93

mu/l

—

Tooth eruption problems

550

1.14

0.42

2.0

1.8

107.19

58.68

mu/l

0.53

505

Cleft lip, lip and palate or palate

1.41

0.42

1.3

1.2

17.43

46.24

mu/l

—

Benign neoplasm: other/unspecified salivary gland

0.63

0.42

1.3

1.2

77.18

47.32

mu/l

—

Malignant neoplasm of retroperitoneum and peritoneum, excluding all cancers (controls excluding all cancers)

1.44

0.42

1.1

1.3

323.13

51.73

mu/l

—

Intentional self-harm by sharp object

1.43

0.41

1.0

1.4

33.19

49.42

mu/l

—

Mandibular retrognathia AND surgery (BSSRO)

1.36

0.41

3.7

1.4

104.44

48.21

mu/l

0.70

Cerebral palsy

1.36

0.41

1.0

1.2

21.86

51.08

mu/l

—

Other specified/unspecified deforming dorsopathies

1.36

0.41

1.6

1.3

17.85

43.66

mu/l

—

Lyme disease

122

1328

0.92

0.41

1.3

1.4

76.27

53.95

mu/l

0.51

108

1185

Retinal breaks without detachment

766

1.11

0.41

2.0

1.4

68.55

61.35

mu/l

0.12

688

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

154

854

1.08

0.41

1.8

1.3

82.00

73.44

mu/l

0.16

134

757

Coronary artery bypass grafting

131

917

1.09

0.40

1.2

1.5

128.01

51.63

mu/l

1.73

113

808

Subacute thyroiditis

150

1.27

0.40

1.9

1.4

204.92

45.90

mu/l

1.02

135

Dental caries 1 and operation codes, only avohilmo

181

847

1.07

0.39

1.6

61.77

61.01

mu/l

0.02

156

776

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

589

1.12

0.39

1.4

1.3

149.47

70.16

mu/l

0.86

519

Other spirochaetal diseases

124

1346

0.92

0.39

1.3

1.4

75.11

54.77

mu/l

0.47

110

1200

Right hemicolectomy

205

1.22

0.39

1.0

1.3

52.90

50.21

mu/l

0.05

177

Deep endometriosis

447

1.14

0.38

1.6

1.5

66.13

46.14

mu/l

0.34

398

Glucosamine medication

296

2244

1.05

0.37

1.4

49.90

56.42

mu/l

0.37

258

1977

Sequelae of other and unspecified infectious and parasitic diseases

225

1.20

0.37

1.7

1.4

71.76

53.45

mu/l

0.26

202

Parkinson's disease, strict definition

572

1.12

0.37

1.2

1.4

36.91

62.02

mu/l

1.14

505

Cytomegalovirus infection, IBD co-morbidity

1.29

0.36

1.7

1.2

63.33

48.72

mu/l

—

Unspecified urinary incontinence

365

1.15

0.36

1.5

1.3

44.74

35.95

mu/l

0.32

317

Hydrocele

431

1.14

0.36

1.3

1.4

42.87

77.85

mu/l

0.99

382

Viral haemorrhagic fevers, not elsewhere classified/unspecified

328

1.16

0.36

1.3

1.4

56.29

56.10

mu/l

0.00

293

Lung diseases due to external agents

526

1.12

0.35

2.1

1.4

51.78

66.85

mu/l

0.49

466

LSIL lesion of the cervix uteri

479

1.13

0.35

2.4

1.6

79.46

46.38

mu/l

0.57

440

Toxic effects of substances chiefly nonmedicinal as to source

479

1.13

0.35

1.5

47.52

56.66

mu/l

0.24

427

Other specified disorders of external ear

126

1.27

0.35

1.3

34.23

50.56

mu/l

0.37

116

Injuries to the hip and thigh

254

2209

1.05

0.34

1.5

1.4

49.49

61.44

mu/l

0.78

223

1953

Other disorders of breast and lactation associated with childbirth

1.34

0.34

3.5

1.3

24.63

41.29

mu/l

—

Pregnancy, childbirth and the puerperium

162

905

0.94

0.33

1.4

1.7

33.50

45.46

mu/l

0.80

147

805

Overjet

1.34

0.33

2.7

1.5

43.93

61.75

mu/l

0.47

Mixed conductive and sensorineural hearing loss

530

1.11

0.32

1.5

1.4

27.55

61.98

mu/l

2.45

475

Fourth [trochlear] nerve palsy

1.36

0.32

1.4

1.3

25.16

48.95

mu/l

—

Migraine without aura, drug-induced

1.28

0.32

1.8

1.3

296.45

56.58

mu/l

—

Traumatic ischaemia of muscle

1.28

0.32

1.7

1.2

96.87

45.37

mu/l

—

Routine general health check-up of defined subpopulation

1.36

0.32

1.2

1.4

18.51

31.70

mu/l

—

Endometriosis ASRM stages 3,4

131

1226

1.07

0.30

1.4

1.6

57.58

50.86

mu/l

0.21

120

1103

Other malignant neoplasms of skin (=non-melanoma skin cancer)

297

2247

1.04

0.29

1.4

30.82

60.45

mu/l

8.36

253

1990

Basal cell carcinoma

305

2331

1.04

0.29

1.4

29.16

59.62

mu/l

9.51

261

2056

Other mental disorders due to brain damage and dysfunction and to physical disease

449

1.11

0.29

1.8

1.4

85.65

61.72

mu/l

0.17

392

Arthropod-borne viral fevers and viral haemorrhagic fevers

411

1.12

0.29

1.3

1.4

50.91

52.78

mu/l

0.04

362

Use of levodopa decarboxylase inhibitor

536

1.10

0.28

1.3

1.4

27.21

64.42

mu/l

3.03

468

Embedded and impacted teeth

111

1009

0.93

0.27

2.0

1.8

85.73

55.11

mu/l

0.60

101

921

ILD, hospital admissions 3, with pneumonia sepsis

301

0.86

0.27

1.3

35.69

70.26

mu/l

1.26

261

Other interventions on the root canals of the tooth

1.25

0.27

1.1

1.2

29.75

50.40

mu/l

—

Pregnancy examination and test

526

1.08

0.27

1.9

2.0

51.20

43.33

mu/l

0.26

486

Barrett oesophagus

177

1.19

0.27

1.3

1.4

41.62

47.68

mu/l

0.09

153

Follow-up care involving plastic surgery

172

0.81

0.27

1.4

26.30

46.72

mu/l

—

153

Basal cell carcinoma, including avohilmo

313

2371

1.04

0.27

1.4

28.98

59.78

mu/l

9.99

266

2096

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

100

777

1.07

0.27

1.4

1.3

118.52

61.04

mu/l

0.86

686

Persistent delusional disorders

309

1.13

0.27

1.3

1.4

22.86

50.01

mu/l

1.56

274

Other disorders of cornea

404

1.12

0.26

1.7

1.5

59.79

46.48

mu/l

0.32

361

Struck by thrown, projected or falling objec

171

0.82

0.26

2.1

1.4

85.11

61.29

mu/l

0.26

151

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

233

1741

1.04

0.25

1.4

1.3

92.05

60.61

mu/l

0.74

206

1545

Other benign neoplasm of uterus: Other parts/unspecified

170

0.82

0.25

1.3

22.18

31.59

mu/l

0.51

146

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

116

915

1.06

0.25

1.4

1.3

103.79

57.96

mu/l

0.79

807

ILD, hospital admissions

608

1.09

0.24

1.3

1.4

51.19

59.71

mu/l

0.22

527

Impacted teeth

719

1.07

0.24

1.8

76.84

56.18

mu/l

0.32

652

Bilateral sagittal split ramus osteotomy operation

124

1.21

0.24

3.4

1.4

98.10

41.46

mu/l

0.87

114

Primary open-angle glaucoma

154

1427

1.05

0.24

1.3

1.4

41.75

58.21

mu/l

1.11

135

1253

Dementia in other diseases classified elsewhere

152

1.19

0.23

1.3

77.59

46.63

mu/l

0.34

131

Burns and corrosions

629

1.08

0.23

1.4

1.5

50.83

58.87

mu/l

0.31

564

All dysplastic lesions of the cervix uteri, vagina or vulva

156

1476

1.05

0.23

2.1

1.7

58.64

53.55

mu/l

0.12

143

1339

Malignant neoplasm of colon

630

0.92

0.23

1.3

1.4

79.08

59.27

mu/l

0.27

551

Pedal cyclist injured in noncollision transport accidents

495

1.09

0.23

1.7

1.5

83.16

50.93

mu/l

0.44

440

Other interstitial pulmonary diseases

611

1.08

0.23

1.3

1.4

51.19

59.30

mu/l

0.21

532

Memory loss

371

1.11

0.22

1.8

1.3

99.77

58.40

mu/l

0.31

323

Golimumab

125

1.20

0.22

1.5

1.4

33.68

45.46

mu/l

0.47

112

Sixth [abducent] nerve palsy

116

1.21

0.22

1.3

15.25

46.97

mu/l

2.37

107

Benign neoplasm: Other and unspecified parts of mouth

135

0.81

0.22

1.5

1.3

63.12

58.83

mu/l

0.04

118

Schizophrenia

768

1.07

0.21

1.2

1.6

49.43

61.28

mu/l

0.26

702

Use of riluzole

0.00

0.21

0.0

1.2

—

14.52

—

Actinomycosis

0.00

0.21

0.0

1.1

—

19.29

—

Lichen planus, including avohilmo

914

1.06

0.21

1.8

1.4

43.81

57.72

mu/l

0.81

811

DVT of lower extremities

914

1.06

0.21

1.4

52.53

57.89

mu/l

0.16

823

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

459

1.09

0.21

1.2

1.3

87.66

58.96

mu/l

0.35

404

Traumatic amputation of wrist and hand

154

1.17

0.21

1.3

1.4

48.34

51.73

mu/l

0.05

132

Interstitial lung disease

615

1.07

0.20

1.3

1.4

51.19

59.11

mu/l

0.21

534

Interstitial lung disease endpoints

615

1.07

0.20

1.3

1.4

51.19

59.11

mu/l

0.21

534

Hepatocellular carcinoma

1.25

0.20

1.0

1.3

564.60

36.32

mu/l

—

Alzheimer’s disease (undefined)

0.00

0.20

0.0

1.1

—

18.33

—

Bacterial pneumoniae

218

1861

1.04

0.20

1.3

1.4

82.74

61.79

mu/l

0.59

190

1639

Dental caries 2

489

3933

0.98

0.20

1.6

55.67

66.34

mu/l

0.52

438

3540

LeFortI or BSSRO operation

155

1.16

0.20

3.3

1.5

82.99

43.92

mu/l

0.65

142

Malignant neoplasm of testis

1.18

0.19

1.3

46.53

48.59

mu/l

—

Primary open-angle glaucoma, strict

126

1199

1.05

0.19

1.3

1.4

45.39

59.65

mu/l

0.70

109

1048

Lichen ruber planus, wide definition including periferal and oral lichen planus

114

1085

1.05

0.19

1.8

1.4

51.70

56.97

mu/l

0.23

102

965

Malignant neoplasm of head and neck

318

1.10

0.18

1.2

1.4

41.89

74.68

mu/l

1.01

281

Maternal care for other known or suspected fetal problems

125

765

1.05

0.18

1.9

37.06

50.41

mu/l

1.02

112

702

Other meningitis

1.21

0.18

1.6

1.2

66.24

37.32

mu/l

—

Other/unspecified cytomegaloviral diseases

1.13

0.17

1.7

1.3

80.21

52.15

mu/l

—

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

1.22

0.17

1.0

1.3

114.08

59.00

mu/l

—

Other assisted single delivery

1.11

0.17

1.1

2.0

22.30

55.37

mu/l

—

Schizoid personality disorder

1.14

0.16

1.3

1.2

40.17

56.01

mu/l

—

Benign neoplasm: Other and unspecified parts of mouth

130

0.84

0.16

1.5

1.4

63.12

57.98

mu/l

0.04

115

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

1.10

0.15

1.1

1.3

5.55

49.62

mu/l

—

Multiple myeloma

1.10

0.15

1.1

1.3

5.55

49.62

mu/l

—

Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)

130

1.16

0.15

1.3

228.94

49.06

mu/l

0.46

119

Torsion of testis

0.77

0.15

2.0

1.6

69.93

63.56

mu/l

—

conjunctival degenerations and deposits

0.75

0.15

3.7

1.3

34.37

41.75

mu/l

—

Obstructed labour due to maternal pelvic abnormality

831

0.95

0.15

1.5

70.79

46.89

mu/l

0.53

747

Benign neoplasm: Lip

1.13

0.15

1.3

11.12

49.59

mu/l

—

Benign neoplasm: Lip

1.10

0.15

1.3

11.12

51.47

mu/l

—

Retinal detachment with retinal break

566

1.06

0.14

1.8

1.4

53.71

64.59

mu/l

0.30

503

Disturbances of smell and taste

171

0.88

0.14

1.5

1.4

67.36

51.05

mu/l

0.15

155

Pterygium

1.18

0.14

1.8

1.3

42.54

52.54

mu/l

0.17

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

664

1.05

0.14

1.5

1.3

66.57

66.28

mu/l

0.00

586

Colon adenocarcinoma

469

1.07

0.14

1.2

1.4

87.66

64.39

mu/l

0.27

409

Dental caries 2 and operation codes

481

3890

0.98

0.14

1.6

56.33

66.15

mu/l

0.46

431

3503

Other benign neoplasms of uterus

227

1.10

0.14

1.2

1.3

52.39

38.05

mu/l

0.20

198

Benign neoplasm of breast

577

1.06

0.14

1.7

1.4

51.53

54.57

mu/l

0.07

514

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

519

1.06

0.13

1.3

49.03

65.94

mu/l

0.63

460

Non-small cell lung cancer, adenocarcinoma

219

1.10

0.12

1.0

1.3

108.10

59.32

mu/l

0.38

188

Non-small cell lung cancer, adenocarcinoma, helper endpoint

219

1.10

0.12

1.0

1.3

108.10

59.32

mu/l

0.38

188

Secondary uncertain malignant neoplasm

519

0.94

0.12

1.5

1.4

76.91

63.48

mu/l

0.10

460

Bacterial pneumonia, not elsewhere classified

203

1751

1.03

0.12

1.3

1.4

81.91

62.98

mu/l

0.48

179

1543

Primary coxarthrosis, bilateral

144

1399

1.03

0.11

1.4

1.3

75.50

57.15

mu/l

0.54

125

1241

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

394

0.94

0.11

1.3

1.4

39.82

69.03

mu/l

1.30

352

Colorectal cancer

100

1034

0.97

0.10

1.3

1.4

62.81

58.85

mu/l

0.07

914

Bacterial pneumonia (organism specified)

229

2045

1.02

0.09

1.3

1.4

81.72

64.07

mu/l

0.49

199

1799

Squamous cell neoplasms and carcinomas of the skin

432

0.95

0.09

1.2

1.3

31.45

60.17

mu/l

1.99

371

malignant neoplasm of male genital organs

192

1193

1.02

0.09

1.8

1.3

80.92

70.36

mu/l

0.24

167

1050

Failed induction of labour

213

1.08

0.09

2.4

1.9

25.79

42.28

mu/l

1.66

189

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

832

1.03

0.09

1.2

1.3

68.65

59.65

mu/l

0.16

739

Superficial injury of neck

1.09

0.09

1.0

1.2

28.95

55.21

mu/l

—

Hypersensitivity pneumonitis due to organic dust

1.07

0.08

2.2

1.2

61.12

43.04

mu/l

—

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

577

1.04

0.08

1.2

1.3

52.96

68.61

mu/l

0.46

508

Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

1.05

0.08

1.3

1.5

46.53

64.42

mu/l

—

Toxic effect of carbon monoxide

1.03

0.08

1.2

1.3

34.57

56.58

mu/l

—

Tuberculosis

214

1.08

0.08

1.5

1.3

21.77

61.44

mu/l

2.40

185

Orthopaedic devices associated with adverse incidents

0.82

0.08

1.0

1.3

18.46

48.89

mu/l

—

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

262

1739

0.98

0.08

1.4

1.5

55.74

52.67

mu/l

0.11

232

1565

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

262

1739

0.98

0.08

1.4

1.5

55.74

52.67

mu/l

0.11

232

1565

Malignant neoplasm of prostate

185

1146

1.02

0.07

1.8

1.3

82.66

70.13

mu/l

0.29

160

1015

Vascular dementia (undefined)

1.09

0.07

1.4

1.1

37.36

71.03

mu/l

—

Disorders of globe

0.85

0.07

2.1

1.3

59.74

34.84

mu/l

—

Premature rupture of membranes

106

798

0.98

0.07

2.2

1.8

50.62

52.63

mu/l

0.07

729

Malignant neoplasm of rectum

377

0.95

0.07

1.4

43.07

71.12

mu/l

1.18

335

Suppurative otitis media, unspecified

1.05

0.07

1.3

1.4

44.24

55.56

mu/l

—

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

124

1169

1.02

0.06

1.4

84.39

50.18

mu/l

1.02

110

1046

Other benign neoplasms of uterus

237

1.06

0.05

1.2

1.3

52.39

40.83

mu/l

0.16

207

Unspecified dementia

274

0.95

0.05

1.0

1.3

53.85

51.55

mu/l

0.04

232

Diffuse brain injury

1.10

0.04

2.3

1.5

44.32

35.61

mu/l

—

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

229

1.05

0.04

1.0

1.3

108.10

72.69

mu/l

0.25

208

Benign neoplasm of breast

597

1.02

0.03

1.7

1.5

51.53

52.66

mu/l

0.02

534

Toxic effect of ethanol

139

0.93

0.03

2.4

1.4

23.16

47.28

mu/l

1.70

124

Coxarthrosis, primary, with hip surgery

243

2321

0.99

0.03

1.4

46.43

56.74

mu/l

0.69

217

2049

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

399

1.03

0.03

1.2

1.3

31.45

59.30

mu/l

1.66

349

All dysplastic lesions of the cervix uteri

125

1262

0.99

0.03

2.2

1.8

50.56

55.47

mu/l

0.14

116

1159

Single delivery by caesarean section

109

622

1.01

0.03

1.7

2.0

40.51

56.82

mu/l

1.23

101

560

Adenocarcinoma and papilloma adenocarcinoma of rectum

380

0.97

0.03

1.3

1.4

39.82

71.12

mu/l

1.40

339

Non-follicular lymphoma, hilmo, excluding all cancers

380

1.03

0.02

1.3

48.75

63.58

mu/l

0.34

337

Colorectal adenocarcinoma

848

1.01

0.02

1.2

1.4

68.65

57.05

mu/l

0.21

748

Myocardial infarction, unclassifiable

748

1.01

0.02

1.2

1.4

63.12

71.24

mu/l

0.18

656

Other predominantly sexually transmitted diseases, not elsewhere classified

819

1.01

0.02

2.0

1.8

62.07

57.67

mu/l

0.09

743

malignant neoplasm of female genital organs

739

0.99

0.01

1.2

1.4

40.60

46.86

mu/l

0.31

652

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

383

1.02

0.01

1.3

46.08

64.57

mu/l

0.65

341

HSIL lesion of the cervix uteri, vagina or vulva

943

1.01

0.01

1.9

1.7

30.84

50.52

mu/l

2.41

860

Maternal care for known or suspected malpresentation of fetus

666

1.01

0.00

2.0

1.9

57.36

52.17

mu/l

0.15

608

Non-follicular lymphoma

384

1.02

0.00

1.3

1.4

48.75

67.57

mu/l

0.45

340

Burns and corrosions of external body surface, specified by site

464

1.01

0.00

1.3

1.5

53.35

54.94

mu/l

0.04

412

ILD, hospital admissions 1, main diag only

556

0.99

0.00

1.3

1.4

50.18

62.75

mu/l

0.32

483

Superficial injury of shoulder and upper arm

467

1.01

0.00

1.2

1.5

52.13

47.56

mu/l

0.09

414

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

395

0.99

0.00

1.3

46.08

63.28

mu/l

0.60

351

Undefined dementia

269

0.99

0.00

1.0

1.3

53.85

53.71

mu/l

0.00

225

Transient global amnesia

426

1.01

0.00

1.3

37.44

44.83

mu/l

0.28

369

Impacted cerumen

404

0.99

0.00

1.7

1.4

144.64

54.86

mu/l

0.60

353

Retained placenta and membranes, without haemorrhage

621

1.00

0.00

1.6

90.99

44.51

mu/l

0.63

561

Motor- or nonmotor-vehicle accident, type of vehicle unspecified - non-traffic accident

0.00

0.0

1.2

—

21.42

—

Other drug-induced osteomalacia in adults

0.00

0.0

1.0

—

24.18

—

Tuberculosis of nervous system

0.00

0.0

1.2

—

22.02

—

Lipodystrophy, not elsewhere classified

0.00

0.0

1.0

—

22.17

—

Erythrasma

0.00

0.0

1.1

—

13.50

—

Contact with lifting and transmission devices, not elsewhere classified

0.89

0.00

1.3

25.03

60.32

mu/l

—

Disorders of olfactory nerve

0.00

0.0

1.0

—

15.54

—

Injury of blood vessels at ankle and foot level

0.00

0.0

1.2

—

20.52

—

Hypotony of eye

0.00

0.0

1.0

—

15.64

—

Other disorders of skin and subcutaneous tissue related to radiation

0.00

0.0

1.0

—

14.92

—

Other injuries involving multiple body regions, not elsewhere classified

0.00

0.0

1.0

—

15.02

—

Other and unspecified nail disorders

0.99

0.00

1.9

1.4

6.00

46.23

mu/l

—

Benign neoplasm of mesothelial tissue

0.00

0.0

1.0

—

12.26

—

Injury of muscle and tendon at ankle and foot level

0.99

0.00

1.0

1.4

195.58

45.24

mu/l

—

Café au lait spots

0.00

0.0

1.2

—

31.94

—

Exposure to electric transmission lines

0.00

0.0

1.0

—

19.08

—

Malignant neoplasm of liver and intrahepatic bile ducts

0.93

0.00

1.1

1.2

433.96

47.34

mu/l

—

Accidental poisoning by and exposure to alcohol

0.91

0.00

4.4

1.3

50.06

34.03

mu/l

—

Malignant neoplasm of accessory sinuses

0.00

0.0

1.1

—

16.81

—

Intentional self-harm by jumping or lying before moving object

0.00

0.0

1.0

—

24.11

—

Pedestrian injured in collision with car, pick-up truck or van

1.01

0.00

1.1

1.3

16.69

43.57

mu/l

—

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

0.93

0.00

1.0

1.3

9.20

36.28

mu/l

—

Toxic encephalopathy

0.00

0.0

1.6

—

10.54

—

Mucinosis of skin

0.00

0.0

1.2

—

17.80

—

Other crystal arthropathies

0.97

0.00

1.2

85.80

54.61

mu/l

—

Craniosynostosis EXCLUDE syndromes

0.00

0.0

1.4

—

40.98

—

Problems related to social environment

0.90

0.00

1.9

1.4

23.46

42.57

mu/l

—

Benign neoplasm: Peripheral nerves and autonomic nervous system

1.00

0.00

1.7

1.2

19.22

55.65

mu/l

—

Thyroid crisis or storm

0.00

0.0

1.0

—

15.66

—

Digeorge syndrome

0.00

0.0

1.2

—

1686.02

—

Organ-limited amyloidosis

0.00

0.0

1.2

—

28.22

—

Drug-induced acute pancreatitis

0.00

0.0

1.1

—

33.04

—

Hypoplasia of dental enamel, prenatal

0.00

0.0

1.7

—

1221.79

—

Sphingolipidosis, other/unspecified

0.00

0.0

1.0

—

21.16

—

Chronic postrheumatic arthropathy [Jaccoud]

0.00

0.0

1.0

—

25.70

—

Kidney diseases associated to Fabry's disease

0.00

0.0

1.0

—

22.15

—

Beta thalassaemia

0.00

0.0

1.2

—

10.98

—

Other conditions originating in the perinatal period

0.00

0.0

1.8

—

45.96

—

Disorders of muscle in diseases classified elsewhere

0.00

0.0

1.2

—

14.44

—

Microcephaly

0.00

0.0

1.8

—

1701.38

—

Polydactyly

0.00

0.0

1.0

—

23.67

—

Turner's syndrome

0.00

0.0

1.0

—

38.52

—

Other congenital malformations of eye

0.00

0.0

1.6

—

1685.48

—

Traumatic amputation of ankle and foot

0.00

0.0

1.2

—

21.42

—

Traumatic amputation of hip and thigh

0.00

0.0

1.2

—

13.14

—

Flexion deformity

0.00

0.0

1.1

—

14.31

—

Juvenile dermatomyositis

0.00

0.0

1.0

—

31.44

—

Brain glioblastoma and astrocytoma, excluding all cancers (controls excluding all cancers)

0.93

0.00

1.4

1.3

21.36

55.29

mu/l

—

Neuralgic amyotrophy

0.00

0.0

1.1

—

17.32

—

Constitutional tall stature

0.00

0.0

1.8

—

60.38

—

Chondrolysis

0.00

0.0

1.0

—

26.08

—

Induced delusional disorder

0.00

0.0

1.0

—

22.52

—

Nightmares

0.00

0.0

1.1

—

31.70

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Renin [Units/volume] in Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS